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Abstract 
Prion protein (PrP), doppel (Dpl) and Shadoo (Sho) encoded by the genes PRNP, 
PRND and SPRN, respectively, are suggested to be homologues, i.e. evolved from 
a common ancestor and, hence are grouped as the prion-protein family. PrP is 
associated with a group of diseases termed as spongiform encephalopathies. Dpl 
plays a role in spermatogenesis and Prnd knockout mice have been shown to be 
infertile. Sho is a recently discovered gene and although very little is known about 
its function, the current information suggests it is important in neural tube 
development (in zebrafish) and has a neuro-protective effect. There is very little 
information about these genes and their functions in lower vertebrates. A relatively 
large number of studies were undertaken to understand the transcriptional 
regulation of PRNP but very few for PRND. There have also been no studies to 
analyze the association of Dpl with human male infertility.  
During my PhD studies I have applied a variety of computational and experimental 
methods to elucidate the function and evolution of these genes, particularly, for 
PRNP and PRND, by identifying and characterizing them in various vertebrate 
lineages. Computational predictions were made by comparative sequence analysis 
to identify the transcription factors (TFs) involved in the regulation of PRNP and 
PRND. One of the key predictions for PRND was experimentally validated by 
functional studies. Single nucleotide polymorphisms (SNPs) in the PRND coding 
and promoter regions were analyzed in the human male infertile population.  
Genes of interest were identified and characterized in various vertebrate species 
(Xenopus species, chicken, Monodelphis domestica, and platypus). The results 
revealed the mechanisms of gene evolution, tissue subfunctionalization and protein 
sequence divergence for PrP and Dpl, which are a result of gene duplication. The 
sequences obtained were used for a range of comparative sequence analyses 
which revealed conserved residues likely to play a role in functional and structural 
stability.  
VII 
Using a comparative sequence method termed phylogenetic footprinting I identified 
conserved transcription factor-binding sites (TFBS), and, thus, putative 
mechanisms for the transcriptional regulation of these genes. These computational 
predictions were performed by developing an automated pipeline for high 
throughput analysis with an interactive web interface to analyze the results. Some 
of the predictions are consistent with known information about these genes, 
including already experimentally validated TFBSs. One of the most interesting 
TFBS predictions for PRND was that of Spz1 (spermatogenic zip) which was 
predicted in the core promoter of the gene. Functional studies revealed a 20-30% 
increase in the promoter activity in cells transfected with Spz1 expression plasmid. 
A 40-50% downregulation of the promoter activity was observed when the Spz1 
binding site was mutated. This suggests that Spz1 is a key TF and may influence 
the tissue-specific expression of PRND which is predominantly expressed in testis 
along with other experimentally validated ubiquitous TFs (USF-1 and NF-Y). 
SNP/mutation analysis was performed by sequencing the coding and promoter 
region of PRND among a sample of the human infertile male population (96 
samples) compared with a control population sample (healthy and fertile men) (96 
samples). The SNPs in the coding region corresponded with those that have 
already been reported. There is no published information on SNPs in the upstream 
region to the transcription start site of PRND. My studies revealed four SNPs in the 
-282 region. Interestingly, I found a SNP in the 3’ end of the core binding site of the 
USF-1 (G-171A) only in the control populations. The C521T polymorphism within 
the open reading frame of PRND showed different allele frequencies in the control 
and infertile populations in which the TT genotype was more common in the control 
than in the infertile population. However, it is difficult to draw definitive conclusions 
about the association of the allele frequencies with infertility due to the size of the 
dataset 
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1 Prion protein family: Introduction 
 
1.1 Prion protein family  
The term “prion” was coined by Stanley B. Prusiner - short for “proteinaceous 
infectious particle” (Prusiner 1982). The intriguing aspect of prions is that the 
infectious particle appears to lack nucleic acid. This is further supported by the fact 
that prions are resistant to ultraviolet and ionizing radiation (Alper et al. 1967; 
Adams 1991) and that prion protein is encoded by the host genome. However, this 
theory is still challenged by others (Manuelidis et al. 2007). The molecular basis for 
this disease is associated with conformational change of the normal cellular prion 
protein (PrPC) to a disease-associated form termed as scrapie (PrPSc). The main 
causation of disease is unclear  
Prion diseases are a group of diseases termed “transmissible spongiform 
encephalopathies” (Ryou 2007). As the term suggests, these diseases can be 
transmitted, both within the species and across species, although with more 
difficulty (species barrier). Prion diseases are termed differently according to the 
mammals affected (Table 1-1). Disease progression results in a sponge-like 
appearance of the affected brain (Figure 1-1) and ultimately death.  
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Figure 1-1 Longitudinal section of (a) normal human brain and (b) brain with spongiform 
encephalopathy. Image source  
a: http://faculty.washington.edu/alexbert/MEDEX/Fall/adcoronalb.jpg. 
b: http://www.neuropathologyweb.org/chapter5/chapter5ePrions.html 
Table 1-1 Prion diseases 
Species Disease 
Human Cruetzfeld-Jakob disease (CJD), variant CJD (vCJD), 
Gerstmann–Straüssler–Scheinker (GSS), kuru, fatal familial 
insomnia (FFI) 
Sheep Scrapie 
Cow Mad cow disease or bovine spongiform encephalopathy (BSE) 
Deer and elk Chronic wasting disease (CWD) 
Structural and sequence similarities to prion protein (Figure 1-2) of three different 
genes are used as the basis to group them as PrP family members (Moore et al. 
1999; Premzl et al. 2003). These genes are PRNP which encodes prion protein 
(PrP); PRND which encodes doppel (Dpl); and a gene recently discovered in my 
group, SPRN, which encodes the PrP-like protein, Shadoo (Sho) (Premzl et al. 
2003).  
a b 
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Figure 1-2 Protein sequence regions for PrP, Dpl and Sho (mouse). S, signal; B, basic; R, 
repeats; BR, basic repeats; H, hydrophobic; Sh, β-sheet; He, α-helix; S-S, disulphide bridge; CHO, 
N-glycan; GPI, GPI-anchor. The number indicates the sequence length. 
 
1.2 Prion protein 
1.2.1 Discovery of the gene coding for PrP 
The identification of a protease resistant PrP27-30 fragment which was present only 
in diseased individuals led to its isolation and purification (Bolton et al. 1982; 
Prusiner et al. 1982) The N-terminal region of purified PrP27-30 was sequenced to 
reveal 17 amino acid residues (Prusiner et al. 1984). The oligonucleotide probe 
designed from the N-terminal sequence was used to screen a hamster cDNA brain 
library which revealed the gene (Oesch et al. 1985). The full length cDNA was 
isolated by Basler et al. (1986) who also sequenced the PrP gene region 
characterizing its gene structure. They proposed for the first time that this gene 
lacked a TATA box and had a potential Sp1 binding site which are characteristic 
features of a house keeping gene.  This work established that PrP is encoded by 
the chromosomal gene and not by a nucleic acid within the prion. This gene was 
later designated as PRNP (Westaway et al. 1987). Despite its structural complexity 
and length (Figure 1-2), PRNP has an interesting organization in that the entire 
open reading frame (ORF) is contained within a (last) single exon though the entire 
gene comprises three exons (two exons in human and hamster).  
S-S2 
S-S1 
  S     B         Sh    He Sh       He  He          S    
CHO  CHO       GPI 
Dpl
PrP 
CHO  CHO     GPI 
 
1                                                                                       254   S-S1 
   S    B                R         B     H    Sh  He  Sh     He    He          S 
 
1                                                      147 
 CHO  GPI 
                  
  S      BR     B      H                       S    
Sho 
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1.2.2 Tissue expression 
Human: Expression of PRNP is highly regulated during cellular differentiation and 
embryonic development (Dodelet and Cashman 1998). PRNP mRNA is found in 
neurones of the hippocampus, cortex, thalamus, cerebellum and medulla 
(McLennan et al. 2001). PRNP has also been reported in the enteric nervous 
system (Shmakov et al. 2000). All mononuclear leucocyte subpopulations and 
platelets express PrPc, but polymorphonuclear leucocytes and red blood cells 
express little or none (Barclay et al. 1999). The presence of both the mRNA and 
the protein has been demonstrated in testicular tissue (Bendheim et al. 1992; Tanji 
et al. 1995). A recent study by Shaked et al. (1999) showed that PrP is also 
present on the membrane of sperm of different species, including humans. PrP has 
also been reported to be present on the surface of  blood cells (Cashman et al. 
1990).  
Mice: PrP may have a role in neural tube development as it has been detected 
throughout the developing neural tube from 13.5 days of development in mouse 
embryos. It continues to be expressed in the adult brain, and is detected in the 
pyramidal and dentate granular cells of the hippocampus, Purkinje cells of the 
cerebellum and in large neurones of the cortex, medulla and septum 
(Kretzschmaret al., 1986; Manson et al., 1992). This suggests that PrP may be 
critical to neural function in the mammalian central nervous system. The pyramidal 
neurons of the hippocampus take part in the learning and memory process. 
Prnp is also expressed at variable levels in different tissues (Prnp mRNA was 
detected at different levels in all tissues tested with the exception of kidney and 
liver) with the highest amount in brain (Ford et al. 2002; Miele et al. 2003). On a 
cellular level, Prnp was shown to be expressed in astrocytes and oligodendrocytes. 
PrPSc accumulates in astrocytes and other glial cells and later the misfolded 
isoform diffuses into other tissues (Moser et al. 1995). 
Hamster: Tissue expression patterns in hamster indicate high concentrations of 
PrP in the brain. In non-neuronal hamster tissues, PRNP mRNA has been detected 
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in circulating leukocytes, heart, skeletal muscle, lung, intestinal tract, spleen, testis, 
ovary, and some other organs (Bendheim et al. 1992).  
Chicken: PrP is widely expressed in cholinergic and non-cholinergic neurons in the 
adult central nervous system and spinal cord. Using in situ hybridization 
experiments, the mRNA was detected as early as embryonic day 6 in brain, spinal 
chord, retina, intestine, and heart (Harris et al. 1993). 
Sheep: Apart from the neuronal tissues, PrP is expressed in several non-neuronal 
tissues in sheep, including spleen, lymph node, lung, heart, kidney, skeletal 
muscle, uterus, adrenal gland, parotid gland, intestine, proventriculus, abomasum 
and mammary gland. However, it was not detected in the liver (Horiuchi et al. 
1995). 
1.2.3 Structure and properties of cellular and scrapie prion protein 
PrP is a relatively short protein comprising if 254 amino acids in mouse. The 
characteristic features of this protein include (Figure 1-2) one disulphide bridge, 
two N-glycosylation sites in the C-terminal domain, an N-terminal basic region, and 
an N-terminal repeat region. The N-terminal repeat region varies in both repeat 
length (8 amino acids in mouse repeated 5 times) and sequence among various 
mammalian species and higher vertebrates (marsupials, birds, reptile). However, 
this region is totally missing in amphibian (Strumbo et al. 2001). The most 
remarkable feature is the highly conserved middle hydrophobic sequence. The N-
terminal and C-terminal ends contain signal sequences. The N-terminal signal 
sequence is an endoplasmic reticulum targeting signal peptide, (Hope et al. 1986), 
and the C-terminal signal peptide is replaced with a GPI-anchor (Stahl et al. 1987). 
Both the signal peptides are cleaved in the mature protein which consists of amino 
acid residues 23-231.  According to solution NMR structure analysis of PrPC, the 
N-terminal domain is highly flexible and lacks a definitive secondary structure (Riek 
et al. 1997) and the C-terminal domain folds to form a globular domain (Riek et al. 
1996) (Figure 1-3a). The latter comprises three helices and a pair of short β-
strands with a single disulphide bond. This is in contrast with low-level structural 
information of PrPSc as determined by Fourier transform infrared spectroscopy 
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(Gasset et al. 1993) which shows it is rich in β-sheet (54% β-sheet and 25% α-
helix). Though these two forms of protein are encoded by the same gene, their 
molecular properties are very different (Table 1-2). 
Table 1-2 Comparison between cellular and scrapie prion protein 
PrPC PrPSc 
Secondary structural units 
comprising the C-terminal domain: 
High α-helix content (40%) 
High in β-sheet (54%) 
Present on the cell surface Accumulates within the cells (lysosomes 
or endosomes) 
Molecular weight of full length 
protein: 30-35 kda 
Molecular weight: 30-35 kda 
Digested completely when treated 
with protease 
Incomplete digestion leading to a 
fragment of 27-30 kda (PrP27-30) 
Encoded by host chromosomal 
gene PRNP 
Encoded by host chromosomal gene 
PRNP 
Soluble in detergent Insoluble 
 
1.2.4 Functions of PrP 
The normal functions of PrP are not well understood despite considerable efforts to 
elucidate them. The studies carried out to date suggest that PrP may perform a 
large range of normal functions. 
1.2.4.1 Knockout mouse studies 
Prnp ablation studies (confined to the coding regions) which were performed to 
study the normal functions of the gene produced mice which appeared 
developmentally and behaviorally normal  (Bueler et al. 1992; Manson et al. 1994). 
Changes in membrane localization of nitric oxide synthase were observed in some 
of the Prnp knockout mice (Ovadia et al. 1996). Other Prnp knockout mice showed 
minor phenotypic defects, however, the cerebellar cells displayed increased 
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sensitivity for copper toxicity (Brown et al. 1998). All these features are also 
characteristic of scrapie-infected animals (Keshet et al. 1999). The phenotypic 
differences observed between different knockout studies has been attributed to the 
strategy used for creating the knockout mice (Weissmann and Flechsig 2003). 
Loss of PrP function in knockout mice may have been compensated by adaptive 
mechanisms operative in embryo masking any effect (Mallucci et al. 2002). To 
overcome this possibility, a post-natal knockout experiment was designed (Mallucci 
et al. 2002). These studies concluded that post-natal loss of PrP in adult neurons 
has no detrimental sequelae (Mallucci et al. 2002). However, the main observation 
from these studies is alteration in the hippocampal CA1 (Cornu Ammonis1) 
properties (Mallucci et al. 2002). 
Mice devoid of PrP did not develop prion disease (Bueler et al. 1993).  
1.2.4.2 Effects on learning, memory and synaptic functions 
Based on the Prnp knockout mice studies, it was demonstrated that PrPC is 
involved in learning and memory (Nishida et al. 1997). Impairment of long-term 
potentiation, a form of synaptic plasticity thought to be important for memory 
formation, was observed in some of the knockout mice using electrophysiological 
studies (Collinge et al. 1994). 
Some of the Prnp knockout mice showed minor neurophysiological effects which 
included defects in synaptic (Collinge et al. 1994; Manson et al. 1995) and 
hippocampal and normal synaptic function (Colling et al. 1995). It has been 
proposed that synaptic proteins play a role in Alzheimer’s disease and other 
neurodegenerative disease (Masliah 2001). This is of some interest as PrP is one 
of the synaptic proteins. PRNP was shown to be overexpressed in neuritic plaques 
seen in Alzheimer’s disease (Ferrer et al. 2001). 
It has also been demonstrated through the knockout mice studies that PrPC is 
involved in circadian rhythm (Tobler et al. 1996). 
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1.2.4.3 Antioxidant activity and copper binding 
The octarepeats of PrP bind copper ions and may play a role in oxidative stress 
(Hornshaw et al. 1995; Brown et al. 1997), as evidenced by the fact that the Prnp 
knockout mice neurons were found to be more vulnerable to oxidative stress 
(Brown et al. 1997). Based on these observations, it was proposed that PrP may 
play a role in the modulation of neuronal excitability (Brown et al. 1998). PrPc has 
also been found to be involved in the regulation of presynaptic copper 
concentration  (Herms et al. 1999). This may help explain why prion diseases are 
connected with a dramatic loss of antioxidant defense, where the presence of the 
abnormal protein during prion disease causes a failure of cellular antioxidant 
defense (Brown 2005). It was also speculated that PrPc, due to its multiple copper-
binding sites may function by activating a copper-dependent antioxidant enzyme 
such as superoxide dismutase (Brown et al. 1997; Brown et al. 1999). However, 
the in vivo studies show that the role of PrPc as a dismutase itself is not significant 
(Hutter et al. 2003).   
A protective role against copper-induced damage has been suggested for PrP in 
mouse spermatozoa (Shaked et al. 1999).  
1.2.4.4 Other functions 
PrPc is also involved in the regulation of intracellular calcium concentrations 
(Colling et al. 1996), activation of lymphocytes (Mabbott et al. 1997), signal 
transduction (Mouillet-Richard et al. 2000; Bounhar et al. 2001; Spielhaupter and 
Schatzl 2001; Chiarini et al. 2002) and has antioxidant and antiapoptotic properties 
(Bounhar et al. 2001).  
PrPc may play a role in skeletal muscle physiology (Massimino et al. 2006). It has 
been demonstrated that transgenic mice over expressing wild-type PrP develop 
skeletal muscle, peripheral nerve and central nervous system degeneration 
(Westaway et al. 1994). PrPc may also help in the differentiation of human 
leukocytes (Dodelet and Cashman 1998). 
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Some of these functions may be disrupted by the conversion of PrPc to PrPSc. 
A number of PrP-binding proteins have been identified and a possible disruption to 
these interactions in prion disease may be one of the contributing factors for the 
pathogenesis. These binding proteins include: antiapoptotic protein Bcl2 
(Kurschner and Morgan 1995), caveolin (Gorodinsky and Harris 1995; Harmey et 
al. 1995), the laminin receptor precursor (Rieger et al. 1997), plasminogen (Fischer 
et al. 2000) and N-CAMs (neural cell adhesion molecules) (Schmitt-Ulms et al. 
2001). 
Nerve growth factor (NGF) was shown to regulate the expression of the PrP gene 
in early post natal development (Mobley et al., 1988). NGF plays a role in CNS, 
sensory and sympathetic neuronal survival (Williams et al., 1986; Kromer, 1987).  
1.2.5 The prion disease process 
The uniqueness of prion diseases from other neurodegenerative diseases like 
Alzheimer’s and Parkinson’s disease is its transmissible nature. The spread of 
Kuru, a form of human prion disease, was attributed to a cannibalistic ritualism 
among a tribe in Papua New Guinea; this stopped after the ban of the ritual in 1958 
(by the Australian authorities) (Mead et al. 2003). However, owing to the long 
incubation period of the prion disease, some fresh cases are still being reported. 
This was the first evidence of human-to-human spread, providing the impression of 
an infectious disease. However, there were also indications of a genetic basis for 
this disease from clusters of cases in families, the first characterized being familial 
Creutzfeldt - Jakob disease (CJD), which were attributed to mutations in the PRNP 
gene. Known familial prion diseases; Gerstmann-Sträussler-Scheinker (GSS), 
CJD, and fatal familial insomnia (FFI); have been linked to mutations on this gene 
(Table 1-3). Among the human prion diseases, however, the most prevalent form is 
sporadic CJD where the actual cause is unknown. It was proposed that this form of 
the disease may be caused by spontaneous somatic mutation in the PRNP gene 
(Prusiner 1989) or by a spontaneous post-translational conformational change 
(Aguzzi 2006). There have been reported cases of iatrogenic CJD caused by 
corneal transplantation, EEG electrode implantation or by contaminated surgical 
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instruments, dura mater grafts, and pericardium grafts. Patients on human growth 
hormone therapy prior to 1982 are also of greater risk of CJD infection as it was 
derived from pituitary glands of cadavers. Variant CJD (vCJD) was first described 
in the United Kingdom in 1996. The disease is strongly linked to the consumption 
of cattle products infected with the prions that causes BSE, or mad cow disease. 
Table 1-3 Familial prion disease (Ironside 1998). 
Class of prion disease Reported mutation 
Creutzfeldt-Jakob disease E200K, D178N, V210I, V180I, T183A, 
H208R, M232R 
Gerstmann-Straussler-Scheinker P102L, A117V, P105L, Y145STOP, 
F198S, Q217R 
Fatal familial insomnia D178N in combination with a 
polymorphism of Met at position 129 
Prion disease begins with the conversion of PrPc to PrPSc by formation of a 
PrPc/PrPSc complex (Prusiner et al. 1990). There is evidence implicating the N-
terminal repeats and the hydrophobic region in facilitating the conformational 
change (Smith et al. 1997; Prusiner 1998). Although by NMR studies it was shown 
that the region up to the hydrophobic region is disordered, the protease resistant 
core of PrPSc includes the hydrophobic region (Huang et al. 1995). The interaction 
between PrPC and PrPSc and conversion to PrPSc is also facilitated by other protein 
molecules (Kocisko et al. 1994). The misfolded isoform, PrPSc, is an infectious 
form, capable of horizontal transmission of the disease, although a species barrier 
exists for the transmission of the disease. This barrier is associated with the amino 
acid sequence at a specific region, which may influence the interaction between 
PrPc and PrPSc (Scott et al. 1989).  
As the majority of Prnp, knockout mice did not show phenotypic or behavioral 
changes, it seems likely that the lack of PrP function is not the primary cause of the 
symptoms seen in the prion disease. This suggests that some cellular process or 
processes are being impaired by the accumulation of PrPSc. It has also been 
shown that the amount of PrPSc is directly related to the onset but not the severity 
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or state of the prion disease (Bueler et al. 1994; Manson et al. 1994). Forloni et al. 
(1993) have shown that cerebral accumulation of PrPSc and its degradation 
products play a role in nerve cell degeneration in prion disease. 
As PrPc and PrPSc share the same epitope, there is no specific cellular or humoral 
immune response (Porter et al. 1973; Kingsbury et al. 1981). No antibody against 
prions can be detected in experimentally infected animals (Porter et al. 1973; 
Kingsbury et al. 1981; Berg 1994). The disease process is not associated with any 
inflammatory reaction, but leads to spongiform degeneration accompanied by 
gliosis and neuronal loss (Budka et al. 1995).  
The susceptibility of an individual to prion disease based on genetic background of 
that individual has long been known (Dickinson and Stamp 1969). Adding to the 
complex nature of this invariably fatal prion disease, there is no diagnostic test 
available to detect prion disease in humans. The genetic forms of prion disease 
can be identified by screening the PRNP gene sequence for known mutations. 
However, this is not applicable to sporadic forms of CJD. Mutation/polymorphisms 
in the functional non-coding regions, i.e. regulatory regions, may also contribute to 
the disease process but this has not been characterized. The presence of amyloid 
plaques in the brain of the affected individual is not a common feature but, when 
present, is diagnostic of prion disease.  
1.3 Doppel 
One set of Prnp knockout mice experiments, conducted in anticipation that the 
mice deficient in PrP might develop a phenotype which could give an insight into 
the normal functions of PrP, produced mice which developed late-onset ataxia 
accompanied by Purkinje cell degeneration (Sakaguchi et al. 1996).  Further 
experiments suggested this phenotype might be a result of upregulation of a 
previously unknown gene (Moore et al. 1999; Li et al. 2000). A suspicion that a 
protein with function overlapping that of PrP might be clustered with it led 
investigators to sequence downstream of the murine Prnp gene. They discovered 
an ORF encoding a PrP-like protein 16kb downstream to Prnp (Moore et al. 1999). 
This gene was designated as downstream prion protein-like or Prnd and the 
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protein as doppel (German for ‘double’) (Moore et al. 1999). As for PrP, the entire 
ORF is found in a single exon although the gene is comprised of 2-3 exons. Dpl 
was the first PrP-like protein to be described in mammals. It shows structural 
similarities to the C-terminal two-thirds of PrP with about 25% sequence identity. 
Dpl has an N-terminal signal sequence indicating it is a secretory protein and a C-
terminal signal sequence for GPI-anchor attachment, and also two N-glycosylation 
sites (Silverman et al. 2000) (Figure 1-2). Both the signal sequences, as in PrP, are 
cleaved to form the mature protein. The sequence and structural similarities 
between PrP and Dpl (Figure 1-3) and the organisation of these two genes are 
indicative of a gene duplication event (Moore et al. 1999).  
Prnp knockout mouse lines produced by different laboratories had shown 
phenotypes ranging from minor electrophysiological and circadian rhythm 
disturbance to one with cerebral purkinje cell degeneration causing late-onset 
ataxia (Moore et al. 1999). These latter findings were interpreted in terms of the 
upregulation of Prnd from the promoter of Prnp. In one of the several Prnp 
knockout mice lines, it was shown that Dpl was upregulated in neuronal tissues, 
causing neurodegeneration (Moore et al. 1999; Li et al. 2000). This phenotype was 
rescued by the introduction of Prnp (Nishida et al. 1999), suggesting an 
antagonistic function of Dpl to PrP (Behrens 2003; Qin et al. 2006). This indicates 
that these genes, at least in higher vertebrates, would have developed regulatory 
control mechanisms to produce a differential expression pattern. Prnp knockout 
mice showed two different phenotypic variants, one with minor defects (Zrch 
Prnp0/0 and Edbg Prnp-/-) (Bueler et al. 1992; Manson et al. 1994) whereas the 
other group (Ngsk Prnp-/-, Zürich II and Rcm0) developed late onset ataxia 
(Sakaguchi et al. 1996; Moore et al. 1999; Rossi et al. 2001).  This behaviour was 
attributed to Purkinje cell degeneration caused not by the absence of PrP but due 
to over expression of Dpl as a result of intergenic splicing with its expression 
controlled by the Prnp promoter (Moore et al. 1999). This form of splice variant was 
also found in low abundance in wild-type mice (Moore et al. 1999).  
Unlike PrP, there is no evidence of conformational changes in the folded domain of 
Dpl. Also, despite the structural and sequence similarities between PrP and Dpl, 
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there is no evidence so far either directly implicating Dpl in prion disease or 
indicating that its regulation is altered in prion disease (Tuzi et al. 2002) even 
though Dpl was shown to be expressed in spleen which is a major reservoir for PrP 
(Li et al. 2000).  However, it should be noted that the major sequence differences 
between PrP and Dpl is the lack of N-terminal repeats and the highly conserved 
hydrophobic region in Dpl. A chimeric mouse protein, composed of the N-terminal 
domain of PrPC (residues 23–125) and the C-terminal part of Dpl (residues 58–
157) lead to the formation of a β-sheet-rich form of Dpl with partial resistance to 
pepsin proteolysis in vitro (Erlich et al. 2008) 
1.3.1 Tissue expression pattern of Dpl 
The tissue distribution of Dpl has been studied in human (Peoc'h et al. 2002), mice 
(Li et al. 2000), and cattle and sheep (Tranulis et al. 2001). In mice, Dpl is widely 
expressed during embryogenesis and in the brain of newborn mice (Li et al. 2000). 
It is also expressed at high levels in adult testis and heart and detected at low 
levels in adult brain (Moore et al. 1999; Li et al. 2000). In cattle and sheep, Dpl is 
strongly expressed in the testes and at low levels in ovary and spleen (Tranulis et 
al. 2001). In humans, Dpl shows very restricted distributions limited to the male 
genital tract (Peoc'h et al. 2002). It is reported to be present in the seminiferous 
tubules, at the adluminal pole of Sertoli cells, spermatozoal extracts, seminal fluid 
and mature ejaculated spermatozoa (Peoc'h et al. 2002). Peoc’h et al. (2002) 
propose that as Sertoli cells communicate with the germ cells either directly (cell-
cell interaction) or indirectly (paracrine interaction) throughout gametogenesis, it 
seems likely that Dpl is involved in spermatogenesis. Dpl is also thought to be 
involved in motility of sperm due to its presence on the flagellum of ejaculated 
spermatozoa. This supports the findings of Behrens et al. (2002) of poor sperm 
motility in mice lacking Dpl. Dpl has not been detected on testicular spermatozoa 
but is present on epididymal spermatozoa, suggesting that this protein is acquired 
after passage of the maturing spermatozoon through the epididymis (Serres et al. 
2006). Dpl is also reported to be expressed during embryogenesis (Moore et al. 
1999; Li et al. 2000). The expression pattern of the goat PRND suggest that it is 
involved in early testes development (Kocer et al. 2007). The studies performed on 
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the ovine testicular tissues strongly support a role for Dpl in the later stages of 
spermatogenesis, in particular the final remodelling and maturation of elongated 
spermatids (Espenes et al. 2006). 
1.3.2 Structure of Dpl 
Similarly to PrP, Dpl is also a short protein comprising 179 amino acid residues in 
mouse. The structural topology of the Dpl folded domain (residues: 26-157) 
determined by solution NMR is similar to PrP (Mo et al. 2001) (Figure 1-3b). The 
secondary structure elements are located at the same regions in the primary 
sequence (Figure 1-3c).The differences between the two are: 
• the presence of a kink in the second α-helix in Dpl  
• the plane of the β-strands (β1 and β2) are parallel to the α2 axis in Dpl but 
perpendicular in PrP.  
• the α3 helix is significantly shorter in Dpl.  
• Dpl has two disulphide bridges compared with only one in PrP.  
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                                                                            ↓ 
MoDpl  1  MKNRLGTWWVAILCMLLASHLSTVKARGIKHRFKWNRKVLPSSG--GQITEA----RVAE 54 
          | | ||  |   |           | |             |  |  |                
MoPrP  1  MAN-LG-YWLLALFVTMWTDVGLCKKRPKPGGWNTGGSRYPGQGSAGAAAAGAVVG--GL 124   
                                 ↑ 
 
                                                    ●   ▲         ○ ♦ 
MoDpl  55 NRPGAFIKQGRKLDIDFG-AEGNRYYAANYWQFPDGIYYEGCSEANVTKEMLVTSCVNAT 113 
                        | ||     |||  |    |   ||             |  ||| |  
MoPrP 125 GG-YMLGSAMSRPMIHFGNDWEDRYYRENMYRYPNQVYYRPVDQ-YSNQNNFVHDCVNIT  182  
                    
 
                                          ○        ●      ↓ 
MoDpl 114 QAAN-QAEF--SREKQDSKLHQRVLWRLIKEICSAKH---CDFWLERGAA------LRVA 161 
                                    |     |                         |  
MoPrP 183 IKQHTVTTTTKGENF--TETDVKMMERVVEQMCVTQYQKESQAY-----YDGRRSSSTVL 235  
                       ▼                                    ↑ 
 
MoDpl 162 VDQPAMVCLLGFVWF-IVK 179  
             |    |  |  | || 
MoPrP 236 FSSPPVILLISFLIFLIVG 254  
 
 
Figure 1-3 Tertiary structure of (a) Mouse PrP (PDB ID: – 1AG2) and (b) Mouse Dpl (PDB ID: – 
1I17) from solution NMR. (c) Structure based sequence alignment of mouse PrP with mouse 
Dpl. Note the well conserved secondary structural units of PrP and Dpl. Residues identical to 
mouse PrP and Dpl are highlighted in light blue. α-Helical regions (α1, α2, α2′ and α3) are indicated 
by red boxes and β-sheet by blue boxes. A kink in Dpl α2 helix is indicated by a blue arrow. A 
region containing the octarepeats that has no equivalent in Dpl has been removed from this 
alignment for clarity. Consensus glycosylation sites are represented by ♦; Cys involved in 
disulphide bridge formation are represented by ● and  ○; Cleavage site of signal peptide ↑↓ (Mo et 
al. 2001; Mastrangelo et al. 2002). 
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1.3.3 Physiological functions of Dpl 
Behrens et al (2002) conducted studies to elucidate the physiological role of Dpl by 
generating homozygous mutant mice lacking Dpl and replacing it by a neomycin 
resistant gene Prndneo/neo. Both male and female Prndneo/neo mice displayed normal 
growth indicating no obvious effects of Dpl deficiency on growth and development. 
But a significant finding was that the adult male Prndneo/neo mice were infertile, in 
contrast to the adult female Prndneo/neo mice, which were fertile. The sexual 
behaviour of Prndneo/neo mice was normal, as evidenced by the normal number of 
copulation plugs. The number of spermatozoa in the cauda epididymis of 
Prndneo/neo males was shown to be reduced to 50% compared with the wild-type 
controls. Also the motility of mutant sperms was reported to be significantly 
reduced. Thus the cause of the infertility in the knockout mice is due to altered 
spermatogenesis rather than its sexual behaviour apparently due to lack of Dpl. 
The mature sperm in Prndneo/neo mice showed several structural abnormalities 
ranging from disorganisation of the flagellum with respect to the sperm head to the 
sperm head being severely malformed and lacking a well developed acrosome 
(Figure 1-4). The latter defect was proposed to be the main reason for the sterility. 
This was supported by a follow up experiment in which partial success was 
achieved with in vitro fertilisation of wild-type oocyte whose zona pellucida was 
partially dissected. As Dpl is a GPI-anchored protein (Silverman et al. 2000), it was 
proposed to be present on the acrosomic vesicles through its GPI-anchor and 
possibly participates in the acrosome reaction. 
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Figure 1-4 Sperm morphology as seen under microscope in wild-type mice and in Prnd 
knockout mice. Image taken from Behrens et al. 2002. 
Another study by Paisley et al. (2004) generated Prnd-/- and Prnp-/- Prnd-/- mouse 
lines. Similar to the results of Behrens et al. (2002), the mutant mice developed 
normally but the male mutant mice were sterile. However, the sperm from both 
mutants showed normal concentration, motility and morphology and the mutant 
spermatozoa were able to fertilise in vitro but at a significantly reduced frequency 
compared with wild-type mice. However, most of the embryos did not reach late 
stage development, which was linked to observed DNA damage within the 
spermatozoa. Their studies supported the earlier findings that Dpl is involved in 
acrosome reaction, but they also hypothesised that Dpl may play a role in 
protecting DNA from oxidative damage in the sperm/testis.  
It has been proposed that, as Dpl is a glycosylated protein, it may be involved in 
active protection of spermatozoa by reducing interactions between cells (Peoc'h et 
al. 2002). 
1.3.4 PrP and Dpl in testis 
Consistent with it its wide tissue distribution pattern PrP is also expressed in testis. 
However, unlike Dpl, PrP knockout (Prnp-/-) mice are fertile (Behrens et al. 2002) 
indicating that Dpl function is not replaceable by PrP.  
Wild type Knockout
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PrP found on ejaculated spermatozoa was reported to be a C-terminally truncated 
isoform (Shaked et al. 1999) but this could not be verified by  Peoc'h et al. (2002). 
Interestingly the latter authors detected N-terminally truncated isoforms on 
ejaculated spermatozoa which were GPI-anchored and thought to result from 
proteolytic cleavage which begins in the epididymal fluid and greatly increases 
during ejaculation. They proposed that, in contrast to the full length form detected 
in seminal plasma, the absence of full length PrP on ejaculated spermatozoa 
indicates either the absence of transfer of PrP from seminal plasma to the 
spermatozoa or, if the transfer occurred, that they are rapidly proteolysed. 
In situ hybridisation studies in mice showed Prnp transcripts in spermatogenic 
cells, but not in somatic cells such as Sertoli cells, Leydig cells, and peritubular 
myoid cells, suggesting that PrP plays a role in spermatogenesis (Fujisawa et al. 
2004). They observed Prnp mRNA moderately in spermatogonia, strongly in 
spermatocytes and round spermatids, but not in elongated spermatids and 
spermatozoa. These findings may indicate a functional role for PrP in 
spermatogenesis.  
Testis-specific prion protein (PRNT): Recently a testis-specific prion protein was 
reported in the genomic environment of PRNP, 3 kb downstream to PRND in 
human and this gene was referred to as PRNT (Figure 1-5) (Makrinou et al. 2002). 
PRNT has three alternative spliced variants (varying size of non-coding exon 1) 
that were detected only in adult testis (Makrinou et al. 2002). It has been proposed 
that this gene resulted from a part of the duplication event early during eutherian 
speciation (Makrinou et al. 2002). However, this gene does not share sequence 
similarity with any of the prion-protein family genes. Also the gene is not well 
conserved in mammalian species, including mouse and cow.  
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Figure 1-5 Genomic environment of PRNP in human and other tetrapod lineages. Note the 
additional gene PRNT in human present downstream to PRND and in the opposite orientation to 
that of PRNP and PRND. 
1.4 Shadoo 
Premzl et al. (2003) recently reported another PrP-like protein, Shadoo (Sho) 
(Japanese shadow) encoded by the gene designated as SPRN (shadow of prion 
protein). This gene has been found on a separate chromosome (No. 7 in mice) 
away from the Prnp-Prnd gene complex (present on chromosome 2 in mice). 
SPRN is expressed in embryo, whole brain, and retina.  Sequence comparison 
shows a highly conserved N-terminal signal sequence, Arg-rich basic region, a 
hydrophobic region with strong homology to prion protein (Figure 1-6a), a C-
terminal domain containing a conserved glycosylation motif, and a C-terminal 
signal sequence for GPI-anchor attachment (Figure 1-2). However, Sho lacks the 
disulphide bridge and has only one N-glycosylation site. It is highly conserved in 
mammals and also well conserved from fish to mammals (Figure 1-6b). As for the 
other prion-protein family genes, the SPRN ORF is contained within a single exon. 
The functions of Sho are not well understood but it is likely to play a role in CNS 
development as demonstrated by gain and loss functional experiments (RNAi and 
overexpression) in zebrafish (Sangiorgio et al. 2007). SPRN has been shown to be 
present in CNS from early postnatal life and was proposed to have a 
neuroprotective effect (Watts et al. 2007). Interestingly, prion-infected mice 
demonstrated reduction in endogenous Sho protein (Watts et al. 2007).  This 
suggests that Sho not only shares sequence similarity but also a number of 
biochemical and cell biological properties with PrP (Watts et al. 2007) and supports 
the initial suggestions that PrP and Sho have overlapping functions (Premzl et al. 
2003).  
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An apparent duplicate of Sho, represented as Sho2 and encoded by the gene 
SPRNB, is found only in fish (Premzl et al. 2004; Strumbo et al. 2006). However, 
whole genome duplication in modern fish (ray finned) (Taylor et al. 2003) 
complicates analysis of the origin of the gene. 
 
                  
MoSho    1   ---MNWTAATCWALLLAAAFLCDSCSAKGGRGGARGSARG---------------VRGG 41 
RaSho    1   ---MNWTTATCWALLLATAFLCDSCSAKGGRGGARGSARG---------------VRGG 41 
HuSho    1   ---MNWAPATCWALLLAAAFLCDSGAAKGGRGGARGSARGG--------------VRGG 42 
FuSho    1   ---MNRGLAACWTCLLLCAFLCEPVLSKGGRGGSRGSSRGSPSRSSTAGSYRGGGAHGG 56 
TeSho    1   MSGANRGLAACCTCLLLCALLREPVLAKGGRGGSRGSSRGSPSRSSTAGSYRGGAAHGG 59 
ZeSho    1   ---MNRAVATCCIFLLLSAFLCDQVMSKGGRGGARGSARGT--------------ARGG 42 
 
MoSho    42  ARGASRVRVR---PAPRYG---SSLRVAAAGAAAGAAAGVAAGLATGSGWRRTSGPGEL 94 
RaSho    42  ARGASRVRVR---PAPRYS---SSLRVAAAGAAAGAAAGVAAGLATGSGWRRTSGPGEL 94 
HuSho    43  ARGASRVRVR---PAQRYGAPGSSLRVAAAGAAAGAAAGAAAGLAAGSGWRRAAGPGER 98 
FuSho    57  T--RSRFRVAGRTSP---------VRVASA-----AAAGAAVALTAD-KWYASAYRRSN 98 
 TeSho    60  T--RSRFRVAGRASP---------VRVAAA-----AAAGAAVALTAD-KWYASAFRRSN 101 
ZeSho    43  R--TSRARGS---PA---------VRVAGA-----AAAGAAVALGAG-GWYASAQRRPD 81 
 
MoSho    95  GLEDDENGAMGGNGTDRGVYSYWAWTSGSGSVHSPRICLLLGGTL-----GALELLRP 147 
RaSho    95  GLEDDENGAMGGNGTDRGVYSYWAWTSGSGSVHSPRICLLLSGTL-----GALELLRP 147 
HuSho    99  GLEDEEDGVPGGNGTGPGIYSYRAWTSGAGPTRGPRLCLVLGGAL-----GALGLLRP 151 
FuSho    99  ADSSDEQLDYSNR-TNY--FDALMSGSSQNGFSVAQLVSVVI-AAVSPNCGLLLDIIL 152 
TeSho    102 SDSSEEQLDSSNR-TNY--FDALLSGSARNGFSVAQLVAVVL-ATLSPNCGLLLDIIL 155 
ZeSho    82  DRSERGDDYYSNR-TNWELYLARTSGATVHDSTITRLSALLL-PI-----NYMMHFAP 132  
Figure 1-6  (a) Alignment of PrP and Sho hydrophobic region showing reasonable sequence 
conservation (image taken from Premzl et al. 2003).  (b) Multiple sequence alignment of Sho 
sequences in Mammals and Fish. The conserved regions are highlighted. Mo, mouse; Ra, rat; 
Hu, human; Fu, Fugu; Te, Tetraodon; Ze, zebrafish; Fu, Fugu; Po, Monodelphis; Ch, chicken; Xe, 
Xenopus. Color coding is based on identity or similarity between the amino acid residues.  
 
1.5 Prion-protein family structural features 
All proteins in the family are secreted as indicated by presence of a well defined 
signal peptide at the N-terminal region, and are embedded in the extracellular 
membrane as indicated by C-terminal signal sequence for GPI-anchor attachment 
(Figure 1-2). PrP and Dpl have approximately 25% sequence identity and Dpl 
a 
b 
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protein resembles an N-terminally abbreviated PrPC protein lacking the octamer 
repeats. No region of Dpl has significant homology to the middle hydrophobic 
region of PrP, which is present in all known PrPs and has strong sequence 
conservation. PrP has two N-glycosylation sites (of the form N X T). Dpl also has 
two N-glycosylation sites but only one of these (the one on the second helix, Figure 
1-2) is maintained in the same position as in PrP.  PrP has two cysteines involved 
in disulphide bridge formation between helix two and helix three, which are also 
conserved in Dpl. In addition, Dpl has another disulphide bridge as shown in Figure 
1-2. Sho has a very well conserved hydrophobic region as for PrP. The alignment 
of the hydrophobic segment shows strong conservation across all PrPs and Shos 
(Figure 1-6) (Premzl et al., 2003). The common feature in all of these proteins is 
that they are encoded by a single exon. It has been suggested that these genes 
were a result of a gene duplication event of an ancestral gene which was SPRN-
like and have diverged sufficiently to have different functions (Premzl et al. 2004).  
1.6 Motivation of the thesis 
My main interest is in studying the evolution, function, tissue expression and 
regulation of PrP family genes. Identifying this group of proteins in newly 
sequenced genomes and also looking for unidentified remote homologues will give 
a better understanding of the evolutionary and functional characteristics of this 
family of proteins. 
There are not many studies on the tissue expression of these genes in various 
lineages. Understanding the regulation of these genes in different vertebrate 
groups can help in understanding the evolution of regulatory mechanisms.  
The Sp1 transcription factor (TF) has been shown experimentally to play a role in 
transcriptional regulation of PRNP (Saeki et al. 1996; Baybutt and Manson 1997; 
Inoue et al. 1997; Mahal et al. 2001). Mahal et al. (2001) also found Ap1 and Ap2 
binding sites in the human PRNP promoter region. Nagyova et al. (2004) 
experimentally validated the role of USF-1 and NF-Y in PRND promoter activity. 
PRNP expression has been shown to be highly regulated during development 
(Manson et al. 1992). Although PRNP is expressed in a wide range of tissues, it is 
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found at different levels in various tissues (high levels in neuronal tissues, 
intermediate levels in heart and lung and low levels in spleen) (Oesch et al. 1985). 
Similarly, Dpl is widely expressed during embryogenesis but has limited tissue 
expression in adult mice (high levels in adult testis and heart and detected at low 
levels in adult brain) (Moore et al. 1999; Li et al. 2000). Tissue-specific regulation 
cannot be mediated by the ubiquitous TFs like Sp1, Ap1, and Ap2 for PRNP, and 
USF-1 and NF-Y for PRND. It could be mediated by a cumulative regulatory control 
at the genetic (transcriptional regulation) level by tissue-specific TFs or at 
epigenetic levels (chromatin remodeling, methylation etc), or by a combination of 
these two mechanisms. The functions of these genes, which are not well known, 
can be approached by predicting the TFs involved in regulating their tissue 
expression. 
It has been demonstrated that mutations/single nucleotide polymorphisms (SNPs) 
of genes involved in spermatogenesis causes human infertility (Nishimune and 
Tanaka 2006). As Dpl is involved in spermatogenesis, it would be interesting to 
study the association of Dpl in human male infertility.  
1.7 Aims of the thesis 
Aim 1: To identify and characterize prion-protein gene family members in newly 
sequenced genomes, and also to look for potential other members in already 
studied vertebrate groups. Based on both published members and those that have 
recently been found, it can be hypothesized that a variable repertoire of family 
members may exist in different vertebrate groups, or for particular species 
branches within a given vertebrate group. Chapters 3 to 6 discuss findings in 
various species. 
Aim 2: To define the regulatory mechanisms for the major vertebrate genes 
(PRNP, PRND and SPRN) by identifying the regulatory binding sites, and 
correlating these with tissue and cell expression results. Chapter 7 deals with the 
prediction of transcription factor-binding sites (TFBSs) among the prion-protein 
family genes. Chapter 8 examines the experimental validation of one of the 
predictions in the PRND promoter. 
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Aim 3: To identify SNPs in PRND among the human population with male 
infertility. Although polymorphisms of the PRND gene have been studied in the 
context of its possible association with prion disease, there have been no reports of 
PRND polymorphisms among the male infertile population. Chapter 9 reports an 
initial study of SNPs observed in a sample of the human infertile and control 
populations. 
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2 Strategy and Methods 
 
2.1 Overview 
The genes, PRNP, PRND, and SPRN  are suggested to be homologues, i.e. 
evolved from a common ancestor (Premzl et al. 2004). PRNP has been reported in 
various mammalian (van Rheede et al. 2003), marsupial (Windl et al. 1995; Premzl 
et al. 2005), reptilian (Simonic et al. 2000), avian (Harris et al. 1991; Gabriel et al. 
1992; Wopfner et al. 1999) and amphibian species (Strumbo et al. 2001). PRND 
was suggested to be a result of duplication of PRNP (Moore et al. 1999). So far, it 
has been reported only in eutherian mammals. SPRN is well conserved between 
fish and mammals (Premzl et al. 2003). Fish are reported to have other genes 
homologous to prion-protein (PrP), coding for stPrPs (Oidtmann et al. 2003), PrP-
like (Suzuki et al. 2002) and Sho2 (SPRNB) (Premzl et al. 2004), but none seems 
to be orthologous to higher vertebrate PRNP. Interestingly, all these genes contain 
a single-exon ORF.  
The regulatory proteins termed transcription factors (TFs) orchestrate spatial and 
temporal transcriptional regulation of gene expression. TFs can be predicted by 
identifying the conserved sites to which they bind using a comparative genomics 
technique termed phylogenetic footprinting (PF) (Tagle et al. 1988). The increased 
amount of vertebrate genomic sequence information now available, and becoming 
available from genome sequencing, provides the opportunity for more sensitive 
(reliable, i.e. fewer false positives) searches for these conserved TF binding sites 
(TFBS). Previous work in my group employed a similar technique to predict TFBS 
for SPRN using sequence information from Takifugu rubripes (Pufferfish), mouse 
and human (Premzl et al. 2004) and for PRNP using tammar wallaby, mouse and 
human (Premzl et al. 2005). Subsequent genome sequencing projects have 
produced further sequence information from Xenopus tropicalis, chicken, 
Monodelphis domestica (gray short-tailed opossum), Macropus eugenii (tammar 
wallaby), and Ornithorhynchus anatinus (platypus), providing an opportunity to 
extend these studies using species across different evolutionary timelines (Figure 
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2-1). Sequence conservation in non-coding DNA among species separated by a 
wider evolutionary distance (for example, mammals and amphibians) is expected 
to be more significant than conservation observed across shorter timelines (for 
example between human and mouse). It is hypothesized that such conserved 
motifs have functional significance, including acting as a TFBS protein binding 
sites. Binding of particular regulatory proteins to these motifs could act to direct 
transcription in a tissue-specific fashion. Tissue specificity information on TFs can 
be obtained from TF databases. Thus, prediction of which TFs might bind to a 
particular gene can rapidly provide initial insights into potential functions of the 
gene, based on known modes of actions of the TFs in regulating other, better 
characterized, genes. Such initial predictions can greatly assist in designing 
focused experiments to define mechanisms for expression of the gene.  
Thus, identifying and characterising (sequencing) the genes of interest in various 
lineages allows facilitates more robust TFBS predictions. As a major focus of this 
thesis (Figure 2-2) is to characterise genes of interest in different vertebrate 
lineages and developing an automated pipeline for TFBS analysis, only a limited 
amount of confirmatory experimental work is performed and only the most 
interesting TF predictions for PRND are tested by functional studies.  
The possible association of polymorphisms in human PRND with infertility is 
investigated by genotyping studies taking into consideration both the ORF and part 
of the promoter region suggested by the results of the TFBS analysis. This work is 
motivated by the infertility observed in male Prnd knockout mice. 
The following gives a brief outline of the methods used in the thesis. More detailed 
descriptions are given in the methods sections in the relevant chapters.  
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Figure 2-1 The molecular evolutionary timescale. The numbers indicate the years of separation 
in millions (Kumar and Hedges 1998). 
 
Figure 2-2 Summary of the workflow covering the main aims of the thesis. 
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2.1.1 Homology search  
Similarity in DNA or protein sequences between individuals of the same species or 
among different species is termed homology. Homology search can be performed 
against single sequence information using methods such as BLAST (Altschul et al. 
1990) or against sequence profile information using methods such as the Hidden 
Markov Model (HMM) (Eddy 1998). 
To identify genes of interest in species selected for comparative studies, first a 
computational prediction of the coding region was performed followed by 
experimental characterization of the cDNA (Figure 2-3). The program TBLASTN 
(Altschul et al. 1997) was employed to scan the draft sequences to identify the 
coding regions of the genes. Genomic DNA sequences for both completely and 
partly sequenced organisms can be obtained from public repositories. Where the 
trace sequences were unassembled, they were downloaded and assembled into a 
local BLAST database. In most instances, the genomic sequence was also 
downloaded and a BLAST searchable local database was created for easy and 
fast searching. EST databases were also screened to identify transcripts of interest 
already deposited in the public repositories. Based on the computational findings, 
experiments to obtain the cDNA ends using the RACE (Rapid Amplification of 
cDNA Ends) technique was employed. Experimental work was carried out only for 
non-mammalian species (Chapters 3, 4 and 5). 
The annotation of the genomic sequence to define the exon-intron boundaries, 
transcription start site (TSS), and ORF was performed using the cDNA sequence 
information which was obtained either from the experimental procedures or from 
the NCBI Reference Sequence (RefSeq) / non-redundant nucleotide database. 
The TSS, exon-intron boundaries and ORF were defined by mapping the cDNA 
sequence onto the genomic sequence using the program “est2genome” from the 
EMBOSS application (Rice et al. 2000). The ORF was annotated using the 
program “getORF” also from the EMBOSS application. As experiments on 
mammalian species were not performed, available EST database were used to 
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annotate the genomic sequences for mammalian sequences. Also fish PrPs are 
not considered to be true PrP and also lack Dpl. Fish sequences were not included 
in the comparative analysis. A Perl module termed createBlastdb.pl was developed 
to handle the process of creating the BLAST database.  
 
Figure 2-3 Flow diagram summarizing the steps involved in gene finding. These were divided 
into computational and experimental components. The end result of the analysis is the 
annotated gene sequence information. 
 
2.1.2 Phylogenetic footprinting and transcription factor-binding site 
(TFBS) analysis 
As TFBSs are under greater selective pressure than other non-protein-coding 
DNA, the reliability of predicting them is greatly improved by comparative genomics 
to filter out noise from genetic drift. Identifying such conserved sequence elements 
in non-coding regions of homologous genes from phylogenetic comparison is 
called ‘phylogenetic footprinting’  (Tagle et al. 1988).  As TFBSs are short DNA 
motifs of 5-15 bp, analyzing a single sequence would lead to a very high 
percentage of false positive hits (Figure 2-4), and even more so if the considerable 
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sequence variation between functional binding sites tolerated by most TFs is taken 
into account. Phylogenetic footprinting offers a solution to this problem by 
identifying such sequence elements that are conserved among genes that are 
either orthologous or co-expressed. Due to low overall similarity of non-coding 
regions across moderate evolutionary distances, many alignment algorithms will 
fail to produce biologically meaningful alignments. This can be improved by 
carefully manipulating the alignment parameters. There are also non-alignment 
methods to perform phylogenetic footprinting. Several programs implement 
phylogenetic footprinting but only a few combine it with TFBS analysis, for 
example, rVISTA (Loots et al. 2002) and ConSite (Sandelin et al. 2004). Chapter 7 
deals with developing a pipeline for performing TFBS analysis using alignment and 
motif-discovery based methods.  
 
Figure 2-4 Output from MatInspector (Quandt et al. 1995) for single (human) PRNP promoter 
sequence (829 bp upstream to TSS). Note the number of large, unrealistic, TFBSs predicted for 
such a small region.  
 
2.1.2.1 Phylogenetic footprinting using alignment method 
DNA sequence alignment can be of two types, local and global. Local alignments 
are based on optimal subregion sequence similarity which would enable the 
detection of rearrangement events. Global alignments are based on optimal 
alignment over the entire length of sequences being compared. This method is 
better when the region compared is between orthologous genes. For initial 
analysis, I used global alignment methods implemented by AVID and LAGAN.  
The AVID (Bray et al. 2003) alignment method is fast, memory efficient, and 
practical for sequence alignments of large genomic regions up to a megabase. 
AVID performs the pairwise alignment of two input sequences; the output 
comprises the alignment and additional information.  The alignment files were used 
for downstream processing. LAGAN (Brudno et al. 2003) is a method for rapid 
global alignment of two homologous sequences. The algorithm is based on three 
-1-829 TFs 
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main steps (Brudno et al. 2003): (1) generation of pairwise local alignments, (2) 
construction of a rough global map, by linking a subset of local alignments, and (3) 
computation of the final global alignment. LAGAN alignments were generated 
using the translate anchor option and binary output format was selected, which 
enables downstream processing. 
2.1.2.2 Phylogenetic footprinting using motif-discovery method 
The motif-discovery method is a non-alignment method which identifies conserved 
motifs based on specific word sizes that are overrepresented in the regulatory 
regions of orthologous genes. FootPrinter (Blanchette and Tompa 2003) uses the 
motif-discovery approach in identifying conserved motifs in a collection of 
homologous sequences. FootPrinter  takes phylogeny into account and, hence, 
weighs the sequence based on the evolutionary relationship and implements most 
of the concepts of phylogenetic footprinting, in contrast to other motif-discovery 
methods such as MEME (Bailey and Elkan 1994). BioProspector (Liu et al. 2001) 
identifies motifs that are overrepresented in the input sequences and, hence, is a 
different approach to handling this problem. 
2.1.2.3 TFBS databases 
The conserved sequence motifs identified by phylogenetic footprinting need to be 
assessed for TF-binding specificity. TFBSs are degenerate sequence motifs that 
are recognized by TFs. TFBSs can be represented as a position weight matrix 
(PWM) or a position-specific scoring matrix (PSSM) (Stormo 2000). Databases of 
experimentally-validated TFBSs such as JASPAR (Sandelin et al. 2004) and 
TRANSFAC (Matys et al. 2003) are available. The largest and most commonly 
used collection of these matrices is the TRANSFAC database. 
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2.1.3 Functional studies of Prnd promoter 
Reporter genes can be used to assay the activity of a particular promoter in a cell. 
The reporter gene is placed under the control of the target promoter and the 
reporter gene product's activity is quantitatively measured. The luciferase reporter 
gene with Prnd promoter attached and expressed in eukaryotic cells can used to 
assess the transcriptional activity of the region being tested. The most interesting 
predictions in the mouse Prnd core promoter were tested by this method (Chapter 
8).  
2.1.4 Polymorphism studies of human PRND 
Nucleotide differences known as single nucleotide polymorphism (SNP) are the 
most common type of genetic variation (1 in every 1,200 bases). Each such 
variation in a chromosomal region is termed an allele, and a collection of alleles in 
a person's chromosomes is known as a genotype. SNPs can exist anywhere in the 
genome including the coding region. However, due to the degeneracy of the 
genetic code not all SNPs in the coding region produce an amino acid change. 
Other consequences of SNPs are in altering gene splicing, TF binding, or the 
sequence of non-coding RNA. SNPs are associated with the etiology of many 
human diseases or can affect susceptibility to human diseases. One of the most 
important applications in identifying SNPs is to compare populations with and 
without a particular disease.  
The PRND ORF and promoter regions of DNA from healthy and infertile men were 
screened to analyze any possible association of SNPs in causing male infertility. 
Identification of SNPs to determine the genotype of a particular individual can be 
performed by a number of methods (Chapter 9). 
2.1.4.1 Idaho technology LightScanner® 
LightScanner® is designed to perform rapid high-throughput Hi-Res MeltingTM of 
amplified nucleic acids for mutation scanning or genotyping.  This assay is 
performed on post-PCR amplicons. The double stranded DNA from the PCR is 
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saturated with DNA binding dye (LCGreen®). A high-precision denaturation is 
performed on the amplicons by slowly heating until fully denatured and the 
fluorescence is recorded generating melting profiles. These melting profiles can be 
used to detect the sequence variants within the amplicons (Wittwer et al. 2003). 
This method was assessed for its suitability for analyzing the PRND gene to 
identify SNPs among the control and infertile population using this method. 
2.1.4.2 Big-Dye sequencing 
DNA sequencing determines the nucleotide order of a given DNA fragment. This 
can be performed using the chain termination method where the DNA to be 
sequenced acts as a template molecule. Sequencing was performed on 96-well 
plates to determine the genotype of the infertile and control samples. The 
chromatogram obtained from sequencing was analyzed using Sequencher to 
identify the SNPs.   
2.1.5 PCR-RFLP assay 
Restriction fragment length polymorphism (RFLP) analysis is used to identify SNPs 
that alter or create a site where a restriction enzyme cuts. By performing a 
digestion on a PCR product and determining fragment lengths through a gel assay 
it is possible to ascertain whether or not the enzymes cut the expected restriction 
sites. Those samples which needed further confirmation following the sequencing 
reaction were analyzed using this technique. 
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3 Findings in Xenopus 
 
3.1 Background 
Xenopus belongs to class amphibian. Although X. laevis has been favored by 
biologists for studying embryonic development, it is tetraploid, and also takes 1-2 
years to reach sexual maturity. Hence X. tropicalis, which is the only diploid 
species in the Xenopus genus, was used as the model organism for genome 
sequencing (by the Joint Genome Institute).  
PRNP has been reported in X. laevis (Strumbo et al. 2001). X. laevis PrP has all 
the sequence and structural motifs found in higher vertebrate PrPs except for the 
lack of the N-terminal repeats and exhibit some variation in residue composition in 
the highly conserved hydrophobic stretch. Although a true homologue of PRNP is 
not found in fish, diverged duplicated homologues and gene loci have been 
reported in ray-finned fish (Oidtmann et al. 2003; Premzl et al. 2004), most likely 
resulting from a whole-genome duplication (Taylor et al. 2003). Neither of these 
duplicated PRNP loci of fish contain the PRND gene. So far, PRND is reported 
only in mammals. In order to analyze the features of PRND in early vertebrates, I 
investigated the prion-protein family genes in Xenopus species (X. tropicalis and X. 
laevis). As X. laevis is tetraploid, it provides an opportunity to investigate whether 
any duplicates of PrP family genes have been retained.  
 
3.2 Material and methods 
3.2.1 Database searches 
Several attempts of searching for Dpl in the X. tropicalis genome trace reads 
database (http://genome.jgi-psf.org/xenopus) using TBLASTN (Altschul et al. 1990) 
(default parameters) and various (full length) mammalian sequences as query did 
not produce any significant hits. The query sequence from human Dpl containing 
the N-glycosylation sites and the first three Cys residues involved in the disulphide 
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bridges (HumDpl 57-140) picked up a hit from trace read TKS687278.g1, which 
corresponded to a stretch of the ORF of 159 residues but lacked the complete N-
terminal region. The BLAST parameters used were a cutoff evalue of 1, default gap 
penalties, gapped BLAST program and low complexity regions permitted. A search 
with the nucleotide sequence from the 5’ end of TKS687278.g1 (using BLASTN) 
gave another overlapping contig AAWU3059.g1 to complete the ORF for X. 
tropicalis Dpl. X. tropicalis PrP was identified using the X. laevis PrP sequence 
(Strumbo et al. 2001) as query. With the later release of assembled versions of the 
genome data, including the present version 3 (http://genome.jgi-
psf.org/Xentr3/Xentr3.home.html), I was able confirm the findings obtained from 
trace reads and was also able to define the genes surrounding PRNP and PRND.  
Screening the EST library (NCBI EST database and Sanger EST database 
http://www.sanger.ac.uk/cgi-bin/blast/submitblast/x_tropicalis) for Dpl in X. laevis 
and X. tropicalis did not produce any positive hits but showed multiple hits for PrP 
for both species. Both BLASTN and TBLASTN programs with default BLAST 
parameters were used. 
3.2.2 Sequence Analysis 
Prediction of Signal sequence: N-terminal signal peptide cleavage sites for X. 
tropicalis and X. laevis PrPs and Dpls were predicted using the SignalP program 
(version 3.0) (Nielsen et al. 1997) (http://www.cbs.dtu.dk/services/SignalP/). The 
program Big-pi (Eisenhaber et al. 1999) 
(http://mendel.imp.univie.ac.at/sat/gpi/gpi_server.html) was used to predict GPI 
modification sites; modification sites for X. tropicalis and X. laevis PrPs were 
identified but clear sites for X. tropicalis and X. laevis Dpls were not predicted.  
Sequence alignment: Multiple sequence alignments were performed using web-
based ClustalW (Higgins 1994)  (http://www.ebi.ac.uk/clustalw/) using default 
parameters, and then manually edited using BioEdit Version 5.0.9 
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html), taking into account results 
obtained using pairwise comparison of protein structures using the DaliLite 
alignment program (Holm and Park 2000) (http://www.ebi.ac.uk/DaliLite/). 
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Calculating the percentage identity was performed using the Needleman-Wunsch 
global alignment algorithm (Needleman and Wunsch 1970) provided by EMBOSS 
(http://www.ebi.ac.uk/emboss/align/). 
3.2.3 Homology modelling 
Homology modeling for X. laevis PrP2 and X. tropicalis Dpl was made using the 
package MODELLER (MODELLER 6v2) (Sali and Blundell 1993). A representative 
structure from mouse Dpl (PDB ID 1I17) and X. laevis PrP (PDB ID 1XU0) were 
used as templates for X. tropicalis Dpl and X. laevis PrP2, respectively, and 
iteratively refined for 4 cycles. 
3.2.4 Identification of conserved regions on mouse Dpl 
Dpl sequences from human, mouse, cow, sheep and Xenopus (X. laevis and X. 
tropicalis) were used to construct a multiple sequence alignment. Degree of 
conservation was plotted using ConSurf (Version 2.0) (Glaser et al. 2003) onto the 
surface of mouse Dpl 3D structure (PDB 1I17). The output was saved as a RasMol 
coloring script source for coloring the protein according to the conservation grades. 
The output was later modified to suit the requirements of PyMol (Version 0.97) 
(DeLano 2002), which generates high quality molecular graphic images. 
3.2.5 Experimental analysis 
3.2.5.1 Isolation and cloning of cDNA 
RNA from adult X. tropicalis brain for PRNP and testis for PRND was obtained as a 
gift from Dr Timothy C. Grammer (Harlands lab, University of California, Berkeley). 
X. laevis tissues were salvaged from animals maintained locally in a colony in 
JCSMR, ANU by Dr David Tremethick's group and were stored in RNAlater® 
(Ambion) until use. The Qiagen RNAeasy kit was used to extract total RNA. cDNA 
synthesis using 1 μg of RNA was performed using the Invitrogen SuperscriptTM III 
First-Strand cDNA Synthesis kit using random hexamers. RACE (Rapid 
Amplification of cDNA Ends) was undertaken in the 5’ and 3’ directions using the 
SMARTTM PCR cDNA Synthesis Kit (BD bioscience) and using gene specific 
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primers and 5’ universal primers gene specific primers (Experiments performed by 
Tatiana Vassilieva. Appendix 1). Platinum®Taq DNA polymerase (Invitrogen) was 
used for PCR analysis (50 ng of DNA template and 4 pmol of primer) with PCR 
conditions 94°C for 30sec, 57°C for 30sec, 72°C for 1min. Only the primers I have 
used myself in this study are listed in Table 3-1. The PCR product was cloned into 
TOPO-TA Cloning® kit (Invitrogen). Sequencing reactions were performed at the 
Biomolecular Resource Facility, John Curtin School of Medical Research using the 
reagents and protocol provided by them. 
Table 3-1 Summary of primers used in RT-PCR assays 
Primer ID Sequence 
LP1 GCTTCTCATTTGCCTTCCTG 
RP1 TGAGGGTATAGAGTGTGCCAAA 
LP2 TCCTGAACCTCCCCCTGTA 
LP3 CGGATCACGAGCTTCTCATT 
RP2 TGAGAGGATAAGTAAGCCCAAA 
LP4 TGCACATTGACTGTATCTTCCA 
RP3 CTGATTACGGGGAAAAGACC 
RP4 CAGTCACGACCACCCTTTG 
RP5 TTCTAACCCATGGGCTGATCC 
RP6 TGTTGAAATTGCTTCCTC 
LD5 CACACTCCCAGACAAGAGCA 
LD6 TTTTCAGGGCAAAGCAGAGT 
RD4 TACGTTCTGCCTTTCCATTCTG 
RD5 TGTGGTCTCTCTTGTCCGAG 
RD6 GAGGACAGGAGAATGGGCCAC 
 
3.2.5.2 Tissue expression 
The following tissues were used for analyzing the tissue expression pattern: brain, 
testis, kidney, liver, lung, muscle, gut, spleen, skin, stomach, eye, heart, pancreas 
and gall bladder. These experiments were performed by Tatiana Vassilieva in my 
group. Primer pairs for tissue expression analysis were (see Appendix 1, Table 
3-1) F4/R4 for PRNP1-a, LP1/R4 for PRNP1-b, LP3/R6 for PRNP2-b(1), F7/R6 for 
PRNP2-b(2), F4/R7 for PRND-a, LD6/R7 for PRND-b(1), F10/R7 for PRND-b(2) 
and F11/R10 for GAPDH. 
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3.3 Results and Discussion 
3.3.1 Genomic characterisation of X. tropicalis PRNP and PRND 
Two variant forms of X. tropicalis PRND which differ in their 3’ UTR length were 
identified (Figure 3-1, Figure 3-2). PRND has four exons with a total of 1272 bp for 
the longer variant and 762 bp for the shorter form. X. tropicalis PRNP also has two 
variant forms which differ in the 5’ UTR, with a total length of 834 and 869 bp for 
shorter and longer variants, respectively, distributed over three exons (Figure 3-1, 
Figure 3-2). The shorter exon 1 is 45 bp and the longer exon 1 is 80 bp (Figure 
3-2). The significant difference in PRND gene organization between Xenopus and 
that of higher vertebrates is that exon 1 and exon 2 in PRND and PRNP are 
common for the two genes (Figure 3-2b, c). Such a transcript with shared exons is 
termed as chimeric. The intron separating exon 2 from exon 3 in PRND is 27,099 
bp. This region contains the exon 3 for PRNP (Figure 3-2h). The entire ORF for 
both PRND and PRNP is contained within the last single exon. The 3’ UTRs in X. 
tropicalis are much shorter than their mammalian counterparts with 536 bp in 
PRND (human 2633 bp; mouse 1337 bp) and 48 bp in PRNP (human 1591bp; 
mouse 1233 bp).   
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(a) X. tropicalis PRNP (chimeric) 
 
     1 
   1 actgctagtcccactgccctcctgatctgcctggcACATCCATCCTCAGTCCCTCTGTCG 60 
                        2 
 61 TATCCTGCCTGGCACAGAGGCACCCACCAGAGCCTGGCACCCAGCTAGCTTCTCTTTGGG 120 
 
     ---------|---------3---------|---------|---------|---------| 
 121 CATACTCACCCACACACAGGTTTGCCATGATGCTAAGAAGCCTCTGGACTTCTTTAGTCC 180 
   1                              M  L  R  S  L  W  T  S  L  V  L 11 
 
     ---------|---------|---------|---------|---------|---------| 
 181 TTATCTCACTTGTATGCGCACTGACTGTATCTTCCAAGAAGAGTGGTAGTGGGAAAAGCA 240 
  12   I  S  L  V  C  A  L  T  V  S  S  K  K  S  G  S  G  K  S  K 31 
 
     ---------|---------|---------|---------|---------|---------| 
 241 AAACCGGAGGATGGAACAGTGGGAGCAACCGGAACCCCAACTACCCAGGAGGCTATGGCT 300 
  32   T  G  G  W  N  S  G  S  N  R  N  P  N  Y  P  G  G  Y  G  W 51 
 
     ---------|---------|---------|---------|---------|---------| 
 301 GGAACACCGGAGGGAATACTGGAGGCAGCTGGGGCCAACCTTATAATCCCAGTGGCGGAA 360 
  52   N  T  G  G  N  T  G  G  S  W  G  Q  P  Y  N  P  S  G  G  N 71 
 
     ---------|---------|---------|---------|---------|---------| 
 361 ACAATTTCAACAACAAGCAATGGAAACCTCCCAAGTCAAAAACCAATATGAAGGCTGTGG 420 
  72   N  F  N  N  K  Q  W  K  P  P  K  S  K  T  N  M  K  A  V  A 91 
 
     ---------|---------|---------|---------|---------|---------| 
 421 CCGTAGGCGCTGCTGCAGGCGCTATCGGGGGCTACATGCTCGGTAATGCAATGGGTCGTA 480 
  92   V  G  A  A  A  G  A  I  G  G  Y  M  L  G  N  A  M  G  R  M 111 
 
     ---------|---------|---------|---------|---------|---------|  
 481 TGAGCTATCATTTCAGCAATCCCATGGAAGCACGTTATTATAACGACTACTACAACCAGA 540 
 112   S  Y  H  F  S  N  P  M  E  A  R  Y  Y  N  D  Y  Y  N  Q  M 131 
 
     ---------|---------|---------|---------|---------|---------| 
 541 TGCCAGAGCGTGTTTACAGGCCAATGTACAGAGGCGAGGAGCACGTGTCAGAGGATAGGT 600 
 132   P  E  R  V  Y  R  P  M  Y  R  G  E  E  H  V  S  E  D  R  F 151 
 
     ---------|---------|---------|---------|---------|---------| 
 601 TTGTCACGGACTGCTACAATATGTCAGTGACAGAGTACATCATCAAGCCAGCTGAAGGGA 660 
 152   V  T  D  C  Y  N  M  S  V  T  E  Y  I  I  K  P  A  E  G  K 171 
 
       ---------|---------|---------|---------|---------|---------| 
 661 AGAACACCAGCGAGGTAAACCAGTTGGAAACCAGGGTGAAGTCCCAAATTATTCGCGAGA 720 
 172   N  T  S  E  V  N  Q  L  E  T  R  V  K  S  Q  I  I  R  E  M 191 
 
     ---------|---------|---------|---------|---------|---------| 
 721 TGTGTATCACTGAGTACAGGAGAGGATCGGGATTTAAGGTGCTCTCTAACCCTTGGCTGA 780 
 192   C  I  T  E  Y  R  R  G  S  G  F  K  V  L  S  N  P  W  L  I 211 
 
     ---------|---------|---------|---------|---------|---------| 
 781 TCCTCACTATCACTCTTTTTGTTTACTTTGTGATAGAGTGACCAGAGGGAAGGCCAAATG 840 
 212   L  T  I  T  L  F  V  Y  F  V  I  E  *                      223 
 
 841 TATGTATATAG 851 
                  
 
(b) X. tropicalis PRND (chimeric) 
 
     1 
   1 GCCCTCCTGATCTGCCTGGCACATCCATCCTCAGTCCCTCTGTCGTATCCTGCCTGGCAC 60 
         2 
  61 AGAGGCACCCACCAGAGCCTGGCACCCAGCTAGCTTCTCTTTGGGCATACTCACCCACAC 120 
         3                                           4 
 121 ACAGGGTCACCATAGATCACCAATGGGGCCATTTTAGCTCTTCCACACTTCTACCACAGG 180 
 
     ---------|---------|---------|---------|---------|---------| 
 181 TGGTGACAGAATGGGAAGGCAGAATCTATTCTCCTGTCTGATTCTTCTCCTGCTCATATT 240 
   1           M  G  R  Q  N  L  F  S  C  L  I  L  L  L  L  I  L  17 
 
     ---------|---------|---------|---------|---------|---------| 
 241 ATATTGTAGTCTCTCTTCTCCTAGAAGAGCAGCAAGCAGCAAAAAAATTAGCAAAACCAC 300 
  18  Y  C  S  L  S  S  P  R  R  A  A  S  S  K  K  I  S  K  T  T  37 
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     ---------|---------|---------|---------|---------|---------| 
 301 AGATTTGAGCAGGGGAGCCAAAAGAAGGCCAAAAGTGACCAATTCTCCTGCCCTCGGAGA 360 
  38  D  L  S  R  G  A  K  R  R  P  K  V  T  N  S  P  A  L  G  D  57 
 
     ---------|---------|---------|---------|---------|---------| 
 361 TCTGTCCTTCAGAGGCAGGGCACTCAATGTGAACTTTAACCTTACCGAGGAATCTGAGCT 420 
  58  L  S  F  R  G  R  A  L  N  V  N  F  N  L  T  E  E  S  E  L  77 
 
     ---------|---------|---------|---------|---------|---------| 
 421 TTATACAGCAAACCTCTACAGCTTCCCGGATGGCCTGTACTACCCACGGCCTGCCCACCT 480 
  78  Y  T  A  N  L  Y  S  F  P  D  G  L  Y  Y  P  R  P  A  H  L  97 
 
     ---------|---------|---------|---------|---------|---------| 
 481 CAGTGGTGCTGGTGGGACTGACGAGTTTATAAGTGGGTGCCTTAACACCACAATAGAAAG 540 
  98  S  G  A  G  G  T  D  E  F  I  S  G  C  L  N  T  T  I  E  R  117 
 
     ---------|---------|---------|---------|---------|---------| 
 541 AAACAAGGTCTGGATCTCTCAACTGGAAGACGATGAAGAAGGGGATATTTATATGAGCGT 600 
 118  N  K  V  W  I  S  Q  L  E  D  D  E  E  G  D  I  Y  M  S  V  137 
 
     ---------|---------|---------|---------|---------|---------| 
 601 GGCCACGCAGGTCCTACAGTTTCTCTGTATGGAAAATTATGTAAAGCCTACCAATGGGGC 660 
 138  A  T  Q  V  L  Q  F  L  C  M  E  N  Y  V  K  P  T  N  G  A  157 
 
     ---------|---------|---------|---------|---------|---------| 
  61 AGTGACCTGCACTGGTGGATTGTGGGTCTTTATAGGTGTCATGCATTTTTTTTTTTTATT 720 
 158  V  T  C  T  G  G  L  W  V  F  I  G  V  M  H  F  F  F  L  F  177 
  
     ---------|---------|---------|---------|---------|---------| 
 721 TAGGAAGGGAGACTAAAGCCTAGGAATTCTGTattttatatgaacttttaagaactaact 780 
 178  R  K  G  D  *                                               181 
 
 781 gtactagcccagaggttcagcagccctataacagcaatgatccaggccttcaaatttgtc 840 
 841 cacagcagctcttggatctcatcttggatcttttgagtgtcagtgacactgcacattctc 900 
 901 agtgtgcagggctgctgttaaagactacgccatctgtcatagaatgcacgtttctacaca 960 
 961 ggaatatactctaatatataggaatatatgtgcatgcaccctactaatagttcagcctgc 1020 
1021 cagagatcaccaaggagttgcatagccttttttacaaacatatccttcatctaaaacttc 1080 
1081 atctgtgacttctaatagtcttataaattacaacaggagcaatattatattctatattat 1140 
1141 atacatataagcaggaattatggctgctgttgtgcacacagggaagttggaggtttggcc 1200 
1201 acggtttgttttccccttattataattgatgaaataaaaatcaggttaaactgg       1254 
 
 
(c) X. laevis PRNP1-a (chimeric) 
 
     1 
   1 agtccgcccccacccctctcctgcatgaAGTCTCTTCCCCATCAGCTCATCCCTAGTCTC 60 
 
  61 ACTGCTTTCCCGATCACCCTGGAACAGCCATCCTGAATCCCCCCCTGGCACATCCATTTC 120 
 
                           2 
 121 GTATTTTCCCCTTGGCACAGAGGCACAGCACCCGGACCTGACACCCACATAGCTTCTCTT 180 
 
 
     ---------|---------|-----3---|---------|---------|---------| 
 181 TGGCACACTCTATACCCTCACCCAGGTTGTTTATGATGCCACAAAGTCTCTGGACTTGTT 240 
   1                                    M  P  Q  S  L  W  T  C  L 9 
 
     ---------|---------|---------|---------|---------|---------| 
 241 TAGTCCTTATCTCCCTAGTATGCACATTGACTGTATCTTCCAAGAAGAGCGGTGGTGGGA 300 
  10   V  L  I  S  L  V  C  T  L  T  V  S  S  K  K  S  G  G  G  K 29 
 
     ---------|---------|---------|---------|---------|---------| 
 301 AAAGTAAAACTGGAGGATGGAACACAGGGAGCAACCGGAACCCCAACTACCCAGGAGGCT 360 
  30   S  K  T  G  G  W  N  T  G  S  N  R  N  P  N  Y  P  G  G  Y 49 
 
     ---------|---------|---------|---------|---------|---------| 
 361 ACCCAGGGAATACTGGAGGCAGCTGGGGGCAACAACCTTATAATCCTAGCGGTTATAACA 420 
  50   P  G  N  T  G  G  S  W  G  Q  Q  P  Y  N  P  S  G  Y  N  K 69 
 
     ---------|---------|---------|---------|---------|---------| 
 421 AGCAATGGAAACCTCCCAAGTCCAAAACCAACATGAAGTCGGTGGCCATAGGCGCTGCTG 480 
  70   Q  W  K  P  P  K  S  K  T  N  M  K  S  V  A  I  G  A  A  A 89 
 
40 
     ---------|---------|---------|---------|---------|---------| 
 481 CTGGTGCTATTGGAGGCTACATGCTCGGTAATGCAGTGGGTCGTATGAGTTATCAATTCA 540 
  90   G  A  I  G  G  Y  M  L  G  N  A  V  G  R  M  S  Y  Q  F  N 109 
 
     ---------|---------|---------|---------|---------|---------| 
 541 ACAATCCCATGGAGTCCCGTTATTATAACGACTACTATAACCAGATGCCAAATCGCGTTT 600 
 110   N  P  M  E  S  R  Y  Y  N  D  Y  Y  N  Q  M  P  N  R  V  Y 129 
 
     ---------|---------|---------|---------|---------|---------| 
 601 ACAGGCCTATGTACAGAGGAGAGGAGTACGTGTCAGAGGACAGGTTCGTGAGGGACTGCT 660 
 130   R  P  M  Y  R  G  E  E  Y  V  S  E  D  R  F  V  R  D  C  Y 149 
 
     ---------|---------|---------|---------|---------|---------| 
 661 ACAATATGTCAGTGACAGAGTACATCATAAAGCCGACTGAAGGAAAGAACAACAGCGAGC 720 
 150   N  M  S  V  T  E  Y  I  I  K  P  T  E  G  K  N  N  S  E  L 169 
 
     ---------|---------|---------|---------|---------|---------| 
 721 TAAACCAGTTGGATACCACGGTAAAGTCCCAAATTATTCGCGAGATGTGCATCACCGAGT 780 
 170   N  Q  L  D  T  T  V  K  S  Q  I  I  R  E  M  C  I  T  E  Y 189 
 
     ---------|---------|---------|---------|---------|---------| 
 781 ACAGGAGAGGATCGGGATTCAAAGTGCTCTCTAACCCTTGGCTGATCCTTACTATCACTC 840 
 190   R  R  G  S  G  F  K  V  L  S  N  P  W  L  I  L  T  I  T  L 209 
 
     ---------|---------|---------|---------|---------|---------| 
 841 TCTTTGTTTACTTTGTGATAGAGTGATCAAAGGAAATATTAATAAAAAGGCCAAATGTAT 900 
 210   F  V  Y  F  V  I  E  *                                     216 
 
 901 GTATATATAGAGAGAGTATAAACCGATTCTGAACTGTTCCGTCTCA 946 
                                                       
(d) X. laevis PRNP1-b (non-chimeric) 
 
     2 
   1 GACCCGGAATTCCCGGGATGATGGGAGCTCTCACTGCTGTAGTGTGTCAGCCTCACATGA 60 
                            
  61 GCTTCTCATTTGCCTTCCTGTAGCACAGCACCCGGACCTGACACCCACATAGCTTCTCTT 120 
 
     ---------|---------|-----3---|---------|---------|---------| 
 121 TGGCACACTCTATACCCTCACCCAGGTTGTTTATGATGCCACAAAGTCTCTGGACTTGTT 180 
   1                                    M  P  Q  S  L  W  T  C  L 9 
 
     ---------|---------|---------|---------|---------|---------| 
 181 TAGTCCTTATCTCCCTAGTATGCACATTGACTGTATCTTCCAAGAAGAGCGGTGGTGGGA 240 
  10   V  L  I  S  L  V  C  T  L  T  V  S  S  K  K  S  G  G  G  K 29 
 
     ----------Sequence continues as in PRNP1-a exon 3----------- 
 
(e) X. laevis PRND-a (chimeric) 
 
     1 
   1 ACTGTCACACTCCCAGACAAGAGCATTCCCCTCCTCCGACACGGACGTGAGGCCCAATTA 60 
  61 AGGGCAGTCCGCCCCCACCCCTCTCCTGCATGAAGTCTCTTCCCCTTCAGCTCATCCCTA 120 
 121 GTCTCACTGCTTTCCCGATCACCCTGGAACAGCTATCCTGAATCCCCCCCCTGGCACATC 180 
                                 2 
 181 CATTTCGTATTTTCCCCTTGGCACAGAGGCACAGCACCCGGACCTGACACCCACATACCT 240 
 
     ---------|---------|---------|-4-------|---------|---------| 
 241 TCTCTTTGGCACACTCTATACCCTCACCCAGGTGGCGACAGAATGGAAAGGCAGAACGTA 300 
   1                                           M  E  R  Q  N  V   6 
 
     ---------|---------|---------|---------|---------|---------| 
 301 TTCTCCTGCCTGATTCTTCTTGTGCTGATATTATATTGTGGTCTCTCTTGTCCGAGAAGA 360 
   7 F  S  C  L  I  L  L  V  L  I  L  Y  C  G  L  S  C  P  R  R   26 
 
     ---------|---------|---------|---------|---------|---------| 
 361 TCGGGAAGTGGCATTAAAAAATATTTCAAAATCAGCGACTTGAGCAGGGGAGCCAAAAAA 420 
  27 S  G  S  G  I  K  K  Y  F  K  I  S  D  L  S  R  G  A  K  K   46 
 
     ---------|---------|---------|---------|---------|---------| 
 421 AGGTCAAAAGTGGCCCATTCTCCTGTCCTCGGACACCTATTCTTCAGAAGTAAGGAGCTC 480 
  47 R  S  K  V  A  H  S  P  V  L  G  H  L  F  F  R  S  K  E  L   66 
41 
 
     ---------|---------|---------|---------|---------|---------| 
 481 GATGTGAACCTTAACTTCACCGAGGAATATGAGCTTTATACAGAGAATCTGTACAGATTC 540 
  67 D  V  N  L  N  F  T  E  E  Y  E  L  Y  T  E  N  L  Y  R  F   86 
 
     ---------|---------|---------|---------|---------|---------| 
 541 CCGGACGGACTTTACTACCCATGGCGCTCCCAGCTGAATGATGCTGCCGGCACGGAGGAG 600 
  87 P  D  G  L  Y  Y  P  W  R  S  Q  L  N  D  A  A  G  T  E  E   106 
 
     ---------|---------|---------|---------|---------|---------| 
 601 TTTATGAACGGGTGCCTTAACACCACCGTAGAGAGAAACAAGGTCTGGATCTCTGGACTG 660 
 107 F  M  N  G  C  L  N  T  T  V  E  R  N  K  V  W  I  S  G  L   126 
 
     ---------|---------|---------|---------|---------|---------| 
 661 GAAGAAGAGGACGAAGGGGAAACCTATATGAGTGTAGGCATGCAGGTCCTACAGTTTCTG 720 
 127 E  E  E  D  E  G  E  T  Y  M  S  V  G  M  Q  V  L  Q  F  L   146 
 
     ---------|---------|---------|---------|---------|---------| 
 721 TGTTATGAAAACTATGTAAAGCCTACCAATGGGGCAGTGACCTGCACAGGAGGACTGTGG 780 
 147 C  Y  E  N  Y  V  K  P  T  N  G  A  V  T  C  T  G  G  L  W   166 
 
     ---------|---------|---------|---------|---------|---------| 
 781 GTCTTCATAGGTGTCATTCACCTCCTTTTTTTTACTCAGAAAGGGAGTTAATGGGAACTA 840 
 167 V  F  I  G  V  I  H  L  L  F  F  T  Q  K  G  S  *            182 
 
 841 AAGCCTGAATTCTGTATTTCTTATATTGAACTaaatgtacccgcccagaggttcagcagc 900 
 901 tct 903 
 
(f) X. laevis PRND-b(1), PRND-b(2) (non-chimeric) 
 
     3 
   1 aaaggcccagatttaggcaggactcattacatctctacatgtttggcactcaggcccgga 60 
  61 ctgacaatctgcccgttcggggcccgccgtctgccctgcatgacactgtcccgtctgcag 120 
 121 ccccctcccacctccacagagcagagtaatatcacagagcagaggtgagggcaggactgc 180 
 181 agaaattttgaactagtgggggaggacgcccacctgacgccatcacacactggtctattt 240 
 241 acaaacagtggactggagacctgtattattactgggggaagctggagagaagtatttttt 300 
 301 tcagggcaaagcagagttggtgCTGAAAGTGGACTGGAGAGTGGGCCAGCAGTGTCTCAT 360 
                            
     ---------|---------|---------|---------4---------|---------| 
 361 CAGTCTGAAGAAGGAAGAAACAGCAGCAAAGGCTCTGAGGTGGTGACAGAATGGAAAGGC 420 
   1                                                   M  E  R  Q 4 
 
     ---------|---------|---------|---------|---------|---------| 
 421 AGAACGTATTCTCCTGCCTGATTCTTCTTGTGCTGATATTATATTGTGGTCTCTCTTGTC 480 
   5   N  V  F  S  C  L  I  L  L  V  L  I  L  Y  C  G  L  S  C  P 24 
       
     -----------Sequence continues as in PRND-a exon 4----------- 
 
(g) X. laevis PRNP2b-1 
     1 
1 GGCTGGACCGGTCCGGATTCCCGGGATGATCAGCCTGGCACAGCCGTCCTGAACCTCCCC 60 
 
                                 2 
   61 CTGTACAGGCACAGTCTTTCTGAATCCCCCCTGGCACAGAGGGCCTGACAGCCAGCTAGC 120 
 
      ---------|---------|---------|-----3---|---------|---------| 
  121 TTCTCTTTGGGCTTACTTATCCTCTCACACAGGTTGGCCAAGATGCCAAGAAGTCTCTGG 180 
    1                                           M  P  R  S  L  W   6 
 
      ---------|---------|---------|---------|---------|---------| 
  181 ACTTGTTTAGTCCTTATCTCCCTAGTGTGCACATTGACTGTATCTTCCAAGAAGAGTGGT 240 
    7 T  C  L  V  L  I  S  L  V  C  T  L  T  V  S  S  K  K  S  G   26 
 
      ---------|---------|---------|---------|---------|---------| 
  241 AGTGGGAAAAGCAAAACCGGAGGCTGGAACAATGGGAACACTGGGAACACCGGGAACACT 300 
   27 S  G  K  S  K  T  G  G  W  N  N  G  N  T  G  N  T  G  N  T   46 
 
      ---------|---------|---------|---------|---------|---------| 
  301 GGGAACAACCGGAACCCCAACTATCCAGGAGGCTATGGCTGGAACACAGGGAACACAGGG 360 
   47 G  N  N  R  N  P  N  Y  P  G  G  Y  G  W  N  T  G  N  T  G   66 
 
42 
      ---------|---------|---------|---------|---------|---------| 
  361 AACACTGGAGGCAGTTGGGGGCAACAACCTTATAATCCTAGCGGAGGAAGCAATTTCAAC 420 
   67 N  T  G  G  S  W  G  Q  Q  P  Y  N  P  S  G  G  S  N  F  N   86 
 
      ---------|---------|---------|---------|---------|---------| 
  421 AACAAGCAATGGAAACCTCCCAAGTCCAAAACCAATATGAAGGCCGTGGCCGTAGGCGCT 480 
   87 N  K  Q  W  K  P  P  K  S  K  T  N  M  K  A  V  A  V  G  A   106 
 
      ---------|---------|---------|---------|---------|---------| 
  481 GCTGCTGGTGCTATTGGAGGCTACATGCTTGGTAATGCAGTGGGTCGTATGAATCATCAT 540 
  107 A  A  G  A  I  G  G  Y  M  L  G  N  A  V  G  R  M  N  H  H   126 
 
      ---------|---------|---------|---------|---------|---------| 
  541 TTCGACAATCCCATGGAATCCCGTTATTATAACGACTACTACAACCAGATGCCAGACCGC 600 
  127 F  D  N  P  M  E  S  R  Y  Y  N  D  Y  Y  N  Q  M  P  D  R   146 
 
      ---------|---------|---------|---------|---------|---------| 
  601 GTTTACAGGCCAATGTACAAAACCGAGGAGTACGTGTCTGAAGATAGGTTCGTCACGGAT 660 
  147 V  Y  R  P  M  Y  K  T  E  E  Y  V  S  E  D  R  F  V  T  D   166 
 
      ---------|---------|---------|---------|---------|---------| 
  661 TGCTACAATATGTCAGTAACAGAGTACATCATCAAGCCATCCGAAGGGAAGAATGGCAGC 720 
  167 C  Y  N  M  S  V  T  E  Y  I  I  K  P  S  E  G  K  N  G  S   186 
 
      ---------|---------|---------|---------|---------|---------| 
  721 GATGTAAACCAGTTGGATACCGTGGTGAAATCCAAAATTATTCGCGAGATGTGCATCACT 780 
  187 D  V  N  Q  L  D  T  V  V  K  S  K  I  I  R  E  M  C  I  T   206 
 
      ---------|---------|---------|---------|---------|---------| 
  781 GAATACAGGAGAGGATCAGGATTCAAAGTGCTTTCTAACCCATGGCTGATCCTCACTATC 840 
  207 E  Y  R  R  G  S  G  F  K  V  L  S  N  P  W  L  I  L  T  I   226 
 
      ---------|---------|---------|---------|---------|---------| 
  841 ACTCTCTTTGTTTACTTTGTGATAGAGTGAccagagggaatcgaaatccaaaggccaatt 900 
  227 T  L  F  V  Y  F  V  I  E  *                                 235 
 
  901 gtatgtatatagagagtatcaaccaattctggactgtctcgtctcatgcccaatatgaca 960 
  961 ctgttgggtgctatgttaatccagcccagcttcctaccatcagtaagcaaccatggatct 1020 
 1021 tgcttcaataccaacctgaattcccacttctgcgtcaactacaacttctgcttgacaaca 1080 
 1081 catgtttctgacattgcaaatgggctttatgtatcagtgcatgtatataataagagatct 1140 
 1141 tcatt 1145 
 
(h) X. laevis PRNP2b-2 
     1’                                 2 
    1 gtccggaattctccggatcacgagcttctcatttgccttcctgtagggcctgacagccag 60 
 
      ---------|---------|---------|---------|3--------|---------| 
   61 CTAGCTTCTCTTTGGGCTTACTTATCCTCTCACACAGGTTGGCCAAGATGCCAAGAAGTC 120 
    1                                                M  P  R  S  L 5 
 
      ---------|---------|---------|---------|---------|---------| 
  121 TCTGGACTTGTTTAGTCCTTATCTCCCTAGTGTGCACATTGACTGTATCTTCCAAGAAGA 180 
    6   W  T  C  L  V  L  I  S  L  V  C  T  L  T  V  S  S  K  K  S 25 
 
     --------------Sequence continues as in PRNP2b-1-------------- 
Figure 3-1 Nucleotide and deduced amino acid sequences of cDNAs for chimeric and non-
chimeric transcripts. (a) X. tropicalis PRNP (chimeric), (b) X. tropicalis PRND (chimeric), (c) X. 
laevis PRNP1-a (chimeric), (d) X. laevis PRNP1-b (non-chimeric). (e) X. laevis PRND-a (chimeric), 
(f) X. laevis PRND-b(1), PRND-b(2) (non-chimeric), (g) X. laevis PRNP2b-1, (h) X. laevis PRNP2b-
2. Exons are numbered and non-coding exons are enclosed by full, dashed or dotted boxes. In the 
absence of genomic sequence for X. laevis the exon boundaries have been predicted based on 
alignments of cDNA sequences with those for X. tropicalis. The cDNA sequence corresponding to 
the ORF is highlighted in grey. The 5' or 3' end variants are represented by lower case letters. 
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Figure 3-2 Transcripts coding for PRNP and PRND. (a) X. tropicalis and (b) X. laevis. The first 
two non-coding exons are shared in the chimeric transcripts and the two products (PRNP and 
PRND) are generated by alternative splicing. The chimeric form of X. laevis PRND lacks an exon 
which is present in X. tropicalis. PRND-b(1) and PRND-b(2) have different start sites.  
 
3.3.2 X. laevis PRNP and PRND 
Primers constructed from X. tropicalis PRND (F3, R2; see Appendix 1) were used 
to amplify the genomic fragment corresponding to the X. laevis PRND ORF. Gene 
specific primers for X. laevis PRNP and PRND (see Appendix 1) were used to 
perform RACE on X. laevis brain cDNA as described in Methods (experiments 
performed by Tatiana Vassilieva). Sequencing of RACE products confirmed the 
shared 5’ ends for PRNP and PRND in X. laevis (Figure 3-2d). These chimeric 
variants are represented as PRNP-1a and PRND-a (Figure 3-2d). It is not possible 
   PRNP-1b 
   PRND-b(1)                     
        
                 
                    PRND-b(2) 
 X. tropicalis (PRNP and PRND gene locus)
 X. laevis (PRNP and PRND gene locus 1)
 X. laevis (PRNP gene locus 2) 
 1            2                                       3                                                                                 3                  4 
  PRNP                                                         PRND 
(a) 
   PRNP-1a                                           PRND-a (d) 
(e) 
(c) 
 1            2                                        3                                                          3                                        4 
(f) 
 1                1’        2                                3                    
 PRNP-2b-               PRNP-2b-  
           (1)                        (2) 
(g) 
(b) 
 X. tropicalis X. laevis 
 PRNP PRND PRNP1a PRNDa PRNP1b PRND-
b(1,2) 
PRNP-
2b(1) 
PRNP-
2b(2) 
Exon1 79v1 
44v2 
64 143v1 
115v2 
208 - - 44 Exon 
1’- 99 
Exon2 60 60 63 63 145 - 56 56 
Exon3 711 55 740 - 649 399v1 
77v2 
990 990 
Exon4 - 1083v1 
573v2 
- 633v1 
569v2 
- 633v1 
569v2 
- - 
Intron1 284 284 286 286 - - * 314 
Intron2 7676 27099 * * * - - - 
Intron3 - 1024 - - - * * * 
(h) 
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to definitively ascribe the exon-intron boundaries as the genomic sequence 
information is not available. Nonetheless, an attempt was made to define the 
boundaries based on the alignment of PRND and PRNP cDNA sequences from X. 
laevis and X. tropicalis. X. laevis PRND may have only three exons (Figure 3-2d).  
Comparison of PrP sequences for X. tropicalis and X. laevis shows, as expected, 
very strong conservation over the complete protein with two short 
insertions/deletions in N-terminal region (Figure 3-3). The C-terminal end is very 
well conserved, including complete conservation of signal sequence. Interestingly, 
X. laevis Dpl shows a larger number of sequence variations compared with X. 
tropicalis (Figure 3-3). This observation is consistent with the behaviors of a 
recently duplicated gene. Following gene duplication, one of the gene becomes 
functionally redundant and it either evolves rapidly to perform novel functions, 
subject to stabilizing selection, or may become a pseudogene relatively 
rapidly(Ohno 1970).  
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A              10        20        30        40        50        60   
        ....|....|....|....|....|....|....|....|....|....|....|....| 
XtPrP   MLRSLWTSLVLISLVCALTVSSKKSGSGKSKTGGWNSGSNRNPNYPGGYGWNTGGNTGGS  
XlPrP1  MPQSLWTCLVLISLVCTLTVSSKKSGGGKSKTGGWNTGSNRNPNYPGGY----PGNTGGS  
        * :****.********:*********.*********:************     ******  
 
                70        80        90       100       110       120  
        ....|....|....|....|....|....|....|....|....|....|....|....| 
XtPrP   WG-QPYNPSGGNNFNNKQWKPPKSKTNMKAVAVGAAAGAIGGYMLGNAMGRMSYHFSNPM  
XlPrP1  WGQQPYNPSG----YNKQWKPPKSKTNMKSVAIGAAAGAIGGYMLGNAVGRMSYQFNNPM  
        ** *******     **************:**:***************:*****:*.***  
 
                130       140       150       160       170       180  
        ....|....|....|....|....|....|....|....|....|....|....|....| 
XtPrP   EARYYNDYYNQMPERVYRPMYRGEEHVSEDRFVTDCYNMSVTEYIIKPAEGKNTSEVNQL  
XlPrP1  ESRYYNDYYNQMPNRVYRPMYRGEEYVSEDRFVRDCYNMSVTEYIIKPTEGKNNSELNQL  
        *:***********:***********:******* **************:****.**:***  
 
                190       200       210       220    
        ....|....|....|....|....|....|....|....|.... 
XtPrP   ETRVKSQIIREMCITEYRRGSGFKVLSNPWLILTITLFVYFVIE  
XlPrP1  DTTVKSQIIREMCITEYRRGSGFKVLSNPWLILTITLFVYFVIE  
        :* *****************************************  
 
 
B              10        20        30        40        50        60   
        ....|....|....|....|....|....|....|....|....|....|....|....| 
XtDpl   MGRQNLFSCLILLLLILYCSLSSPRRAAS-SKKISKTTDLSRGAKRRPKVTNSPALGDLS  
XlDpl   MERQNVFSCLILLVLILYCGLSCPRRSGSGIKKYFKISDLSRGAKKRSKVAHSPVLGHLF  
        * ***:*******:*****.**.***:.*  **  * :*******:*.**::**.**.*   
 
                 70        80        90       100       110       120  
        ....|....|....|....|....|....|....|....|....|....|....|....| 
XtDpl   FRGRALNVNFNLTEESELYTANLYSFPDGLYYPRPAHLSGAGGTDEFISGCLNTTIERNK  
XlDpl   FRSKELDVNLNFTEEYELYTENLYRFPDGLYYPWRSQLNDAAGTEEFMNGCLNTTVERNK  
        **.: *:**:*:*** **** *** ********  ::*..*.**:**:.******:****  
 
               130       140       150       160       170       180  
        ....|....|....|....|....|....|....|....|....|....|....|....| 
XtDpl   VWISQLEDDEEGDIYMSVATQVLQFLCMENYVKPTNGAVTCTGGLWVFIGVMHFFFLFRK  
XlDpl   VWISGLEEEDEGETYMSVGMQVLQFLCYENYVKPTNGAVTCTGGLWVFIGVIHLLFFTQK  
        **** **:::**: ****. ******* ***********************:*::*: :*  
 
         
        .. 
XtDpl   GD  
XlDpl   GS  
        *.   
Figure 3-3 Sequence comparisons for X. tropicalis and X. laevis (a) PrP and (b) Dpl.  
3.3.3 Generation of chimeric trancript 
The mapping of the cDNA sequences onto the genomic organization of the PRNP 
and PRND genes in X. tropicalis shows that these genes share the first two exons 
and a common promoter, and are therefore referred to as chimeric transcripts. This 
is evident from the fact that the 5’ ends of PRNP and PRND are nearly identical. 
Such a process of a single promoter being responsible for transcription of more 
than one gene is termed polycistronic transcription, and where it involves two 
(a)
(b)
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genes, as in this, it is termed dicistronic transcription. Other cases of polycistronic 
transcription have been reviewed by Blumenthal (Blumenthal 1998). The common 
primary dicistronic transcript is processed to give one of two alternative mature 
monocistronic transcripts, PRNP or PRND. Such a phenomenon of clustering and 
co-transcription could be a result of gene duplication (Blumenthal 1998). 
Interestingly, the PRNP coding region is entirely contained within the long second 
intron of PRND.  
This unusual and interesting phenomenon can be better understood by the 
following analysis applied to the available X. tropicalis genomic sequence. Once a 
polycistronic pre-mRNA is transcribed, a decision has to be made as to whether to 
form a PRNP or PRND monocistronic transcript. PRNP can be made by splicing 
and clipping/polyadenylation at the 3’ end of PRNP exon 3 (Figure 3-2a). 
Alternatively, the PRNP coding exon and a large non-coding intergenic sequence 
can be removed as an intron by a splice made at the second 5’ splice site to the 
third PRND exon, resulting in a functional PRND mRNA (Figure 3-2b). Possible 
explanations for mediation of this alternative splicing are through (1) exon skipping, 
(2) differences in acceptor site signal sequence, or (3) actions of exonic enhancers 
and silencers. 
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Figure 3-4 Schematic representation of dicistronic transcription leading to two different gene 
products, PrP and Dpl The numbering corresponds to the exon/intron number and the letter “P” 
and “D” represents PrP and Dpl respectively. Introns are represented by (’) and Splicing events are 
represented by “*”.  See text for more detailed explanation.  
 
3.3.3.1 Alternative splicing mediated by exon skipping 
Alfonso et al., (1994) proposed an explanatory model for such a phenomenon of 
coordinated gene expression using the example for transcripts of unc-17 and cha-1 
proteins in Caenorhabditis elegans; these transcripts also share the first exon and 
promoter. According to this model, the two proteins with related function are 
produced as a result of alternative splicing of a common mRNA precursor. Such a 
gene complex is referred to as a eukaryotic operon. They classified the rate of 
splicing into rapid and slow steps based on the complexity of the decision to be 
made for alternative splicing. Based on this hypothesis, the splicings of the 
common intron 1’, and PRND intron 3D’ (Figure 3-4) are rapid events as they do 
not affect the final outcome. This would be followed by two slow steps involving 
splicing at exon 2 (splice donor) and clipping/polyadenylation reactions to either 
3P 4D 1 2  3D 3D’          2P’ 1’ 
2D’
3D’ 
3P 4D 1 2  3D          2P’ 
1’ 
3P 1 2 
4D  3D          2P’ 
4D 1 2  3D 
3P          2P’ 
  *   * 
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48 
exon 3P or 3D (splice acceptor) (Figure 3-4). This is a slow process as once the 
clipping at the 3’ end of PRNP (exon 3P) is made, it is no longer possible to make 
the PRND mRNA. The alternative splicing by exon skipping involves a single exon 
that is either included or not included with a single splice donor (3’ end of exon 2) 
and two alternative splice acceptors (5’ end of 3P or 3D). As this splicing is a 
critical step, it is important that it be a slow reaction step to make a proper exon 
choice.  The lack of a canonical AATAAA signal in the 3’ end of the last PRNP 
exon may help in this slow reaction (Alfonso et al. 1994). The consensus 
sequence, TATAAA in the 3’ end of the PRNP gene in X. laevis (Strumbo et al. 
2001) (Figure 3-5b) may not be a true polyadenylation signal as this might 
otherwise influence the alternative splicing. Evidence to support this conjecture is 
that although such a region is present in the genomic DNA of X. tropicalis 3’ to the 
last PRNP exon, it is not included in the PRNP mRNA transcript (Figure 3-5a) 
suggesting that it may not correspond to the polyadenylation signal in X. laevis. 
The 3’ end of the last PRND exon in X. tropicalis has AATAAA whereas in X. laevis 
it is ACTAAA (Figure 3-5c, d). It is not evident whether these regions act as signals 
for polyadenylation for PRND. The lack of a proper polyadenylation signal in the 
last exon of PRNP may slow down the process of splicing and help in controlling 
the choice of exon selection. 
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(a). 3’ end of X. tropicalis Prnp 
 
AAGTCCCAAATTATTCGCGAGATGTGTATCACTGAGTACAGGAGAGGATCGGGATTTAAG 
GTGCTCTCTAACCCTTGGCTGATCCTCACTATCACTCTTTTTGTTTACTTTGTGATAGAG 
TGACCAGAGGGAAGGCCAAATGTATGTATATAGAGATTTAAAGAGAATATAAACCGATTC 
TGAACTGTCCTGTCTCACGCCCA 
 
(b). 3’ end of X. laevis Prnp 
 
AAGTCCCAAATTATTCGCGAGATGTGCATCACCGAGTACAGGAGAGGATCGGGATTCAAA 
GTGCTCTCTAACCCTTGGCTGATCCTTACTATCACTCTCTTTGTTTACTTTGTGATAGAG 
TGATCAAAGGAAATATTAATAAAAAGGCCAAATGTATGTATATATAGAGAGAGTATAAAC 
CGATTCTGAACTGTTCCGTCTCA 
 
(c). 3’ end of X. tropicalis Prnd 
 
CTACAGTTTCTCTGTATGGAAAATTATGTAAAGCCTACCAATGGGGCAGTGACCTGCACT 
GGTGGATTGTGGGTCTTTATAGGTGTCATGCATTTTTTTTTTTTATTTAGGAAGGGAGAC 
TAAAGCCTAGGAATTCTGTATTTTATATGAACTTTTAAGAACTAACTGTACTAGCCCAGA 
GGTTCAGCAGCCCTATAACAGCAATGATCCAGGCCTTCAAATTTGTCCACAGCAGCTCTT 
GGATCTCATCTTGGATCTTTTGAGTGTCAGTGACACTGCACATTCTCAGTGTGCAGGGCT 
GCTGTTAAAGACTACGCCATCTGTCATAGAATGCACGTTTCTACACAGGAATATACTCTA 
ATATATAGGAATATATGTGCATGCACCCTACTAATAGTTCAGCCTGCCAGAGATCACCAA 
GGAGTTGCATAGCCTTTTTTACAAACATATCCTTCATCTAAAACTTCATCTGTGACTTCT 
AATAGTCTTATAAATTACAACAGGAGCAATATTATATTCTATATTATATACATATAAGCA 
GGAATTATGGCTGCTGTTGTGCACACAGGGAAGTTGGAGGTTTGGCCACGGTTTGTTTTC 
CCCTTATTATAATTGATGAAATAAAAATCAGGTTAAACTGG 
 
(d). 3’ end of X. laevis Prnd 
 
CTGGAAGAAGAGGACGAAGGGGAAACCTATATGAGTGTAGGCATGCAGGTCCTACAGTTT 
CTGTGTTATGAAAACTATGTAAAGCCTACCAATGGGGCAGTGACCCGCACAGGAGGACTG 
TGAGTCTTCATAAGTGTCATTCACCTCCTTTTTTTTTACTCAGAAAGGGAGTTAATGGGA 
ACTAAAGCCTGAATTCTGTATTTCTTATATTGAACTAAATGTACCCGCCCAGAGGTTCAG 
CAGCTCT  
Figure 3-5 The 3’ ends of PRNP and PRND in X. tropicalis and X. laevis. Bases in bold 
correspond to the ORF. Bases highlighted in grey correspond to cDNA. Bases underlined 
correspond to shorter transcript. Bases which are boxed correspond to putative polyadenylation 
signal. (a) Bases not highlighted correspond to genomic DNA. This region is similar to the putative 
TATAAA site in (b) but is not included in the mRNA transcript. Also the putative polyadenylation 
sites in PRND (c) and (d) are also not conserved indicating that they may not be the true 
polyadenylation signal. 
 
3.3.3.2 Alternative splicing mediated by differences in acceptor site 
signal sequence 
Bailleul et al., (1997) reported the first mammalian example (OB-RGRP and OB-R) 
of genes sharing a promoter and the first two exons. They suggested that the 
acceptor splice site signal plays an important role in alternate splicing to produce 
different gene coding transcripts. The splice acceptor signal is comprised of a 
branch site located 20 - 50 bases upstream of the acceptor site with the consensus 
RNP
RNP
RND 
RND
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"CU(A/G)A(C/U)" and a pyrimidine-rich region upstream to the splice acceptor site 
(AG) (Figure 3-6a). This splice acceptor signal is not strong in either PRNP and 
PRND intron 2 (2P and 2D) (Figure 3-6c,d) due to a weak branch site and/or the 
presence of purine bases in the required pyrimidine-rich region. Two out of twelve 
nucleotides upstream to the splice acceptor site in PRNP intron 2P are purine while 
four out of twelve nucleotides are purine in PRND intron 2D. By comparison, PRNP 
intron 2 has a stronger splicing signal than PRND intron 2 and the latter also lacks 
the branch site needed for the splice signal (Figure 3-6d). These features likely 
determine the ratio between the PRNP and PRND transcripts.  
(a) Consensus for acceptor splice site. 
 
 
    CUPuAPy   APy-rich AG G 
 
 
(b) Common intron 1 
 
TGGCTGTAGCGTTTCACCCTCACATCAGCTTCTCATTTGCCTTCCTGTAGGCACCCACCAGAGCCTGGCA 
 
(c) PRNP intron 2P 
 
GTCACTTTTATGTGAACTCACTTGATTAAAATGATGTCTTTTCATTGTAGGTTTGCCATGATGCTAAGAA 
 
(d) PRND intron 2D 
 
GGTAGGAATCCTAGGGAAAATGTATGACCCCTTCCTTTTATATATCATAGGGTCACCATAGATCACCAATG 
 
(e) PRND intron 3D 
 
CCCTGATGTGTATACAAATCCCGATTTATTGTCATTTCTCTCTTTCGTAGGTGGTGACAGAATGGGAAGG 
 
Figure 3-6 Analysis of splice signal for PRNP and PRND. (a). The consensus sequence for 
splicing.  Purine (Pu) = A or G; Pyrimidine (Py) = C or U. The putative branch sites for PRNP 
and PRND are boxed in (b), (c), (d) and (e). The Py-rich region is highlighted in grey. Note that the 
branch site is not strong in all the introns and there are some purine bases in the Py-rich region with 
a maximum of such occurrences in PRND intron 2 which also lacks the branch site.  
 
3.3.3.3 Role of exonic enhancers and silencers 
Signals for splice-site recognition have been identified in intronic and exonic cis-
elements of genes which either act by stimulating (enhancers) or repressing 
20-50 bases
Branch Site
Splice 
acceptor site 
Intron Exon
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(silencers) splicing. Cartegni et al. (2002) proposed a model for enhancer-
dependent splicing whereby a Ser/Arg-rich protein is thought to bind to the exonic 
DNA though the RNA Recognition Motif and assist in the splicing process by 
directly recruiting splicing machinery. Such a regulated splicing may occur to 
strengthen weak splice sites and regulate the splicing to either PRNP or PRND.  
3.3.4 Non-chimeric transcripts in X. laevis    
Sequencing of 5’ RACE products (performed by Tatiana Vassilieva) indicated two 
additional splice variants for the PRND transcript with a different first exon than that 
found in chimeric PRND. Using left primers (LD5, LD6) constructed from these new 
exons I tried to amplify cDNA using PRNP right ORF primer (RP1) without 
success, confirming the existence of non-chimeric PRND, represented as PRND-b 
in Figure 3-2e. I also made an attempt to sequence the genomic DNA between 
these new PRND exons to determine their relative position but this was not 
successful.  
A PRNP sequence obtained from the EST database searches showed a different 
exon 1 but with the same exon 2 as in the chimeric form (Figure 3-2e). Sequencing 
results confirmed it as a non-chimeric PRNP transcript (PRNP-1b in Figure 3-2e) 
as no PCR product was obtained when either the new PRNP-1b exon 1 left primer 
(LP1) or the PRND exon 4 (Figure 3-2c) right primer (RD5) was used on cDNA 
from brain and testis. Genomic DNA sequencing results indicated that the new 
exon 1 is a 5’ extension of the common exon 2 (left primer: LP1; right primer: RP1) 
and, hence, the longer variant was represented as PRND-b(1) and the shorter 
variant as PRND-b(2).  
3.3.5 Duplicate of PrP in X.  laevis 
EST database searches revealed an X. laevis PrP sequence with some sequence 
variation from that which was already known (Strumbo et al. 2001). Sequence 
comparison of the new PrP sequence with that previously reported indicated two 
distinct PrP sequences, most likely encoded by two distinct genes in X. laevis. I 
designated the previously reported gene as PRNP1 and the new duplicate gene as 
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PRNP2, coding for PrP1 and PrP2, respectively. This represents the first discovery 
of retained PRNP duplicates in a tetrapod. The existence of duplicated genes is 
consistent with the genome duplication that occurred at least 30 million years ago 
(Hughes and Hughes 1993). X. laevis is a pseudo-tetraploid species which has 36 
chromosomes, as compared with the diploid number (20) in X. tropicalis. Several 
retained duplicates have been characterized (Hughes and Hughes 1993). The 
retention of PRNP2 indicates that these genes have been under strong selective 
pressure and that subfunctionalisation or neofunctionalisation would have been the 
factors in retaining the duplicate form. 
Sequences for PRNP2 from the EST database indicate two different first exons 
(exon 1 and exon 1’) but a common second exon (Figure 3-2g). PCR experiments 
confirmed the existence of these variant forms. Amplifying the genomic DNA 
between these exons (exon 1 and 2: Primer LP2 and RP2; exon 1’ and 2; primer 
LP3 and RP2) defined the size of only intron 1’. For the other transcript, there was 
no PCR product, indicating either that it may be rich in repeat regions or that the 
intron is large. The various PrP2 sequences obtained from the EST database 
showed sequence variation in the 3’ end (resulting in different C-terminal amino 
acid sequences) suggesting the possibility of alternative terminal exon usage 
(Figure 3-7c). In order to test this, different right primers (RP3, RP4 and RP5) were 
constructed from the different sequences and tried with the common left primer 
(LP4). Only one of the primers showed PCR product (LP4 and RP5). This result 
suggests the sequence variations likely result from sequencing errors. 
The two PrPs (PrP1 and PrP2) share high sequence homology (Figure 3-7a), with 
PrP2 showing maximum variation in the N-terminal region and the post 
hydrophobic region from residue 124-128 (“NHHFD”), which interestingly 
resembles the corresponding region of chicken and turtle PrP rather than X. laevis 
PrP1 (refer to Figure 6-5). An homology model for PrP2 based on the NMR 
structure of X. laevis PrP (Calzolai et al. 2005) was made to map the residues that 
differ from PrP1 (Figure 3-7b).  
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XlPrP1  MPQSLWTCLVLISLVCTLTVSSKKSGGGKSKTGGWN---------TGSNRNPNYPGGY-- 49  
XlPrP2  MPRSLWTCLVLVSLVCTLTVSSKKSGSGKSKTGGWNNGNTGNTGNTGNNRNPNYPGGYGW 60  
        **:********:**************.*********         **.**********   
 
XlPrP1  ----PGNTGGSWGQQPYNPSG----YNKQWKPPKSKTNMKSVAIGAAAGAIGGYMLGNAV 101  
XlPrP2  NTGNTGNTGGSWGQQPYNPSGGSNFNNKQWKPPKSKTNMKAVAVGAAAGAIGGYMLGNAV 120  
            .****************     **************:**:**************** 
 
 
                                                      # 
XlPrP1  GRMSYQFNNPMESRYYNDYYNQMPNRVYRPMYRGEEYVSEDRFVRDCYNMSVTEYIIKPA 161  
XlPrP2  GRMNHHFDNPMESRYYNDYYNQMPDRVYRPMYRSEEYVSEDRFVTDCYNMSVTEYIIKPS 180  
        ***.::*:****************:********.********** **************: 
 
 
                                                         # 
XlPrP1  EGKNNSELNQLDTTVKSQIIREMCITEYRRGSGFKVLSNPWLILTITLFVYFVIE 216  
XlPrP2  EGKNGSDVNQLDTVVKSKIIREMCITEYRRGSGFKVLSNPWLILTITLFVYFVIE 235  
        ****.*::*****.***:************************************* 
 
β1 
β2 α1 α2 
α3 
 
 
 
 
xlPrP2_Eye      CGATGTAAAACAGTTGGGATACCGGGGTGGAAATCCCAAATTATTCCGCGAGATGTGCCT 779 
xlPrP2_Brn3     CGATGTAAACCAGTTGG-ATACCGTGGTG-AAATCCAAAATTATTCCAAGTGCTCTGATC 636 
xlPrP2_Brn2     CGATGTAAACCAGTTGG-ATACCGTGGTG-AAATCCAAAATA--TTCGCGAGATGTGCAT 684 
xlPrP2_Brn1     CGATGTAAACCAGTTGGGATACCGCTGGTGAAATCCAAAATTATTCC-CGAGATGTGCAT 723 
xlPrP2_Test     CGATGTAAACCAGTTGG-ATACCGTGGTG-AAATCCAAAATTA-TTCGCGAGATGTGCAT 495 
                ********* ******* ******  *   ****** ****   * *  * * * **    
 
xlPrP2_Eye      CCCTGATTACGGGGAAAAGACCGGGTCTTCNGGGGTGCTTTTCTAACCCAGGGGGATAAT 839 
xlPrP2_Brn3     GAAGCGTCA----GTCACGACCACCCTTTGAGGAGTAGAN-------------------- 672 
xlPrP2_Brn2     CACTGAATACAG-GAGAGGATCAGGATTCAAAGTGC---TTTCTAACCCATGGGC-TGAT 739 
xlPrP2_Brn1     CACTGAATACAG-GAGAGGATCAGGATTCAAAGTGC---TTTCTAACCCATGGGC-TGAT 778 
xlPrP2_Test     CACTGAATACAG-GAGAGGATCAGGATTCAAAGTGC---TTTCTAACCCATGGC--TGAT 549 
                        *    *  * ** *     *    * *                          
 
xlPrP2_Eye      CCTCCAAAAACCACTTCCTTTTTGGTTAACTTTTGGTGAATAAAGTGAACCAGGAAGGGA 899 
xlPrP2_Brn3     ------------------------------------------------------------ 
xlPrP2_Brn2     CCTC--ACTATCAC--CCTCTTTGGTTAACTTTGTG---ATAGAGTGACCCAGG--GGGA 790 
xlPrP2_Brn1     CCTC--ACTATCAC--TCTCTTTGTTTACTTTTGGG---ATAGAGTGACCCAAA--GGGG 829 
xlPrP2_Test     CCTC--ACTATCAC--TCTCTTTGTTTACTTTGTGA----TAGAGTGA-CCAGA---GGG 597 
                                                                             
 
xlPrP2_Eye      ATTC-------------------------------------------------------- 903 
xlPrP2_Brn3     ------------------------------------------------------------ 
xlPrP2_Brn2     ATTCGAAATCCAAAGGCCCATTTGTATGTAATATAGAAGAGTATCCAACCAATTTCTGAA 850 
xlPrP2_Brn1     AATCCAAATCCCAAGGCCAATTGGTATGTTATATAGAAGAGTATCAACCCAATTCTGAAA 889 
xlPrP2_Test     AATCGAAATCCAAAGGCCAATTGTATGTATATAGAGAGTATCAACCAATTCTGGACTGTC 657  
Figure 3-7 Sequence analysis of X. laevis PrP2. (a) Pairwise alignment of X. laevis PrP1 and 
PrP2. The secondary structural components are shown above the sequence (arrows indicate 
cleavage site; Cys involved in disulphide bridge are represented by #). (b) The NMR structure of X. 
laevis PrP1 (PDB 1XU0) with the substituted residues between PrP1 and PrP2 labeled and 
highlighted in red. Model of PrP2 (modeled using Modeller with 1XU0 as template) is shown next to 
it for comparison. (c) 3’ ends of PrP2 sequences from different tissue sources (Brn1, Brn2, Brn3 –
brain; Test- testis). Bases highlighted in grey indicate sequences corresponding to ORF. Note the 
different stop codons. 
PrP1 PrP2
a 
b 
c 
N 
C 
N 
C Gly168 
Arg179 
Ala194
Glu201
Leu202 
Thr208
Gln212
Asn159
Asn142
Gln140
Tyr139 Ser138
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Attempts to isolate a duplicate form of PRND in X. laevis were unsuccessful. This 
may be due to loss of this gene or to extreme divergence from the original 
sequence. The availability of genomic sequence for the PRNP2 gene environment 
is necessary to resolve the question whether the duplicate form of PRND exists in 
X. laevis. 
  
3.3.6 Tissue expression of PRNP and PRND in X. laevis 
Tissue expression experiments using RT-PCR for X. laevis PRNP1, PRNP2 and 
PRND transcripts together with their variant forms were performed (Figure 3-8).  
Expression of PRND variants: The expression of PRND variants is tissue specific 
with the chimeric form (PRND-a) expressed in a wide range of tissues and 
predominantly in brain. The non-chimeric variants (PRND-b(1) and PRND-b(2))  
are restricted to testis, eye and pancreas and, significantly, show no expression in 
adult brain. This latter finding resembles the expression pattern of higher 
vertebrates (i.e. higher expression testis and none in brain). This differential 
expression is due to usage of two different promoters.  
Expression of PRNP1 variants: PRNP1 chimeric variant (PRNP-1a) showed 
expression in all the tissues analyzed suggesting a possible house-keeping 
function. The non-chimeric variant of PRNP1 (PRNP-1b) though widely expressed 
is, interestingly, absent in testis, also suggesting a different promoter usage.  
Expression of PRNP2 variants: PRNP2 forms also show expression in a range of 
tissues but are absent in a few. The coexistence of PRNP1 and PRNP2 in various 
tissues suggests that they may be performing slightly different functions and hence 
PRNP2 was retained. Although there is general consistency in the expression 
patterns of PRNP2 variants (PRNP-2b-1 and PRNP-2b-1), they appear to be 
expressed at different levels as evident by the relative contrast of the PCR bands. 
However, quantitative analysis using Real time PCR experiments was not 
performed. 
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Comparison of expression of PRNP1 with PRNP2: In general, expression 
between the two duplicate forms varies only slightly. The most significant 
difference is that PRNP2 is missing in the liver and in the gall bladder. This pattern 
matches that reported in mammals; expression of PrP was absent in liver of sheep 
(Horiuchi et al. 1995). It is tempting to speculate that PRNP2 functions have 
evolved to resemble those of PRNP in higher vertebrates, an idea also supported 
by the existence of small insertions in the N-terminal sequence of PRNP2. 
 
Figure 3-8 Compilation of gel picture from different experiments showing the expression 
pattern in different tissues along the horizontal axis and the different variants (see Figure 
3-2) tested along the vertical axis. GAPDH was used as a positive control.  
 
3.3.7 Genomic environment of PRNP in X. tropicalis 
The release of the assembled version (version 3) of X. tropicalis (http://genome.jgi-
psf.org/Xentr3/Xentr3.home.html) enabled me to define the complete genomic 
environment for PRNP. This version of the assembly shows PRNP and PRND 
sequence in Scaffold 110. The nucleotide sequence upstream (50 kb) and 
downstream (50 kb) to the PRND ORF was analysed by GenScan (Burge and 
Karlin, 1997). Although it failed to predict PRND and PRNP, Rassf2 and SCL23A1 
were predicted in a position downstream to PRND. The organization and 
orientation of PRNP, PRND, Rassf2 and SCL23A1 is consistent with that of the 
mammalian PRNP/PRND environment indicating that this region has been 
conserved for 360 million years (Figure 3-9).  
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Figure 3-9 Genomic context of PRNP gene as in Xenopus, Mouse and Human. The gene 
organization and orientation is conserved. For Xenopus, the dotted lines represent the chimeric 
transcript.  
 
3.3.8 Sequence analysis of Xenopus Dpl 
Xenopus Dpl is slightly longer than the other known Dpl sequences (X. laevis 182 
residues, X. tropicalis 181 residues, mouse 179 residues, human 176 residues). As 
in its mammalian counterpart, the Dpl sequence contains a sequence motif at the 
N-terminus, which encodes signals for targeting to cellular compartments like the 
ER for posttranslational modifications, as well as hydrophobic C-terminal region for 
addition of a GPI-anchor (Figure 3-10). The signal-peptide cleavage site is 
predicted by SignalP to be between residues 27 and 28 (RRA-AS) in X. tropicalis, 
and between residues 22 and 23 (GLS-CP) in X. laevis (Nielsen et al. 1997). Dpl 
has been reported to undergo other posttranslational modifications including 
addition of a GPI-anchor and N-glycosylation (Silverman et al. 2000). The Big-Pi 
tool was used to predict the C-terminal sites (Eisenhaber et al., 1999) for GPI-
anchor attachment. These were Asn155 in X. tropicalis and Asn156 in X. laevis 
Dpls. X. tropicalis and X. laevis Dpl have two consensus N-glycosylation sites of 
form N-X-T. Although the second site (X. tropicalis: Asn 112) is conserved in 
position with other mammalian Dpls, the first site (X. tropicalis: Asn 70) is more N-
terminally located than its mammalian counterpart (Figures 3-10 and 3-11).  The 
location of the glycan attachment site can alter the behavior of glycoproteins, 
making them more soluble or stable, protecting them locally from proteolysis or 
aggregation, or masking their antigenic sites (Dwek 1996; Rudd et al. 1999; 
Xenopus 
0                         50                      100                     150                    200                     250                     300                     
Mouse 
Human 
    PRNP       PRND       PRNT         Rassf2          SCL23A1 
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Wormald and Dwek 1999; Helenius and Aebi 2001). Such factors explain the 
difference in the position of the first glycosylation site.  
Qin et al. (2003) reported that His 131 binds to copper in mouse Dpl. Xenopus Dpl 
lacks this His residue. However, both bovine and ovine Dpl also lack His residue at 
this position. Xenopus Dpl has the least number of His residues (two) and none of 
its positions are conserved as compared with mammalian Dpls (Figure 3-11). 
Together, these results argue that copper binding is not an important function of 
Dpl. 
The overall sequence conservation between Xenopus Dpl and mammalian Dpl is 
low. The well conserved mammalian sequence (AFI) of the first β-strand is not 
conserved in Xenopus Dpl (residues 58-60) which has DLS in X. tropicalis and HLF 
for X. laevis (Figure 3-11). The longest continuous stretch of identical residues in 
mammalian and Xenopus Dpls (residues 86-89) is “FPDG”, corresponding to the 
region at the start of the second β strand.  
The pairwise global alignment of X. tropicalis Dpl with other mammalian Dpl 
sequences showed a maximum sequence identity of 26% with ovine Dpl (45% 
similarity) and a minimum of 19 % in human (35% similarity). The low overall 
sequence conservation suggests that the functions of Dpl in these two vertebrate 
groups have diverged significantly since the divergence of amphibian from the 
common ancestor 360 million years ago (Kumar and Hedges 1998).  
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Figure 3-10 Schematic diagram of the structure of X. tropicalis Dpl and PrP, together with 
Mouse (Dpl and PrP) and Chicken (PrP) for comparison. 
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                10        20       30        40        50        60  
       ....|....|....|....|....|....|....|....|....|....|....|....| 
                                          
MoDpl  MKNRLGTWWVAILCMLLASHLSTVKARGIKHRFKWNRKVLPSSGGQITEARVAENRPGAF  
HuDpl  MRKHLSWWWLATVCMLLFSHLSAVQTRGIKHRIKWNRKALPSTA-QITEAQVAENRPGAF  
OvDpl  MRKHLGGCWLAIVCVLLFSQLSSVKARGIKHRIKWNRKVLPSTS-QVTEAHTAEIRPGAF  
BoDpl  MRKHLGGCWLAIVCILLFSQLCSVKARGIKHRIKWNRKVLPSTS-QVTEARTAEIRPGAF  
XtDpl  MGRQNLFSCLILLLLILYCSLSSPRRAAS-SKKISKTTDLSRGAKRRPK-VTNSPALGDL  
XlDpl  MERQNVFSCLILLVLILYCGLSCPRRSGSGIKKYFKISDLSRGAKKRSK-VAHSPVLGHL  
 
                70        80        90       100       110       120  
       ....|....|....|....|....|....|....|....|....|....|....|....| 
 
                                          #               * 
MoDpl  IKQGRKLDIDFG-AEGNRYYAANYWQFPDGIYYEGCSEAN--VTKEMLVTSCVNATQAAN  
HuDpl  IKQGRKLDIDFG-AEGNRYYEANYWQFPDGIHYNGCSEAN--VTKEAFVTGCINATQAAN  
OvDpl  IKQGRKLDINFG-VEGNRYYEANYWQFPDGIHYNGCSEAN--VTKEKFVTSCINATQVAN  
BoDpl  IKQGRKLDIDFG-VEGNRYYEANYWQFPDGIHYNGCSKAN--VTKEKFITSCINATQAAN  
XtDpl  SFRGRALNVNFNLTEESELYTANLYSFPDGLYYPRPAHLSGAGGTDEFISGCLNTTIERN  
XlDpl  FFRSKELDVNLNFTEEYELYTENLYRFPDGLYYPWRSQLNDAAGTEEFMNGCLNTTVERN  
 
               130       140       150       160       170       180  
       ....|....|....|....|....|....|....|....|....|....|....|....| 
 
                                  *    #        
MoDpl  QAEFSREKQDS--KLHQRVLWRLIKEICSAKHCDFWLERGAALRVAVDQPAMVCLLGFVW  
HuDpl  QGEFQKP--DN--KLHQQVLWRLVQELCSLKHCEFWLERGAGLRVTMHQPVLLCLLALIW  
OvDpl  QEELSREKQDN--KLYQRVLWQLIRELCSIKHCDFWLERGAGLQVTLDQPMMLCLLVFIW  
BoDpl  QEELSREKQDN--KLYQRVLWQLIRELCSTKHCDFWLERGAGLRVTLDQPMMLCLLVFIW  
XtDpl  KVWISQLEDDEEGDIYMSVATQVLQFLCMEN---YVKPTNGAVTCTGGLWVFIGVMHFFF  
XlDpl  KVWISGLEEEDEGETYMSVGMQVLQFLCYEN---YVKPTNGAVTCTGGLWVFIGVIHLLF  
 
              
       ....|. 
MoDpl  FIVK--  
HuDpl  LTVK--  
OvDpl  FIVK--  
BoDpl  FIVK--  
XtDpl  LFRKGD  
XlDpl  FTQKGS   
Figure 3-11 Multiple sequence alignment of Dpl sequences from six different species. The 
secondary structural units are indicated based on mouse Dpl structure (PDB 1I17).  The N-
glycosylation sites are indicated in red boxes. The Histidine residues are highlighted in black. Cys 
involved in disulphide bridge: *, #; Cleavage site: ↓. (MoDpl: Mouse Dpl, HuDpl: Human Dpl, OvDpl: 
Ovine Dpl, BoDpl: Bovine Dpl, XtDpl: X. tropicalis Dpl, XlDpl: X. laevis Dpl).  
 
3.3.9 Comparison of C-terminal domain 
As the putatively folded domain of Xenopus Dpl is more conserved than the 
apparently disordered N-terminal region of the protein, the C-terminal domains of 
PrP and Dpl were compared among Xenopus and mammals. A comparison of PrP 
with Dpl within the same species was performed to calculate the percentage 
identity (Figure 3-12). A higher sequence identity might be expected between 
Xenopus Dpl and PrP compared with that for mammals, considering it to be at an 
early stage after duplication. But the percentage similarity between the C-terminal 
domain of mouse PrP and Dpl was 42%, which is only slightly higher than that 
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between Xenopus PrP and Dpl, at 39%. The latter finding suggests rapid mutations 
have occurred during 360 million years of independent evolution as the functions of 
amphibian Dpl have evolved.  
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(a)                                                                        ↓ 
MoDpl  1  MKNRLGTWWVAILCMLLASHLSTVKARGIKHRFKWNRKVLPSSG--GQITEA----RVAE 54 
          | | ||  |   |           | |             |  |  |                
MoPrP  1  MAN-LG-YWLLALFVTMWTDVGLCKKRPKPGGWNTGGSRYPGQGSAGAAAAGAVVG--GL 124   
                                 ↑ 
 
                                                    ●   ▲         ○ ♦ 
MoDpl  55 NRPGAFIKQGRKLDIDFG-AEGNRYYAANYWQFPDGIYYEGCSEANVTKEMLVTSCVNAT 113 
                        | ||     |||  |    |   ||             |  ||| |  
MoPrP 125 GG-YMLGSAMSRPMIHFGNDWEDRYYRENMYRYPNQVYYRPVDQ-YSNQNNFVHDCVNIT 182  
                    
 
                                          ○        ●      ↓ 
MoDpl 114 QAAN-QAEF--SREKQDSKLHQRVLWRLIKEICSAKH---CDFWLERGAA------LRVA 161 
                                    |     |                         |  
MoPrP 183 IKQHTVTTTTKGENF--TETDVKMMERVVEQMCVTQYQKESQAY-----YDGRRSSSTVL 235  
                       ▼                                    ↑ 
 
MoDpl 162 VDQPAMVCLLGFVWF-IVK 179  
             |    |  |  | || 
MoPrP 236 FSSPPVILLISFLIFLIVG 254  
 
(b)  
                                                                              ↓ 
XtDpl  1  MGRQNLFSCLILLLLILYCSLSSPRRAAS-SKKISKTTDLSRGAKRRPKVTNS------- 52   
          | |      | |  |   | |          |        |            
XlDpl  1  MERQNVFSCLILLVLILYCGLSCPRRSGSGIKKYFKISDLSRGAKKRSKVAHS------- 53   
          | |      | |  |   | |          |        | 
XlPrP  1  MLR-SLWTSLVLISLV--CALTVSSKKSGSGK-SKTGGWNSGSNRNPNYPGGYAVGAAAG 90   
                                   ↑ 
 
                            ▲                                       ○ 
XtDpl  52 -PALGDLSFRGRALNVNFNLTEESELYTANLYSFPDGLYYPRPAHLSGAGGTDEFISGCL 111  
                |          :|   |:  |       |   | |           : |   | 
XlDpl  53 -PVLGHLFFRSKELDVNLNFTEEYELYTENLYRFPDGLYYPWRSQLNDAAGTEEFMNGCL 112  
                |          :|   |:  |       |   | |           : |   | 
XlPrP  91 AIGGYMLGNAVGRMSYQFNNPMESRYYNDYYNQMPNRVYRP-MYRGEEYVSEDRFVRDCY 149  
 
          ♦                                  ○         ↓      
XtDpl 112 NTTIER-NKVWISQLEDDEEGDIYMSVATQVLQFLCMENYVKPT-NG-AVTCTGGLWVFI 168  
          |                 :       |  |     |   |      |         |      
XlDpl 113 NTTVER-NKVWISGLEEEDEGETYMSVGMQVLQFLCYENYVKPT-NG-AVTCTGGLWVFI 169  
          |  |         |    :       |  |     |   |      |         | 
XlPrP 150 NMSVTEYIIKPAEGKNNSELNQLDTTVKSQIIREMCITEY----RRGSGFKVLSNPWLIL 205  
                          ▼                          ↑ 
 
XtDpl 169 GVMHFFFLFRKGD 181  
              : 
XlDpl 170 GVIHLLFFTQKGS 182  
              :  | 
XlPrP 206 TITLFVYFVIE-- 216  
Figure 3-12 Sequence comparison of PrP and Dpl in (a) mouse and (b) Xenopus.  Identical 
residues between  PrP and Dpl are shown by “|”. Identical residues between XtDpl and XlPrP not present 
in XlDpl are represented by “:”. Secondary structural units: Helix; Sheet 
 
Glycosylation: ♦ PrP, Dpl; ▲ Dpl; ▼ PrP; 
○ S-S PrP, Dpl; ● 2nd S-S Mo Dpl;   
↓↑ Signal sequence; 
 
 Truncated repeats. 
 44-111 
 50-83 
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3.3.10 Comparison of Dpl sequences  
Peoch et al. (2000) reported the possible involvement of genetic variation in 
(human) Dpl in the etiology of human prion diseases. Four polymorphisms in 
PRND (three protein coding changes, human- T26M, P56L and T174M and a silent 
polymorphism, T174T) were detected but no strong association was reported 
between any of these polymorphisms and human prion diseases. There was some 
indication for a role in other human diseases. None of these residues is conserved 
in Xenopus suggesting these residues do not play a critical functional role, or if so 
then it was acquired at a later stage of evolution. 
 
3.3.11 Xenopus Dpl model 
A homology model for Xenopus Dpl built by the program MODELLER using mouse 
Dpl as template (Figure 3-13b) exhibited a similar structural fold except that the 
plane of the first β-strand (β1) is perpendicular to the long axis of the helices rather 
than being parallel. This feature resembles that for mammalian or Xenopus PrPs 
(Calzolai et al. 2005). The notable difference is that Xenopus Dpl has only one 
disulphide bridge as opposed to two in mammalian Dpl, suggesting that 
mammalian Dpl has acquired the second disulphide bridge at the later stages of 
evolution for more structural stability. Significantly, PrP in all species has only one 
disulphide bridge in the position corresponding to that in Xenopus Dpl. One of the 
N-glycosylation sites is displaced from the loop region between β2 and α2 to the 
loop region between β1 to α1 (Figure 3-9, Figure 3-11, Figure 3-13a,b). ConSurf 
(Glaser et al. 2003), which uses a color coding system to represent the degree of 
conservation, was used to plot the most conserved residues onto the mouse Dpl 
structure (Figure 3-13a). Amino acid residues that are critical for structure and 
function are expected to be conserved throughout evolution and though these 
conserved residues may be widely distributed in the sequence, some usually show 
spatial proximity.  There are two major regions of the folded domain where groups 
of residues (clusters) are conserved.  
63 
The first region (group-1) is associated with α1 and its preceding loop, β1 and its 
preceding loop, and α3 (Gly-64, Arg-65, Leu-67, Phe-71, Glu-74, Tyr-79, Ala-81, 
Asn-82, Phe-86, Pro-87, Asp-88, Gly-89 and Val-34) (Figure 3-13c). The 
conserved residues are located largely in the interior, shielded from solvent, and 
are mainly constituted by hydrophobic residues. In the second region (group-2), the 
six residues (Gly-58, Tyr-92, Cys-109, Asn-111, Thr-113 and Asn-117) are closely 
associated (Figure 3-13c). The other conserved residues include Ser-96, Asn-99, 
Glu-93, Leu-95, Ser-122, Asp-127 (Figure 3-13). These observations suggest that 
part of the sequence conservation is associated with the maintenance of structural 
integrity of the protein, and that whatever functional similarity is preserved between 
Dpl in higher and lower vertebrates may be associated with these regions and the 
remaining conserved residues. Mouse Cys-148 and Cys-95 are involved in the 
second disulphide bridge formation; Xenopus Dpl lacks both these Cys residues  
(Figure 3-12).  
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Figure 3-13 Analysis of Xenopus Dpl model and conserved residues. (a) Conservation of the 
residues projected on mouse Dpl (51- 157) (PDB id 1I17) based on sequences from human, 
mouse, sheep, cow and Xenopus. (b) A predicted model of Xenopus Dpl. Cys and Asn involved in 
disulphide bridge formation and N-glycosylation are labeled. Note the difference in the 
Glycosylation site 1 between mouse and Xenopus. (c) Highly conserved residues are grouped into 
clusters in three dimensional spaces though the residues are widely separated at the primary 
sequence level. Scale of conservation to interpret the color code in (a).  
 
3.4 Conclusion 
This is the first evidence for Dpl in early vertebrates. The organization of the 
PRNP/PRND locus and of the cDNAs strongly suggests the existence of a 
common primary dicistronic transcript, which is processed to give one or other of 
the two alternative mature transcripts. This suggests a functional requirement for 
coordinated expression of PRNP and PRND. In addition, non-chimeric transcripts 
for PRNP and PRND were found in lower abundance due to a ‘juvenile’ promoter. 
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In this scenario, the presence of non-chimeric transcripts indicates an inclination to 
evolve as two independent genes as is the case in higher vertebrates. The co-
existence of chimeric and non-chimeric transcripts suggests an effective 
mechanism whereby an 'infant' gene, apparently tandemly duplicated without its 
promoter, can survive and begin to develop novel functions. It does this through 
sharing the promoter of its gene 'mother', but while also developing its own 
independent promoter de novo. This is evident by the differential expression of the 
dicistronic and monocistronic PRND transcripts. The former resembles the widely 
distributed PRNP expression, including high expression in brain, whereas the latter 
shows a more restricted pattern similar to that of PRND in adult mammals, 
specifically high expression in testis and none in brain.  The existence of a chimeric 
PRND transcript was first reported in mouse (Moore et al. 1999). However, this 
transcript was expressed at extremely low levels and the predominant transcripts 
are that of non-chimeric form. The transformation of the predominant chimeric 
PRND transcript in Xenopus to a predominant non-chimeric PRND transcript in 
mouse strongly suggests a process of functional specialization with development of 
its own stronger promoter in higher vertebrates.  
The other finding for duplicates is that both PRNP genes (PRNP1 and PRNP2) are 
retained in the tetraploid X. laevis, but only one PRND gene appears to have been 
retained. Several studies have reported retention and diversification by 
subfunctionalization of genomic gene duplicates in X. laevis (Wu et al. 2003).  The 
findings for PRNP provided an opportunity to compare expression patterns and 
protein sequence of the two variants during this quite short time from duplication, 
as well as compare these features with the single PRNP gene of the diploid X. 
tropicalis. The existence of a duplicate of PRNP in X. laevis raises questions about 
its role of either subfunctionalisation or neofunctionlisation. However, the wide 
expression of PrP1 and PrP2 in almost all the tissues tested may not support the 
subfunctionlisation theory wherein a complementary loss of tissue expression 
would have been expected. This may be due to slightly diverged functions being 
performed by both the proteins. 
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The discovery of the primitive form of Dpl enabled me to perform sequence 
comparison which led to the identification of key residues that may be critical for 
function or fold stability. 
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4 Findings in chicken 
 
4.1 Background 
Chicken PrP was the first reported avian PrP (Harris et al. 1991; Gabriel et al. 
1992). The previous structural analysis performed on chicken PrP suggested that 
the N-terminal region is structurally different from the corresponding region in 
mammalian PrP (Marcotte and Eisenberg 1999). It was also suggested that the 
mature chicken PrP, unlike its synthetic peptide (Hornshaw et al. 1995), does not 
bind to copper (Marcotte and Eisenberg 1999), one of the proposed functions of 
mammalian PrP (Brown et al. 1997). This probably is the result of the residues 
involved in copper binding being buried by the rest of the protein (Marcotte and 
Eisenberg 1999). Wopner et al. (1999) performed a comparative analysis of 
mammalian and avian species. They observed that though the identity among 
avian PrPs was about 90%, it reduced to 30% identity compared with mammalian 
PrPs, with about 55% identity at the C-terminal domain (Gabriel et al. 1992).  
Within reported avian PrPs, chicken PrP was the most divergent species (Wopfner 
et al. 1999). The NMR structure of the recombinant PrP from chicken has the same 
molecular architecture as mammalian PrP (Calzolai et al. 2005). 
In order to understand the evolutionary events that took place in the PRNP locus 
between amphibian and higher vertebrates, I analyzed the avian PRNP gene 
region, based on chicken for which the genome sequence is available (Wallis et al. 
2004). Interestingly, this locus differed significantly from that in Xenopus (Chapter 
3). It lacked the expected PRND, and instead I discovered a novel coding region 
found downstream and in opposite orientation to PRNP with similarities to Sho, 
which I named Sho-like. 
In an attempt to understand the evolutionary events that led to an apparent loss of 
the PRND gene and the existence of the Sho-like gene in chicken, I investigated 
two species which are evolutionarily more closely related to chicken: emu (another 
bird) and alligator (a reptile).  
68 
 
4.2 Materials and Methods 
4.2.1 Computational analysis 
The chicken genome was screened for Dpl using the homology-based method, 
TBLASTN (Altschul et al. 1990). Various BLAST parameters (repeat masker turned 
off, gapped BLAST) were tried using a range of different query sequences. Initially, 
a local BLAST database was created for chicken chromosome 22 containing the 
PRNP gene locus. This was later expanded to the whole genome. Six-frame 
translation and the ORF analysis was performed using the EMBOSS applications 
(Rice et al. 2000) sixpack and getORF. Ab-initio gene predictions were performed 
using GenScan (http://genes.mit.edu/GENSCAN.html). Mapping of exons onto 
genomic DNA was performed using the EMBOSS application est2genome. Signal 
peptide sequence was predicted using SignalP 
(http://www.cbs.dtu.dk/services/SignalP/), GPI anchor attachment by big-Pi 
(http://mendel.imp.ac.at/gpi/gpi_server.html), nuclear localization signal (NLS) 
using PredictNLS (http://cubic.bioc.columbia.edu/cgi/var/nair/resonline.pl), and 
topology prediction using TopPred 
(http://bioweb.pasteur.fr/seqanal/interfaces/toppred.html). Multiple sequence 
alignments were performed using ClustalW (http://www.ebi.ac.uk/clustalw/). 
Alignments were edited using BioEdit 
(http://www.mbio.ncsu.edu/BioEdit/bioedit.html). The sequences used in the 
analysis are listed in Table 4-1. Phylogenetic analysis was performed using a 
maximum likelihood method, PROTML implemented by MOLPHY (Adachi and 
Hasegawa 1996) with the JTT-F model for amino acid substitution. Avian PrP 
sequences were obtained by BLASTing chicken PrP sequence against the NCBI nr 
protein sequence database (Table 4-1). Platypus PrP sequence was obtained from 
the NCBI trace archive by BLASTing M. domestica PrP sequence using TBLASTN 
(see Chapter 5). 
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Table 4-1 Sequences used for multiple sequence alignments  
 
Sequence Source 
Mammal  
Human ref|NP_001009093.1| 
Mouse ref|NP_035300.1| 
Rat ref|NP_036763.1| 
Sheep ref|NP_001009481.1| 
Cow ref|NP_851358.1| 
Reptile  
Pelodiscus BAC66701.1 
Turtle  
Bird 
CAB81568.1 
 
Taeniopygia   CAL59565.1 
Balearica        AAD47046.1 
Pachyptila      AAD47050.1 
Melopsittacus  AAR21237.1 
Chicken            NP_990796.1 
Anas                 AAF82604.1 
Columba           AAF73436.1 
Coturnix           AAF73437.1 
Pavo                 AAR21236.1 
Tyto                  AAD47049.1 
Vultur               AAD47045.1 
Pelodiscus BAC66701.1 
Ostrich 
Fish 
AAD47048.1 
 
Fugu Sho2 CAG34292.1 
Tetraodon Sho2 AL239301 
Zebrafish Sho2 AAT72771.1 
Fugu PrP-like Scaffold_7 (version 4): 
2849936 to 2850464 
Tetraodon PrP-like Chromosome 12 (version 7) 
Zebrafish PrP-like Chr:8 (version 7): 38803941 
to 38804505 
Monotreme  
Platypus Trace read: 723211856; 
Assembly version 5: Contig 
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Pairwise alignments for the sequences listed in Table 4-2 were performed using 
standalone AVID (Bray et al. 2003). The alignments were annotated using VISTA 
(Frazer et al. 2004). 
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Table 4-2  Sequences used for comparison between fish and chicken PRNP region. (Zebrafish 
assembly version 7; Fugu assembly version 4). 
 
Sequence Source 
Zebrafish stPrP1 SPRNB Chromosome:ZFISH5:10:13945664-13964779 
Zebrafish stPrP2 Chromosome:ZFISH5:8:36362134-36390056 
Fugu stPrP2 PrP-like  Scaffold:FUGU4:scaffold_7:2849455-2854674 
Fugu stPrP1 SPRNB  Scaffold:FUGU4:scaffold_84:78890-87871 
Chicken PRNP Sho-like  Chromosome:WASHUC2:22:433592-444383 
 
 
4.2.2 Isolation and cloning of Sho-like gene 
Tissues were collected from a freshly dissected adult chicken and rooster 
(provided by Stuart Wilkinson, The University of Sydney Faculty of Veterinary 
Science) and were stored in RNAlater® (Ambion) until use. The Qiagen RNAeasy 
kit was used to extract total RNA. RNA quality was checked using the Bioanalyser 
(Agilent) and quantification was performed on the NanoDrop (equipment in the 
BRF, JCSMR, ANU). cDNA synthesis using 1 μg of RNA was performed using the 
Invitrogen SuperscriptTM III First-Strand cDNA Synthesis kit using random 
hexamers. I started with an assumption that this gene may be expressed at high 
levels in brain based on available information from the literature for PrP and Sho 
transcripts and hence first used the cDNA from brain. Two primer sets (Lslike1, 
Rslike1; Lslike2, Rslike2) (Table 4-3) were designed from the predicted ORF. Both 
these primer sets were used to amplify cDNA using Platinum®Taq DNA 
polymerase (Invitrogen) (4pmol of primer and 50 ng of cDNA as template) with 
PCR conditions 94°C for 30sec, 57°C for 30sec, 72°C for 1min. One band of 
expected size was obtained. In order to obtain the 3' and 5' ends, RACE technique 
was employed. SMARTTM PCR cDNA Synthesis Kit (BD Bioscience) was used with 
gene specific primers (5’slike-GSP, 5’slike-nGSP, 3’slike-GSP, 3’slike-nGSP) and 
5’ universal primers. An additional step of amplifying the cDNA by using single 
GSP primer was employed for 30 cycles and the resultant product was used for 
RACE PCR. This step improved amplification as the regular RACE PCR did not 
give any specific band. The PCR product was cloned into TOPO-TA Cloning® kit 
(Invitrogen). Sequencing reactions were performed at the Biomolecular Resource 
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Facility, John Curtin School of Medical Research using the reagents and protocol 
provided by them.  
Table 4-3 Summary of primers used in RT-PCR assays 
 
Primer Sequence 
Lslike1 GGTGGAGGAGGAGGGCTAC  
Lslike2 GCCCTGTTCAGCAACACTG  
Rslike1 CCAGAAGTAGAGTGGGGACAA  
Rslike2 TCTGCTGGGTCAACCATG 
Lslike-ex1 GGAAGGAGGCACAGGAAAC 
5’slike-GSP TTGCCAGAAGTAGAGTGGGGACAATGC 
3’slike-GSP ACAGGGTATGGGATGGGGCTCCT 
5’slike-nGSP AGGAGCCCCATCCCATACCCTGT 
3’slike-nGSP TGTCCCCACTCTACTTCTGGCAAA 
Lgapdh TCTGGCAAAGTCCAAGTGGT 
Rgapdh AGAACTGAGCGGTGGTGAAG 
Lsho GGGACGTGGGAGCGGAAG 
Rsho CCTCAGCGATTCAACAGTGA 
Lprp GGCTTCTTGGATCGCTCATA 
Rprp TACCACAACCAGAAGCCATG 
 
4.2.3 Emu and alligator search 
Emu and alligator genomic DNA samples were obtained as a gift from Prof Scott 
Edwards and Dr Dan Janes (Department of Organismic and Evolutionary Biology 
and Museum of Comparative Zoology, Harvard University).  
 
Homology search: Whole-genome sequence for alligator (Alligator 
mississippiensis) and emu (Dromaius novaehollandiae) are not available, but the 
NCBI trace archive has ~40,000 trace reads for both alligator and emu. A local 
BLAST-searchable database was created for these sequences to facilitate 
homology searches.  
 
PCR-based methods:  Evolutionary PCR using non-specific primers designed on 
the basis of known nucleotide sequences was performed using three different 
methods. 
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Method 1: Primers were designed from sequences evolutionarily close to alligator 
and emu. Turtle and chicken sequence was used for PrP, and Xenopus sequence 
was used for Dpl (Table 4-4).  
Method 2: Vector NTI module “alignment PCR” was used to design primers from 
the input multiple nucleotide sequence alignment corresponding to ORF for PrP 
obtained from the following sequences: human, rat, mouse, cow, sheep, M. 
domestica, and turtle. For Dpl, the following sequences were used: human, mouse, 
rat, cow, sheep, M. domestica, and Xenopus (Table 4-4).  
Method 3: Degenerate primers based on the most conserved amino acid sequence 
regions for PrP and Dpl were constructed (using same species as in Method 2). 
The degenerate primers used for isolating turtle PrP (Simonic et al. 2000) were 
also tried (Table 4-4). These primers were used with touch down PCR with 
annealing temperature ranging from 5 °C above to 5 °C below the minimum 
melting temperature.  
Table 4-4 Degenerate primers used for evolutionary PCR. Degenerate code: M (AC), R (AG), W 
(AT), S (CG), Y (CT), K (GT), V (ACG), H (ACT), D (AGT), B (CGT), N (ACGT) 
 
Name Sequence Comment 
rdgDpl252-n GTARTRGATBCCRTCIGGRAA 
ldgDpl89-n ARCAIARAAWTAAGYVRAAC 
ldgDpl187-n GVAAGCTBGWYRTIAACTTY 
Primers based on nucleotide 
conservation 
rdgDpl86-a RTARTADATNCCRTCIGG 
rgDpl108-a ACRAAYTTACGITGN 
ldgDpl86-a CCIGAYGGIATHTAYTAY 
ldDpl69-a GAYTTYGGIGARGARGGIAAN 
Primers based on amino acid 
sequence 
ldgPrP-na TGGGRMGYGYWATGTCAGG 
rdgPrP-na TAYTGCTGCAYGCACATCTC 
Based on nucleotide conservation 
between reptile and chicken 
ldgPrP-aa CCIAARACIAATATGAAR 
LdgPrP ATAAACCCAAAACCAACATG 
RdgPrP CACATCTCCTGGATCACTTGC  
Based on amino acid 
conservation 
ldgPrP-pp CCCAACCRIGTNTACTAC 
rdgPrP-pp AYIGTIATRTTIANRCARTC 
(Simonic et al. 2000) 
 
 
 
4.2.4 Tissue expression 
Total RNA isolation and cDNA synthesis for the following chicken tissues were 
performed: brain, testis, liver, heart, kidney, lung, eye, gallbladder, muscle, spleen, 
pancreas, skin, gut, stomach, ovary, and uterus. Tissue expression was studied for 
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PrP, Sho-like and Sho transcripts with GAPDH as control. Primers (Sho-like: 
Lslike-ex1, Rslike2; PrP: Lprp, Rprp; Sho: Lsho, Rsho; GAPDH: Lgapdh, Rgapdh) 
listed in Table 4-3 were used with PCR conditions 57 °C and 30 cycles using 
GoTAQ® green master mix (Promega, USA).  
 
4.3 Results and Discussion 
4.3.1 Analysis of the chicken PRNP genomic locus 
Homology-based searches and gene prediction using ab-initio methods on 
chromosome 22 (using various search strategies) suggests the absence of the Dpl 
gene, PRND. While it is possible that the PRNP gene region has undergone 
rearrangements leading to the shuffling of the gene position, this seems unlikely as 
the homology search of the whole genome also did not produce any significant 
results. Lack of rearrangement is further supported by the conservation in the 
position and orientation of other adjacent genes, SCL23A1 and RASSF2, reported 
in vertebrates from fish to mammals (Suzuki et al. 2002; Premzl et al. 2004). To 
further investigate the PRNP gene locus, I performed a six-frame translation of the 
sequence downstream from the PRNP gene to look for traces of the PRND gene or 
its remnants (pseudogene). Although no region similar to PRND was found, an 
ORF with sequence homology to Sho was found, which I call chicken Sho-like. 
 
An EST database search for this new gene did not produce any significant hits. To 
clarify the relationship of this gene to Sho, a homology search was performed 
using the human Sho sequence against the chicken genome database. This 
confirmed that a true orthologue of Sho is present at a different genomic location 
(chromosome 6), where it is flanked by genes previously reported to be conserved 
at the Sho genomic locus (Premzl et al. 2003; Premzl et al. 2004).  
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4.3.2 Isolation and molecular characterization of Sho-like cDNA 
A single transcript was isolated from chicken brain RNA. Mapping this sequence 
onto the genomic sequence revealed 2 exons (Figure 4-1). As for all other PrP 
family genes (PrP, Dpl and Sho, and the fish genes), the entire ORF is found within 
a single exon (exon 2) (Premzl et al. 2004), which codes for a protein of 150 
residues. The gene contains a 65 bp 5’ UTR and a 425 bp 3’ UTR. The intron 
between the two exons is 1102 bp (Figure 4-1b).  
 
Figure 4-1 Sequence features for Sho-like gene. (a) cDNA sequence (brain) obtained from 5’ and 
3’ RACE. Sequence for first exon is shown boxed and ORF in grey with translation shown below the 
nucleic acid sequence. (b) Schematic representation of exons with the numbers indicating the size 
in base pairs. (c) Hydrophobicity plot (blue line) for the Sho-like sequence indicates three distinct 
hydrophobic regions – the N-terminal and putative C-terminal signal sequences and a middle 
hydrophobic region. (d) Amino acid sequence for the 150-residue Sho-like protein. The N-terminal 
and putative C-terminal signal sequence are bolded and boxed, with the putative GPI attachment 
site indicated by an arrow. The RG-rich region corresponding to the NLS is shown in bold red, and 
the middle hydrophobic region of 19 residues (66-84) is shown bolded and underlined.  
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4.3.3 Sequence analysis of Sho-like 
The search against the NCBI nr database using BLAST did not show significant 
similarity of the Sho-like sequence to known proteins. The hydrophobicity plot 
showed three well characterized regions: N-terminal, middle and C-terminal region 
(Figure 4-1c). The N-terminal hydrophobic region suggests the presence of a 
signal peptide for extracellular export of the protein; this is supported by the 
SignalP analysis (Figure 4-1d). The hydrophobic region at the C-terminal end could 
be a signal sequence for GPI-attachment; this is also supported by the big-Pi 
prediction of a possible GPI-modification site (Figure 4-1d; Figure 4-2b,c). Both 
these features are found in PrP family proteins from fish to mammals (Silverman et 
al. 2000; Premzl et al. 2004; Miesbauer et al. 2006; Strumbo et al. 2006) Other 
similarities to PrP family proteins, excepting Dpl, include the presence of an N-
terminal basic region, in this case RG-rich as for the short proteins (Sho, PrP-like 
and Sho2), and the usual middle hydrophobic region unique to this family of 
proteins. As for the other short proteins, Sho-like lacks the Cys residues which 
form the disulphide bridge(s) in the folded C-terminal domain of PrP and Dpl, or 
putatively in the long-form fish proteins (stPrPs). Sho-like also lacks an N-
glycosylation site, similar to PrP-like but in contrast to the conserved sites in Sho 
and Sho2 (Figure 4-2 b). In common with Sho, Sho-like is predicted to have a 
nuclear localization signal (NLS) in the N-terminal region (Figure 4-1d) which 
suggests a function within the nucleus. 
 
The multiple sequence alignment with the known short PrP-related fish proteins 
shows some interesting features (Figure 4-2 b, c). Although the C-terminal region 
does not share sequence homology with these known PrP-related short proteins , 
the N-terminal region is most similar to fish PrP-like and the middle hydrophobic 
region is most similar to Sho2 (Figure 4-2 b, c; alignment with Sho not shown). 
Phylogenetic analysis indicates that Sho-like is more closely related to both PrP-
like and Sho2 than to Sho (Figure 4-2 a), which is consistent with its presence at 
the PRNP genomic locus.  
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Analysis of the 3’ UTR sequence indicates a substantial amount of secondary-
structure forming motifs, but no known functional UTR elements were found (data 
not shown). 
 
   
Figure 4-2 Comparison of chicken Sho-like with Sho, Sho2 and PrP-like. (a) Phylogenetic tree 
showing the relationship of Sho-like with the other short PrP-related fish genes and with Sho. The 
tree was generated by the Maximum Likelihood method. (b) Multiple sequence alignment between 
fish Sho2 and chicken Sho-like. (c) Multiple sequence alignment between fish PrP-like and chicken 
Sho-like. Arrows in (b) and (c) show N-terminal cleavage and GPI-anchor attachment sites, the 
hydrophobic region is shown underlined, and the conserved N-glycosylation site for Sho2 is boxed. 
[Fu: Fugu, Te: Tetraodon, Ze: Zebrafish, Ch: Chicken]  
 
 
(a) (b) 
 
                   10        20      ↓   30        40        50        60        
           ....|....|....|....|....|....|....|....|....|....|....|....| 
FuSho2     MTGQQKLLSLWVWLLLMAALCPGVQHAYGKRGGVFKGRGKGDSTQAAPSQGRGLP-KPGL 59  
TeSho2     MTGQQKLLSLWAWLLLMAALCPGVQHAYSKRGGAFKARGKSDGNQAAPSQSRGLP-KPGL 59  
ZeSho2     MLGHQNLLIIWVWMLLLASLCP-CFHCKRGFGGRGMSKGA-APAKAPPSQSKGSSSRQGL 58  
ChSholike  MRPRD--AWCWVAMLLLALFSN-TAGGRRGAGGRAGGRGGGGGGGGGGLRGGFRSISRGG 57  
Consensus  *  ::     *. :**:* :.          **   .:*      .   :.   .   *     
 
                    70        80        90       100       110       120        
           ....|....|....|....|....|....|....|....|....|....|....|....| 
FuSho2     KWAG---AAAG-ILGGTGTGYGLGFLGRHKHGSGG-HHSHRAEQDQRPYHNQRHGFYNQS 113 
TeSho2     KWAG---AAAG-ILGGTGTGYGLGFLGRHKHRSGS-HYSQRTEQDQRPYHNQRQGFYNQS 113 
ZeSho2     KLAG--AAAAG-AIGGAAIGYGLGSLGRPRYG-----HNGYSDG----YH---QPVYNQS 102 
ChSholike  NTAGRGSKMASAIAAGAATGYGMGLLGRPRPPRLG--HGPPAQR-----QPPPAGGFHAA 109 
Consensus    **     *.   .*:. ***:* *** :       :.  ::      :      :::     
 
                 130       140       150       160    
          ...|....|....|....|....|....|....|....|... 
FuSho2    LWKAIVNAAAPVSTSKAFLAFAHMFSFLVT---VWIRDI-   150  
TeSho2    AWRAVANAAAPVFTSNVSLPLAHMVSVLFT---VWIRNI-   150  
ZeSho2    HRGYYGSTGSSEHMGSLLITLG-TVAHVVI---MWA----   135  
ChSholike AWPDLGAKRGSPNQAPKGPCGGIVPTLLLANAICWVNHGM   150  
Consensus          .. ↑   .      .   : :.     *           
 
 
                                                                                                
                    10        20     ↓ 30        40        50        60          
           ....|....|....|....|....|....|....|....|....|....|....|....| 
FuPrPlike  MSSQQKLPLTLTLCLLLLASLLPSSEARRGGGGFGRGGG-GRSWGRSQGQSRGWGGGGAG 59  
TePrPlike  MSSLQKS-LTLTLCLLLL---LPSSEARRGGGGFGRGGG-GRGWGRSPSQSRGWGGGTGG 55  
ZePrPlike  MHSKFKL-FSWRNCLLLLAVLLPVAQSRRGGG-FGRGGGRGGGWGGSSSGRAGWGAAGGH 58  
ChSholike  MRPRDAW---CWVAMLLLALFSNTAGGRRGAG--GRAGGRGGGGGG--------GGGGLR 47  
Consensus  * .     :    .:***  :   : .***.* :**.** * . *         *..       
 
                    70        80        90       100       110       120        
           ....|....|....|....|....|....|....|....|....|....|....|....| 
FuPrPlike  QAYRPVQ-----------------SSNPSAGKVAGAAAAGAIGGAMIGSALS---RPGYG 99  
TePrPlike  QAYRPAQ-----------------SSGPSAGKVAGAAAAGAIGGAMIGSALS---RPGYG 95  
ZePrPlike  HRAPPVHTGHMGHIGHTGHTGHTGSSGHGVGKVAGAAAAGALGGMLVGHGLSSMGRPGYG 118 
ChSholike  GGFRSIS-----------------RGGNTAGRGSKMASAIAAG-AATGYGMGLLGRPRPP 89  
Consensus      .                    ..  .*: :  *:* * *    * .:.   **       
                                                     
 
                   130       140       150       160       170       180     
           ....|....|....|....|....|....|....|....|....|....|....|....| 
FuPrPlike  YGGYGGYGMGYGGYGGGYGGGYGRGYGYP-RGGYSNEPEGSGDMEYYYSGTSSSPAYSSI 158 
TePrPlike  YG-HGGYGMGYPGYGGGYGG-YGRGYGYP-RGGYANEPEGSGDMEYYYSGASSSPAYSSI 152 
ZePrPlike  YG-YGGYG----GHGYGYGHGYGHGHGHGGHGGHSGDHNET-DADYYLDGAASGHAYSCV 172 
ChSholike  RLGHGPPAQRQPPPAGGFHAAAWPDLGAK-RGSPNQAPKGP------CGGIVPTLLLANA 142 
Consensus     :*  .      . *:      . *   :*. ↑   : .       .*  .    :    
                                                    
 
                    190       
           ....|....|....|.... 
FuPrPlike  III-TSLMALLMGHWVASI 176  
TePrPlike  IFISTSLMSLLMGHWASIV 171  
ZePrPlike  TVF-GLMMSFLIGHFLS-- 188  
ChSholike  ICWVNHGM----------- 150  
Consensus         * :::      :   
(c) 
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4.3.4 Expression analysis of PRNP, SPRN and Sho-like transcripts 
in chicken 
To investigate the distribution pattern of Sho-like, expression analysis was carried 
out using RT-PCR on a range of chicken tissues (testis, heart, kidney, lung, eye, 
gall bladder, muscle, spleen, pancreas, skin, gut, stomach, ovary and uterus). The 
SPRN expression pattern in chicken was also investigated, as there is no 
published data. The results are compared in Figure 4-3. Sho-like transcript was 
detected in most tissues at variable levels but is completely absent in muscle and 
is minimally present in pancreas and gut. Interestingly, brain did not show high 
levels of transcript; the highest levels were in internal organs, particularly 
gallbladder, spleen and ovary. This may explain my initial problem in amplifying the 
transcript using RACE on brain RNA (see Methods). On the other hand, PRNP and 
SPRN are highly expressed in chicken brain, consistent with reported results for 
mammals and other vertebrates (Cagampang et al. 1999; Premzl et al. 2003). 
PRNP is expressed strongly or relatively strongly in all chicken tissues analyzed, 
consistent with reported results in other vertebrates (Ford et al. 2002). The 
previous in situ hybridization studies (Harris et al. 1993) also indicated a wide 
spread distribution of chicken PRNP mRNA. SPRN transcript also showed 
widespread expression at various levels, consistent with our revised results for 
mammal, marsupial and frog [Vassilieva et al., unpublished results]; it is highly 
expressed in heart as well as brain, and is completely absent in testis and liver.  
 
 
Figure 4-3 Comparison of tissue expression of transcripts of Sho-like, SPRN, PRNP and 
GAPDH in various chicken tissues tested with RT-PCR.  
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4.3.5 Comparison with the PRNT gene 
The human PRNP gene locus contains a gene, PRNT between PRND and 
RASSF2 on the opposite strand to PRNP (see Figure 4-4), which encodes a testis-
specific protein (Makrinou et al. 2002). It has been suggested that PRNT is the 
result of a duplication of PRND (Makrinou et al. 2002). As the gene orientation and 
location of PRNT are similar to that of the chicken Sho-like gene, I performed a 
sequence comparison between the two loci. No significant sequence similarity was 
observed either at amino acid or nucleotide levels, excluding a possible correlation 
between PRNT and the Sho-like gene.  
4.3.6 Comparison of chicken PRNP genomic loci with other 
vertebrates 
Current knowledge of the organization of genes at the PRNP genomic loci in 
vertebrates is shown in Figure 4-4. Except for the PRNT gene which appears to be 
unique to eutherian mammals, other tetrapod lineages for which the locus has 
been defined (frog and marsupial) show only PRNP and PRND. The current 
Platypus assembly (assembly version 5) shows a part of the PRNP 3’ UTR and the 
Dpl ORF. However, there are a number of ambiguous regions in this assembly 
and, hence, it is not possible to draw conclusions regarding the gene organization 
in the PRNP locus. Fish show two loci for the PrP-related genes, stPrPs (Oidtmann 
et al. 2003), PrP-like (Suzuki et al. 2002) and SPRNB (Premzl et al. 2004), likely 
resulting from a whole-genome duplication (Taylor et al. 2003). Two recent papers 
(Cotto et al. 2005; Rivera-Milla et al. 2006) have shown that these fish PrPs are 
differentially expressed, indicating that these duplicated genes have developed 
specialized functions. It is remarkable that the organization of the chicken PRNP 
locus correlates with the arrangement of genes at the two fish loci, and not that of 
the other tetrapods (Figure 4-4). This raises a very interesting question on the 
evolution of the locus in the intermediate-vertebrate avian and reptile branches.  
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Figure 4-4 Summary of the gene organization in the PRNP genomic locus in vertebrate 
lineages elucidated to date. The order and orientation of the genes downstream from PRNP 
are shown. “Other tetrapod” includes frog (X. tropicalis), marsupial (M. domestica) and several non-
primate Eutherian mammals. Figure not drawn to scale. 
 
4.3.7 Comparison of chicken and fish PrP-related genes 
The organization of chicken PRNP locus correlates with the arrangement in the fish 
PrP-related genes and SPRNB (Figure 4-4). To understand the origin of Sho-like 
gene, comparisons were made between the chicken PRNP and Sho-like gene 
region with that of the fish PrP genomic regions. The fish PrP-related gene regions 
included in the analysis were: Fugu stPrP1 and SPRNB, Fugu stPrP2 and PrP-like, 
zebrafish PrP-like, and zebrafish stPrP1 and SPRNB, for which pairwise 
comparisons in all possible combinations were performed (Figure 4-5). The 
conservation patterns did not show any homology between the different fish PrP 
gene loci and the chicken PRNP gene locus. About 70% sequence identity was 
observed in the region corresponding to the ORF of orthologous fish PrP genes 
and about 50-60% among the paralogous PrP genes (Figure 4-5).  
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Figure 4-5 Pairwise comparisons using 
VISTA between chicken and fish PrP gene 
loci in various combinations. The peaks 
that show more than 70% conservation 
across 40 bp.length are colored  
 
Chicken Fugu 
Fugu Zebrafish
Zebrafish Chicken PRNP, Sholike 
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4.3.8 Identification of PRNP locus genes in emu and alligator 
In the absence of whole-genome sequence data for other bird branches or any 
reptile, I started to address this evolutionary puzzle by homology searches for PrP 
family genes (PrP, Dpl, Sho-like) against a local BLAST database I constructed for 
emu and alligator trace sequences and EST databases. This did not produce any 
significant results. Using evolutionary PCR, I was able to identify PrP and Sho-like 
in emu. The partial Sho-like sequence obtained (residues 16-139) is identical to 
that of chicken, except at residues 171 (A/T) and 176 (T/A) which interestingly are 
in the hydrophobic region (Figure 4-1D); the emu Sho-like and PrP sequence data 
are given in Appendix 2. Several PCR methods were used to amplify PrP, Dpl and 
Sho-like genes from alligator genomic DNA, but without success. Failure may have 
been due, in part, to use of genomic DNA rather than RNA. Unfortunately, RNA 
from alligator tissues was not available. 
4.3.9 Comparison of PrP sequence from birds and other tetrapods 
A multiple sequence alignment of a selection of available PrP sequences from the 
tetrapod lineages (mammal, marsupial, monotreme, bird, reptile and frog) is shown   
in Figure 4-6. For the purposes of the current discussion, the selection has been 
highly weighted towards the bird sequences and the scant sequence data available 
for non-eutherian mammals. The sequences include the partial sequences for emu 
PrP and the platypus sequence extracted from my manual assembly of trace file 
data (discussed in Chapter 5); the latter contains many obvious errors and is 
included here solely to illustrate a point. As previously observed, PrPs from all 
lineages, including platypus, show a highly conserved hydrophobic region, but with 
variable lineage-specific repeats (Wopfner et al. 1999) which are lacking in 
amphibian PrP (Strumbo et al. 2001).  
 
Although there is significant sequence variation of the post-hydrophobic (C-
terminal) domain between amphibians and mammals, the PrP sequence around 
the conserved Cys residues is highly conserved and NMR structures for all the 
main branches (Xenopus (Calzolai et al. 2005), turtle (Calzolai et al. 2005), chicken 
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(Calzolai et al. 2005) and eutherian mammal (Riek et al. 1996) show a similarly 
folded structure. The striking difference in this region is a characteristic 9-10 
residue insert in avian PrP (Figure 4-6), which structurally is located between the 
second and third helices and is flexibly disordered (Calzolai et al. 2005).  The insert 
also contains a third conserved N-glycosylation site unique to birds. Homology 
search in databases for this sequence insert failed to identify other proteins with 
similar sequence.  
 
Thus, the alignment reveals at least two features of the primary structure which 
differentiate chicken PrPs from both lower (frog) and higher vertebrates. These 
anomalies may possibly be related to the absence of Dpl in birds, perhaps through 
evolution of the C-terminal domain for functions which compensate for the functions 
of this structurally homologous domain of Dpl (Mo et al. 2001). A variant of this 
hypothesis is that absence of Dpl in birds has removed an evolutionary constraint 
on the C-terminal domain of avian PrPs, which has been suggested to interact with 
Dpl (Sakudo et al. 2005), allowing it to develop novel functions. A third hypothesis 
is that the insert is correlated with the presence of Sho-like, and perhaps suggests 
a direct interaction with Sho-like. Although the sequences of the fish stPrPs differ 
greatly from those of the tetrapod PrPs, it is interesting to note that much of their 
increased length (e.g. ~560 residues for zebrafish stPrP2 compared with ~250 
residues for mammalian PrPs and ~275 residues for avian PrPs) comes from a 
very large insertion in the C-terminal domain predicted by homology modeling to be 
between the second and third helices (Rivera-Milla et al. 2003), i.e. the same as for 
the chicken PrP insert.  
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  Mouse          ------MAN-LGYWLLALFVTMWTDVGLCKK--RPKPGG-WNTGG-SRYPGQGS----------PGGNRYPPQ-GGTWGQPHGGG--WGQPHGGS--WGQPHGG--------SWGQPH-GGG-WGQGGGTHNQWNKPSKPKTNLKHVAGAAAAGAVVGGLGGYML  
  Rat            ------MAN-LGYWLLALFVTTCTDVGLCKK--RPKPGG-WNTGG-SRYPGQGS----------PGGNRYPPQSGGTWGQPHGGG--WGQPHGGG--WGQPHGG--------GWGQPH-GGG-WSQGGGTHNQWNKPSKPKTNLKHVAGAAAAGAVVGGLGGYML  
  Human          ------MAN-LGCWMLVLFVATWSDLGLCKK--RPKPGG-WNTGG-SRYPGQGS----------PGGNRYPPQGGGGWGQPHGGG--WGQPHGGG--WGQPHGG--------GWGQPH-GGG-WGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYML  
  Cow            ----MVKSH-IGSWILVLFVAMWSDVGLCKK--RPKPGGGWNTGG-SRYPGQGS----------PGGNRYPPQGGGGWGQPHGGG--WGQPHGGG--WGQPHGGGWGQPHGGGWGQPH-GGGGWGQGG-THGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYML  
  Sheep          ----MVKSH-IGSWILVLFVAMWSDVGLCKK--RPKPGGGWNTGG-SRYPGQGS----------PGGNRYPPQGGGGWGQPHGGG--WGQPHGGG--WGQPHGG--------GWGQPH-GGGGWGQGG-SHSQWNKPSKPKTNMKHVAGAAAAGAVVGSLGGYML  
  Monodelphis    ----MGKIH-LGYWFLALFIMTWSDLTLCKKP-KPRPGGGWNSGG-NRYPGQ------------SGGWGHPQGGGTNWGQPHAGGSNWGQPRPGGSNWGQPHPGG------SNWGQPHPGGSNWGQAGSSYNQKWKPDKPKTNMKHVAGAAAAGAVVGGLGGYML  
  Tammar         ----MAKIQ-LGYWILALFIVTWSELGLCKKP-KTRPGGGWNSGGSNRYPGQ------------PGSPGGNRYPG--WGHPQGGGTNWGQPHPGGSSWGQPHAGG------SNWGQPH-GGSNWGQGGGSYG-KWKPDKPKTNLKHVAGAAAAGAVVGGLGGYML  
  Platypus       MWPHWGKSP-VHHWIIDICVVHLERRCRGHLHPNPCPGGGWNSGN--RYPGQPAN---------PGGWGHPQGGGASWGHPQGGGASWGHPQGGGSNWGHPQGGG------ASWGHPQ-GGG---------YSKYKPDKPKTGMKHVAGAAAAGAVVGGLGGYMI  
  Pelodiscus     ----MGRHL-ISCWIIVLFVAMWSDVSLAKKGKGKTGGGGWNTGS-NRNP---SNPGYPSNPGYPRNPSYPHNPGYPNNPAYPPNPSYPRNPSYPQNPGYPNNPG------VGGQPYYPPGG---GTDFKNQKGWKPAKPKTNLKAVAGAAAAGAVVGGIGGIAL  
  Turtle         ----MGRYR-LTCWIVVLLVVMWSDVSFSKKGKGK-GGGGGNTGS-NRNPNYPSNPGYPQNPGYPRNPSYPHNPAYPPNPAYPPNPGYPHNPSYPRNPSYPQNPGY-----PGGQHYNPAGG---GTNFKNQKPWKPDKPKTNMKAMAGAAAAGAVVGGLGGYAL  
  Taeniopygia    ----MAKLPGTSCLLLLLLLLLGADLASCKKGKGKPGGGGWGTGS--RQPSYPRQP------GYPQNPGYPHNPGYPHNPGYPHNPGYPHNPGYPHNPGYPHNPGY-----PGWNQGYNPSS---GGNYH-QKPWKAPKPKTNLKHVAGAAAAGAVVGGLGGYAM  
  Balearica      -----------------------------KKGKGKPSGGGWGTGS-HRQPSYPRQP------GYPQNPGYPHNPGYPHNPGYPHNPGYPHNP--------------------GWGQGYNPSS---GGSYHNQKPWKPPKSKTNLKHVAGAAAAGAVVGGLGGYAM  
  Pachyptila     -----------------------------KKGKGKPSGGGWGTGS-HRQPSYPRQP------GYPQNPGYPHNPGYPHNPGYPHNPGYPHNPGYPQNP--------------GWGQGYNPSS---GGTYHNQKPWKPPKSKTNFKHVAGAAAAGAVVGGLGGYAM  
  Melopsittacus  ----MARLL-TTCCLLALLLAACTDVALSKKGKGKPSGGGWGAGS-HRQPSYPRQP------GYPHNPGYPHNPGYPHNPGYPHNPGHPHNPGYPQNPGYPHNPGY-----PGWGQGYNPSS---GGSYHNQKPWKPPK--TNFKHVAGAAAAGAVVGGLGGYAM  
  Chicken        ----MARLL-TTCCLLALLLAACTDVALSKKGKGKPSGGGWGAGS-HRQPSYPRQP------GYPHNPGYPHNPGYPHNPGYPHNPGYPHNPGYPQNPGYPHNPGY-----PGWGQGYNPSS---GGSYHNQKPWKPPK--TNFKHVAGAAAAGAVVGGLGGYAM  
  Anas           ----MARLL-TTCCLLALLLAACTDVALSKKGKGKPSGGGWGAGS-HRQPSYPRQPGYRHNPGYPHNPGYPHNPGYPHNPGYPHNP------GYPQNPGYPHNPGY-----PGWGQGYNPSS---GGSYHNQKPWKPPK--TNFKHVAGAAAAGAVVGGLGGYAM  
  Columba        ----MARLL-TTCCLLALLLAACTDVALSKKGKGKPSGGGWGAGS-HRQPNYPRQP------GYPHNPGYPHNPGYPHNPGYPHNP------GYPQNPGYPHNPGY-----PGWGQGYNPSS---GGSYHNQKPWKPPK--TNFKHVAGAAAAGAVVGGLGGYAM  
  Coturnix       ----MARLL-TTCCLLALLLAACTDVALSKKGKGKPSGGGWGAGS-HRQPSYPRQP------GYPHNPGYPHNPGYPHNPGYPHNP------GYPQNPGYPHNPGY-----PGWGQGYNPSS---GGSYHNQKPWKPPK--TNFKHVAGAAAAGAVVGGLGGYAM  
  Pavo           ----MARLL-TTCCLLALLLAACTDVALSKKGKGKPGGGGWGGGS-HRQPSYPRQP------GYPHNPGYPHNPGYPHNPGYPHNP------GYPQNPGYPHNPGY-----PGWGQGYNPSS---GGSYHNQKPWKPPK--TNFKHVAGAAAAGAVVGGLGGYAL  
  Tyto           -----------------------------KKGKGKPSGGGWGTGS-HRQPSYPRQP------GYPQNPSYPHNPGYPHNPGYPHNP------GYPHNPGYPHNP--------GWGQGYNPSS---GGSYHNQKPWKPPKSKTNFKHVAGAAAAGAVVGGLGGYAM  
  Vultur         -----------------------------KKGKGKPSGGGWGTGS-HRQPSYPRQP------SYPQNPGYPHNPGYPHNPGYPHNP------GYPHNP--------------GWGQGYNPSS---GGSYHNQKPWKPPKSKTNFKHVAGAAAAGAVVGGLGGYAM  
  Emu            ---------------------------------------------------------------------------------------------------------------------W-----------------KPPKSKTNLKHVAGAAAAGAVVGGLGGYVM  
  X.tropicalis   ----MLRSLWTSLVLISLVCALT--VSSKKSGSGKSKTGGWN-------------------------SGSNRNPNYP--------------GGYGWNTG--GNTGG-----SWG-QPYNPSG---GNNF-NNKQWKPPKSKTNMKAVA----VGAAAGAIGGYML 
  X.laevis2      ----MPRSLWTCLVLVSLVCTLT--VSSKKSGSGKSKTGGWNNGN-TGNT---------------GNTGNNRNPNYP--------------GGYGWNTGNTGNTGG-----SWGQQPYNPSG---GSNF-NNKQWKPPKSKTNMKAVA----VGAAAGAIGGYML  
  X.laevis1      ----MPQSLWTCLVLISLVCTLT--VSSKKSGGGKSKTGGWN-------------------------TGSNRNPNYP--------------GGY------PGNTGG-----SWGQQPYNPSG--------YNKQWKPPKSKTNMKSVA----IGAAAGAIGGYML  
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  Mouse          GSAMSRPMIHFGNDWEDRYYRENMYRYPNQVYYRPVDQYSN-----QNNFVHDCVNITIKQHTVTTTTKG---------ENFT---ETDVKMMERVVEQMCVTQYQKESQAYYDGRRSSSTVLFSSPPV-ILLISFLIFLIVG--  
  Rat            GSAMSRPMLHFGNDWEDRYYRENMYRYPNQVYYRPVDQYSN-----QNNFVHDCVNITIKQHTVTTTTKG---------ENFT---ETDVKMMERVVEQMCVTQYQKESQAYYDGRRSS-AVLFSSPPV-ILLISFLIFLIVG--  
  Human          GSAMSRPMIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSN-----QNNFVHDCVNITIKQHTVTTTTKG---------ENFT---ETDVKMMERVVEQMCITQYERESQAYYQ--RGSSMVLFSSPPV-ILLISFLIFLIVG--  
  Cow            GSAMSRPLIHFGSDYEDRYYRENMHRYPNQVYYRPVDQYSN-----QNNFVHDCVNITVKEHTVTTTTKG---------ENFT---ETDIKMMKRVVEQMCITQYQRESQAYYQ--RGASVILFSSPPV-ILLISFLIFLIVG--  
  Sheep          GSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDQYSN-----QNNFVHDCVNITVKQHTVTTTTKG---------ENFT---ETDIKIMERVVEQMCITQYQRESQAYYQ--RGASVILFSSPPV-ILLISFLIFLIVG--  
  Monodelphis    GSAMSRPIMHFGNDYEDRYYRENQYRYPNQVMYRPIDQYNN-----QNNFVHDCVNITVKQHTTTTTTKG---------ENFT---ETDIKIMERVVEQMCITQYQNEYRSA------YSVAFFSAPPVTLLLLSFLIFLIVS--  
  Tammar         GSAMSRPVMHFGNEYEDRYYRENQYRYPNQVMYRPIDQYGS-----QNSFVHDCVNITVKQHTTTTTTKG---------ENFT---ETDIKIMERVVEQMCITQYQNEYQAAQR---YYNMAFFSAPPVTLLLLSFLIFLIVS--  
  Platypus       GSAMSRPPMHFGNEFEDRYYRENQNRYSNQVYYRPVDQYGS-----QDGFVRDCVNITVTQHTVTTTEGK----------NLN---ETDVKIMTRVVEQMCGSTTWN-------------LQWFG--------VSFNF-------  
  Pelodiscus     GSAMSGMRMNFDRPDESRWWNENQNRYPNQVYYR---EYGDR-SVPRGTFVNDCVNITVTEYKIDPKENQ----------NVT---EIEVKVLKRVIQEMCMQQYQKYQLASG-------VKLLLCDPLLMLMIMLVFFLVMR--  
  Turtle         GSAMSGMRMNFDRPEERQWWNENSNRYPNQVYYK---EYNDR-SVPEGRFVRDCLNNTVTEYKIDPNENQ----------NVT---QVEVRVMKQVIQEMCMQQYQQYQLASG-------VKLLS-DPSLMLIIMLVIFFVMH--  
  Taeniopygia    GRVMSGMQYRFDSPDEYRWWSENAARYPNQVYYR--D-YRGG-AVPQDVFVADCFNITVTEHNIGPAAKK-NASEAGAALNQT-EAELETRVVTKVIREMCIQQYQEYRLAAG-------TRPRLAADAALAALLLLAL--AALR  
  Balearica      GRVMSGMHYRFDSPDEYRWWNENSARYPNQVYYR--D-YSS--PVSQDVFVADCFNITVTEYNIGPAAKK-NVSEAGAAVNQT-ETELETKVVTKVIREMCIQQYREYRL-----------------------------------  
  Pachyptila     GRVMSGMHYRFDSPDEYRWWNENSARYPNQVYYR--D-YRS--PVSQDVFVADCFNITVTEYNIGPAAKK-NVSEAAPAANQT-ETELETKVVTKVIREMCIQQYREYRL-----------------------------------  
  Melopsittacus  GRVMSGMNYHFDSPDEYRWWSENSARYPNRVYYR--D-YSS--PVPQGVFVADCFNITVTEYSIGPAAKK-NTSEAVAAANQT-EVEMENKVVTKVIREMCVQQYREYRLASG-------IQLHP-ADTWLAVLLLLLTTLFAMH  
  Chicken        GRVMSGMNYHFDSPDEYRWWSENSARYPNRVYYR--D-YSS--PVPQDVFVADCFNITVTEYSIGPAAKK-NTSEAVAAANQT-EVEMENKVVTKVIREMCVQQYREYRLASG-------IQLHP-ADTWLAVLLLLLTTLFAMH  
  Anas           GRVMSGMSYRFDSPDEYRWWNENSARYPNRVYYR--D-YSS--PVSQDVFVADCFNITVTEYSIGPAAKK-NTSEAVPAANQT-DVETENKVVTKVIREVCVQQYREYRLASG-------IQLHP-ADTWLAVLLLLTT-LFAMH  
  Columba        GRVMSGMSYRFDSPDEYRWWNENSARYPNRVYYR--D-YSS--PVSQDVFVADCFNITVTEYSIGPAARK-NTSEAVPAANQT-DVEMENKVVTKVIREMCVQQYREYRLASG-------IQLHP-ADTWLAVLLLLTT-LFAMH  
  Coturnix       GRVMSGMSYRFDSPDEYRWWNENSARYPNRVYYR--D-YSS--PVSQDVFVADCFNITVTEYSIGPAAKK-NTSEAVPAANQT-DVEMENKVVTKVIREMCVQQYREYRLASG-------IQLHP-ADTWLAVLLLLTT-LFAMH  
  Pavo           GRAMSGMSYHFDSPDEYRWWNENSARYPNRVYYR--D-YSS--PVSQDVFVADCFNITVTEYSIGPAAKK-NTSEAAPAANQT-DVEMENKVVTKVIREMCVQQYREYRLASG-------IQLHP-ADTWLAVLLLLAT-LFAMH  
  Tyto           GRVMSGMHYRFDSPDEYQWWNENSARYPNRVYYR--D-YSS--PVTQDVFVADCFNITVTEYNIGPAAKK-NTSEAGPAVNQT-EMEMETKVVTKVIREMCVQQYREYRL-----------------------------------  
  Vultur         GRVMSGMHYRFDSPDEYRWWNENSARYPNQVYYR--D-YSS--PVSQDIFVADCFNITVTEYNIGPAAKK-NTSEAGLAVNQT-ETELETKVVTKVIREMCIQQYREYRL-----------------------------------  
  Emu            GRAMSGMHYNFDSPDEYRWWNENSGRYPNRVYYR--D-YSS--PVSQDLFVADCFNITVTEYNIGPAAKKSNASEAGQDGNKT-ETEMETKVVTKVI------------------------------------------------  
  X.tropicalis   GNAMGRMSYHFSNPMEARYYNDYYNQMPERVYRP---MYRGEEHVSEDRFVTDCYNMSVTEYIIKPAEGK----------NTSEVNQLETRVKSQIIREMCITEYRR---GSG-------FKVLS-NPWLILTITLFVYFVIE--  
  X.laevis2      GNAVGRMNHHFDNPMESRYYNDYYNQMPDRVYRP---MYRSEEYVSEDRFVTDCYNMSVTEYIIKPSEGK----------NGSDVNQLDTVVKSKIIREMCITEYRR---GSG-------FKVLS-NPWLILTITLFVYFVIE--  
  X.laevis1      GNAVGRMSYQFNNPMESRYYNDYYNQMPNRVYRP---MYRGEEYVSEDRFVRDCYNMSVTEYIIKPTEGK----------NNSELNQLDTTVKSQIIREMCITEYRR---GSG-------FKVLS-NPWLILTITLFVYFVIE--  
Figure 4-6 Alignment of PrP among tetrapods. Shading is based on 70% conservation. The unique region found in birds is shown in the rectangular box. 
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4.4 Absence of Dpl in chicken: Its implications and insights into 
the evolution of acrosome reaction 
 
Dpl is associated with spermatogenesis in mice, and male Prnd-knockout mice 
were shown to be infertile with defects in morphology and number of sperm 
(Behrens et al. 2002; Paisley et al. 2004). The other function affected in Prnd-
knockout mice was the inability of sperm to perform the acrosome reaction. This is 
a physiological process which occurs in the acrosome of the sperm as it 
approaches the outer layer of the egg in order to assist its fusion with the egg. The 
absence of PRND in the avian genome may indicate that this function was not 
acquired by Dpl in the lower vertebrates (e.g. frog), or it is compensated for by 
other evolutionary changes in birds. However, the acrosome reaction in lower 
vertebrates (Table 4-5) differs considerably from that in higher vertebrates. Bakst 
and Howart (1977) proposed that the cock sperm did not exhibit a typical 
mammalian or invertebrate type acrosome reaction. One factor underlying this may 
be anatomical differences between the chicken egg and that of higher vertebrates. 
Although the outermost perivitelline layer in the avian egg is morphologically 
homologous to mammalian zona pellucida (Bakst and Howarth 1977), they differ 
completely in their properties. It was also shown that Xenopus sperm can undergo 
the acrosome reaction (Ueda et al. 2002). Thus, though the acrosome reaction 
occurs in lower vertebrates, there exist considerable anatomical differences in the 
egg among the eutherian and subtherian groups, which suggests a different 
physiological mechanism. It has been proposed that in subtherian groups, including 
chicken (Bedford 1998), it is primarily by the lytic role of acrosomal enzymes. In 
eutheria, by contrast, the interaction of spermatozoa with the egg coat appears 
quite different, with some variation among the many genera (Bedford 1998). With 
the development of the thicker zona pellucida in eutherian mammals (Bedford 
1998), Dpl may have acquired a new role in assisting the acrosome reaction. The 
role of Dpl in male fertility may, thus, be a modern function. The rapid evolution of 
the gene which is evident from sequence differences within the two closely related 
Xenopus species, X. laevis and X. tropicalis (Figure 3-3), and the low conservation 
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between Xenopus and mammalian Dpls supports its potential to develop new 
roles.  
Table 4-5 Comparison of the anatomy of egg and fertilization mechanisms in chicken, 
Xenopus and mammals 
 Chicken Xenopus Mammal 
Acrosome Reaction Present Present  Present 
Fertilization Internal External Internal 
Doppel Absent Present Present 
Outer layer of egg Perivitelline layer Vitelline 
envelope 
Zona pellucida
 
4.5 Conclusions 
 
With the established relationship between PrP and Dpl in higher vertebrates, and 
now with the presence of both these genes in amphibian confirmed (Chapter 3), 
the absence of Dpl in chicken is intriguing. This may indicate that Dpl has not 
acquired a specialized role in lower vertebrates or that its functions are 
compensated by other evolutionary changes in birds. It is unlikely that the new 
Sho-like gene found in chicken downstream to PRNP, which has no sequence 
homology to Dpl, could be its functional replacement in avian lineages. The Sho-
like protein has some regions of sequence similarities compared with fish PrP-like 
and Sho2 suggesting that this genomic locus has evolved from a common 
ancestor. 
The absence of Dpl may have influenced the changes that are observed between 
avian PrPs compared with the other tetrapod lineages, the most interesting being 
the insertion of a 9-10 residue region in the C-terminal domain which is unique to 
avian species.  
Finally, the chicken PRNP gene locus may be used as a basis for evolutionary 
studies of aves to establish its relationship to amphibian and reptiles once the 
genome sequence for reptilian PRNP loci is known. It is known that Dpl plays a 
role in the acrosome reaction in higher vertebrates. There are many anatomical 
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differences between the egg of eutheria and subtherian species. The presence of 
weaker outer perivitelline layer in lower vertebrates compared with a zona pellucida 
in higher vertebrates, suggests the physiology of the acrosome reaction may be 
more complex in higher vertebrates, and that Dpl would have acquired the 
specialized role in testis only in mammalian lineages.  
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5 Findings in other species 
5.1 Background 
To investigate further the evolution of prion-protein family genes, examples of the 
most distant mammalian groups (Marsupials and Monotremes) were studied. The 
draft genomes of interest were those of grey short-tailed opossum (Monodelphis 
domestica) and Platypus (Ornithorhynchus anatinus). Sequencing for M. domestica 
and platypus are being undertaken by the Broad Institute of MIT and Harvard, and 
by Washington University Genome Sequencing Center, respectively. Platypus, a 
prototherian has both reptilian and mammalian characteristics. The mammalian 
features include fur bearing and mammary glands to feed the young with milk. The 
reptilian features include egg laying and the possession of venom. The unique 
evolutionary relationship of monotremes and marsupial mammals to eutherian 
mammals attracts particular interest. Platypus is, however, classified as a true 
mammal because of the milk producing ability (Griffiths 1978). Evolutionary 
biologists agree that monotremes diverged before the Therian (eutherian and 
marsupial) mammals (Figure 5-1). The platypus genome offers a unique resource 
for comparative genomics to identify genes and regulatory sequences.  
 
Figure 5-1 Evolutionary history of mammalian class. 
The marsupial (metatherian) is the closest outgroup to placental mammals 
(eutherian) (Figure 5-1). Its genome provides an opportunity to understand the 
organization and evolution of the mammalian genome.  
At the time of this study, the M. domestica draft genome assembly was released; I 
used this for my analysis. However, for platypus, the only available sequence 
information was in the form of trace sequences. To probe for the origin of the PrP 
family I also analyzed the Ciona intestinalis genome (sequenced by Joint Genome 
Class 
Mammalia 
Marsupilia [pouched mammals] 
Monotremata [egg-laying mammals] 
Eutheria [placental mammals] 
Theria 
Prototheria
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Institute); C. intestinalis is a primitive and smallest chordate. To understand the 
PrP family genes at an intermediate stage between fish and amphibian, I also 
studies salamanders which belong to order caudate of class amphibia. 
Salamanders are distinguished from other amphibia by the presence of a tail in 
adults. Ambystoma mexicanum (Axolotl) is a model organism for this group and is 
used for evolutionary and regeneration studies. Finally, human sequence 
databases (EST and genome) were also analyzed to look for any variant forms, or 
new members of PrP family genes.  
5.2 Monodelphis domestica 
The first reported marsupial PrP sequence was that of Tricosurus vulpecular 
(brush-tailed opossum) (Windl et al. 1995). Premzl et al. (2005) later reported 
tammar wallaby PrP. The other PrP family members (Dpl and Sho) were not 
reported in marsupial species. My interest was to identify these genes for 
comparative sequence analysis. 
5.2.1 Homology search 
A local standalone BLAST database was created which was managed by Perl 
scripts (createBlastdb.pl). Initial searches were made on the assembled version 
0.5, which was the latest at the time of study. Homology searches were performed 
using TBLASTN for the PrP family genes with the following amino acid query 
sequence: PrP- T. vulpecular; Dpl- Human; Sho- Human. 
Partial sequences were found for all the genes of interested (Figure 5-2). This 
sequence information was used to design primers for experimental work. The 
protein sequences were analyzed for known sequence features. 
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>MdPrP 
MGKIHLGYWFLALFIMTWSDLTLCKKPKPRPGGGWNSGGNRYPGQSGGWGHPQGGGTNWGQPHAGGSNWGQPRPGGSNWGQPHPGGSNWGQP
HPGGSNWGQAGSSYNQKWKPDKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPIMHFGNDYEDRYYRENQYRYPNQVMYRPIDQYNNQNN
FVHDCVNITVKQHTTTTTTKGENFTETDIKIMERVVEQMCITQYQNEYRSAYSVAFFSAPPVTLLLLSFLIFLIVS 
 
>MdDpl 
MRRHLGICWIAIFFALLFSDLSLVKAKTTRQRNKSNRKGLQTNRTNPTTVQPSEKLQGTFIRNGRKLVIDFGEEGNSYYATHYSLFPDEIHY
AGCAESNVTKEVFISNCVNATRVINKLEPLEEQNISDIYSRILEQLIKELCALNYCEFRTGKGTGLSALFRPICYGLPGDSDLLDSEIHKHR
A 
 
>MdSho 
MNWAAVTCWTLLLLAAFFCENVTSKGGRGGARGAARGRSRSSSSSSRMRMKSAPRYSSSGSAFRVAAAASAGAAAGAAAGAVAGAAGRRMSG
EVGTSVNLERDLYYSNQTGEGIYSYRWTSGTDRGGVEPNLSLCLTLGFFQLFHP 
 
Signal sequence 
Cysteine involved in disulphide bridge formation 
N-glycosylation site 
GPI anchor site 
 
Figure 5-2. Sequence information for M. domestica PrP, Dpl and Sho (obtained from genome 
sequence database).  
5.2.2 Defining exon-intron boundaries in M. domestica 
The full length cDNA sequences were obtained from 3’ and 5’ RACE experiments 
which were carried out by Tatiana Vassilieva in my group. The M. domestica 
Version 2 assembly was available at this stage of the study, and I used it for gene 
annotation. I mapped the cDNA sequence onto the genomic sequence to obtain 
the intron/exon boundaries (Figure 5-3). Two variant transcripts for PRNP and four 
different variants for PRND were identified. 
As in Xenopus species where the predominant variant for PRND was a chimeric 
transcript, a similar observation was made in M. domestica. Different intergenic 
exons (2D, 3D, and 4D) were identified (Figure 5-3). The 3’ UTR also showed a 
long and a short variant (Figure 5-3).  
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Figure 5-3 Schematic representation of the exons identified by mapping the experimental 
cDNA sequences onto the M.domestica genome assembly sequence. (a) Exons of PRNP and 
PRND. The number above the exon represents the exon number. The letter “P” is used to represent 
PRNP and “D” for PRND. (b) Non-chimeric PRNP variant. (c) Non-chimeric PRNP variant with 
intron in the coding region. (d), (e), (f) Chimeric transcripts with different intergenic exons. (g) Non-
chimeric PRND. The 3’ UTR of PRND showed two different sizes. The longer variant is represented 
with dotted lines. The length of the introns is shown in the transcripts in bp.  
 
5.2.3 Alternative splicing leading to two different C-terminal PrP 
sequences 
The structures of the two M. domestica PrP transcripts show different C-terminal 
sequence corresponding to the GPI-signal sequence. One variant is formed by 
alternative splicing of the 3’ end of the ORF (Figure 5-3 c); this is the only case of 
an intron in the ORF found in a PrP gene family. This results in two different coding 
regions, ORF1 which does not have an intron (regular type), and ORF2 which has 
the intron (unique type) (Figure 5-4). Although the ORF2 variant was reported by 
Premzl et al. (2005) (NCBI accession number: AY659989 and BK005535) the 
presence of the intron was not recognized due to lack of genomic sequence 
information at the time of their study. The significance of the variation in the C-
terminal signal sequence is unclear; it may not produce a significant functional 
difference as there is no change in the predicted GPI-modification site. The splicing 
may arise from the presence of additional splice donor and acceptor sites, resulting 
in some leaky splicing (see Appendix 3). Further analyses of these variants were 
 
a 
 
b 
 
 
c 
 
d 
 
 
e 
 
 
f 
 
 
g 
15675 
 1 (common)                        2P         3P        2D        3D           4D            5D                 6D
48851                                                                 36089          6895              
30510                                        2059                      52402 
85126 
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made as part of a different project carried out by Tatiana Vassilieva and are not 
discussed further.  
                            10        20        30        40        50        60 
                   ....|....|....|....|....|....|....|....|....|....|....|....| 
MdPrP_ORF1         MGKIHLGYWFLALFIMTWSDLTLCKKPKPRPGGGWNSGGNRYPGQSGGWGHPQGGGTNWG 
MdPrP_ORF2         MGKIHLGYWFLALFIMTWSDLTLCKKPKPRPGGGWNSGGNRYPGQSGGWGHPQGGGTNWG 
                   ************************************************************ 
 
                            70        80        90       100       110       120 
                   ....|....|....|....|....|....|....|....|....|....|....|....| 
MdPrP_ORF1         QPHAGGSNWGQPRPGGSNWGQPHPGGSNWGQPHPGGSNWGQAGSSYNQKWKPDKPKTNMK 
MdPrP_ORF2         QPHAGGSNWGQPRPGGSNWGQPHPGGSNWGQPHPGGSNWGQAGSSYNQKWKPDKPKTNMK 
                   ************************************************************ 
 
                           130       140       150       160       170       180 
                   ....|....|....|....|....|....|....|....|....|....|....|....| 
MdPrP_ORF1         HVAGAAAAGAVVGGLGGYMLGSAMSRPIMHFGNDYEDRYYRENQYRYPNQVMYRPIDQYN 
MdPrP_ORF2         HVAGAAAAGAVVGGLGGYMLGSAMSRPIMHFGNDYEDRYYRENQYRYPNQVMYRPIDQYN 
                   ************************************************************ 
 
                           190       200       210       220       230     240  
                   ....|....|....|....|....|....|....|....|....|....|....|....| 
MdPrP_ORF1         NQNNFVHDCVNITVKQHTTTTTTKGENFTETDIKIMERVVEQMCITQYQNEYRSAYSVAF 
MdPrP_ORF2         NQNNFVHDCVNITVKQHTTTTTTKGENFTETDIKIMERVVEQMCITQYQNEYRSAYSVAF 
                   ************************************************************ 
    
                           250       260        
                   ....|....|....|....|....|.... 
MdPrP_ORF1         FSAPPVTLLLLSFLIFLIVS---------  
MdPrP_ORF2         FSAPPVTLLLLSFLIFLIIPDAHSVEAIS  
                  ******************:.           
Figure 5-4 Comparison of the two M. domestica PrP ORF variants, ORF1 and ORF2. Note the 
only difference is in the C-terminal signal sequence shown in the box.  GPI attachment site is 
indicated by arrow. 
5.3 Platypus 
 
5.3.1 Homology search 
A BLAST-searchable platypus trace sequence database was created from the 
downloaded sequences. This was screened for the PrP family genes using the 
known sequence information: Dpl- M. domestica; PrP- Human; Sho- Human. 
Partial to full length sequences of all the PrP family members were found (Figure 
5-5).  
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>PrP 
MWPHWGKSPVHHWIIDICVVHLERRCRGHLHPNPCPGGGWNSGNRYPGQPANPGGWGHPQGGGASWGHPQGGGASWGHPQGGGSNWGHPQGG
GASWGHPQGGGYSKYKPDKPKTGMKHVAGAAAAGAVVGGLGGYMIGSAMSRPPMHFGNEFEDRYYRENQNRYSNQVYYRPVDQYGSQDGFVR
DCVNITVTQHTVTTTEGKNLNETDVKIMTRVVEQMCGSTTWNLQWFGVSFNF 
 
>Dpl 
MMTVRRRRRSGGARWLLVFLVLLSGDLSSLQARGPRPRNKAGRKPPPVQRRALTLRAPRPPAGARGTFIRRGGRLSVDFGPEGNGYYQANYP
LLPDAIVYPDCPTANGTREAFFGDCVNATHEANRGELTAGGNASDVHVRVLLRLVEELCALRDCGPALPTGPAPRPGPPGPPAALALLTLVL
LGAQ 
 
>Sho 
MNWVAVACWTLLLLTAFLCDSVTCKGGRGGARGAARGAARGATRVRLKSVPRYSSSGSGLRVEAS 
 
Signal sequence 
Cysteine involved in disulphide bridge formation 
N-glycosylation site 
GPI anchor site 
Figure 5-5 Translated ORFs obtained by homology search against the platypus trace 
sequence database. The Sho sequence shows a premature stop codon which may be due to poor 
sequence quality rather than a psuedogene; this can be confirmed only by a later release of better 
quality assembled sequence or by direct sequencing. 
5.3.2 Sequence analysis 
PrP and Dpl sequences were analyzed for known sequence elements (signal 
sequence, disulphide bridge and N-glycosylation). The N-terminal sequence of PrP 
and Dpl showed very significant variation from other known sequences. This may 
be erroneous and related to the low sequence coverage of the unassembled trace 
sequences. Interestingly, the PRND ORF is in a GC rich region in contrast to other 
species (see Appendix 4) (Table 5-1). 
Because of the lack of good quality assembled sequence information required for 
comparative sequence analysis, no further analysis was performed using these 
sequences. Experimental work to characterize the cDNAs and the tissue 
expression were studied as a part of other project (work of Tatiana Vassilieva) and 
hence not discussed further.  
Table 5-1 Estimating the percentage of C and G bases in PRND ORF among different species 
 
 Human Mouse Cow Sheep Monodelphis Platypus Xenopus 
C% 30.1 27.7 24.6 24.8 20.0 39.2 21.8 
G% 29.9 31.8 27.6 27.2 22.6 35.3 24.0 
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5.4 Miscellaneous searches 
5.4.1 Ciona intestinalis 
The evolutionary model proposed by Premzl et al. (2004) suggested a primitive 
Sho-like gene to be the ancestor of all the PrP family genes. Based on this 
hypothesis, a homology search was performed to look for the origin of the PrP 
family genes in the Ciona intestinalis genome. Homology-based searches using 
BLAST revealed no regions of sequence similarity to those of PrP family genes. 
5.4.2 Axolotl 
Databases containing Axolotl EST sequences are reported in the literature 
(Habermann et al. 2004; Putta et al. 2004). Searches for Dpl, PrP and Sho using 
online BLAST http://salamander.uky.edu/ESTdb/blast.php (TBLASTN and 
BLASTN) did not yield positive results. To confirm this, a standalone BLAST 
database was created (using createBlastdb.pl) and was searched using various 
combinations for PrP, Dpl and Sho from several known sequences. However, no 
significant homologous sequences were obtained.  
5.4.3 Human 
Analysis of EST sequences: The possibility of spliced PRNP ORF variants as 
seen in MdORF2 was investigated in the human EST database. Several EST 
sequences corresponding to human PrP sequences were retrieved from the NCBI 
EST database (see Appendix 5). A multiple sequence alignment was performed to 
look for any variations; no variants similar to MdORF2 were discovered. However, 
this search lead to discovery of two interesting PRNP variants, one with fewer N-
terminal repeats (GI: 15582753, 15581955) and the other with a frame shift 
mutation (GI: 52091525, 15438946) (Figure 5-6). The presence of fewer N-terminal 
repeats compared with wild-type PrP represents a rare polymorphism. Splice-site 
prediction using SpliceView software (Zhang et al. 2002) 
(http://l25.itba.mi.cnr.it/~webgene/wwwspliceview.html) was performed after 
introducing T255A (number corresponds to the nucleotide position in the wild-type 
human PRNP ORF). The introduction of this polymorphism created a new splice 
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acceptor site at that position with the splice donor site located at position 157 
(Figure 5-6). This splicing created the exact variant with fewer N-terminal repeats 
as that found in the EST sequences (GI: 15582753, 15581955). There is no 
published information on these PrP variants and hence the implication of such a 
variant is unknown. However, insertions in the octapeptide repeat region have 
been associated with prion disease (Ironside 1998) and deletions are known in 
other mammals (eg. cattle) (Walawski and Czarnik 2003). The variants with frame 
shift mutations caused by insertions/deletions in the two ESTs (GI: 52091525, 
15438946) may be a result of sequencing errors. 
a 
HumPrP          MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQP 
15581955        MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGG----- 
15582753        MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGG----- 
                *******************************************************      
 
HumPrP          HGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGA 
15581955        ---------------------------GWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGA 
15582753        ---------------------------GWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGA 
                                           ********************************* 
 
HumPrP          VVGGLGGYMLGSAMSRPMIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCV 
15581955        VVGGLGGYVLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCV 
15582753        VVGGLGGYVLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCV 
                ********:********:****************************************** 
 
HumPrP          NITIKQRTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPV 
15581955        NITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQ----------------------- 
15582753        NITIKQHTVTTXTKGENFTETDVKMMERVVEQMCIT------------------------ 
                ******:**** ************************                         
 
HumPrP          ILLISFLIFLIVG 
15581955        ------------- 
15582753        -------------  
b 
ATGGCGAACCTTGGCTGCTGGATGCTGGTTCTCTTTGTGGCCACATGGAGTGACCTGGGCCTCTGCAAGAAGC
GCCCGAAGCCTGGAGGATGGAACACTGGGGGCAGCCGATACCCGGGGCAGGGCAGCCCTGGAGGCAACCGCTA
CCCACCTCAGGGCGGTGGTGGCTGGGGGCAGCCTCATGGTGGTGGCTGGGGGCAGCCTCATGGTGGT 
                                       T255A 
GGCTGGGGGCAGCCCCATGGTGGTGGCTGGGGACAGCCTCATGGTGGTGGCTGGGGTCAAGGAGGTGGCACCC
ACAGTCAGTGGAACAAGCCGAGTAAGCCAAAAACCAACATGAAGCACATGGCTGGTGCTGCAGCAGCTGGGGC
AGTGGTGGGGGGCCTTGGCGGCTACATGCTGGGAAGTGCCATGAGCAGGCCCATCATACATTTCGGCAGTGAC
TATGAGGACCGTTACTATCGTGAAAACATGCACCGTTACCCCAACCAAGTGTACTACAGGCCCATGGATGAGT
ACAGCAACCAGAACAACTTTGTGCACGACTGCGTCAATATCACAATCAAGCAGCACACGGTCACCACAACCAC
CAAGGGGGAGAACTTCACCGAGACCGACGTTAAGATGATGGAGCGCGTGGTTGAGCAGATGTGTATCACCC 
Figure 5-6 Human PrP with fewer N-terminal repeats. (a) Comparison of wild-type human PrP 
with human PrP showing fewer N-terminal repeats. (b) Genomic region corresponding to the ORF 
of human PrP. One possible explanation for the presence of fewer repeats may be a rare 
polymorphism of T255A leading to splicing of the ORF (the splice donor and acceptor sites are 
shown in dotted box.  
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Whole genome analysis: A homology search using BLAST to look for any other 
undiscovered PrP-like genes was performed on the human genome sequence 
using PrP, Dpl and Sho sequences from different lineages.  
After trying different query sequences in various combinations, only one interesting 
ORF (huNewORF) (Figure 5-7A) was obtained when chicken Sho was used as 
query (Figure 5-7B). However, it shares low sequence homology with human Sho 
(Figure 5-7C).  
This new sequence lacks the N-terminal and C-terminal signal sequences. When a 
50 KB region around this ORF was analyzed with GenScan, it predicted a gene in 
the opposite direction (Figure 5-8). This corresponds to Zinc finger protein (ZNF) 
(NP_001028895) as in the NCBI protein database. This gene is on the 
complementary strand to that of the new ORF which is overlapping exon no. 6 of 
ZNF gene (Figure 5-8). EST database searches with the huNewORF sequence 
indicated that this transcript is expressed. However, this observation is due to the 
exon 6 of ZNF gene. Interestingly, within the ZNF gene environment, there is 
another pseudogene, CDC28 (NC_000008), spanning the intron between ZNF 
exon 2 and 3 (Figure 5-8). 
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a 
>HuNewORF 
MQKTAWLTTNLSFPGNGLVEEQVAGLRLVDAVVWLRGAAEGLEAVSRERRRRRGRVGLVAGGAPAPVAAAAGA
GRHAAALLPGSAEALCMHTNTVSARTPACPGMVQWGNGSLGSTPVKPPQPSQSSATAGYVSFCSIYTPPPKSH
IVVYKHLIILTS 
 
B                   10        20        30        40        50        60   
           ....|....|....|....|....|....|....|....|....|....|....|....| 
HuNewORF   MQKTAWLTTNLSFPGNGLVEEQVAGLRLVDAVVWLRGAAEGLEAVSRERRRRRGRVGLVA  
ChickSho   MRQRVACCWVLLLLAATFCQPAAA----KGGRGGSRGAARGMARG-AARSRHRGLP--RY  
           *:: .     * : .  : :  .*     ..    ****.*:      * *:**        
 
                    70        80        90       100       110       120   
           ....|....|....|....|....|....|....|....|....|....|....|....| 
HuNewORF   GGAPAPVAAAAGAGRHAAALLPGSAEALCMHTNTVSARTPACPGMVQWGNGSLGSTPVKP  
ChickSho   GGALRVAAAAAAAGAAAGAALHQARAETEYHEGNGTAWTSVAPGWVEWGWAMPWLCPLAA  
           ***   .****.**  *.* *  :      * .. :* *...** *:** .     *: .  
 
                   130       140       150         
           ....|....|....|....|....|....|....|... 
HuNewORF   PQPSQSSATAGYVSFCSIYTPPPKSHIVVYKHLIILTS  
ChickSho   ILHHWHPP--GPLRSSAIQQRGNKAGQ-----------  
                 ..  * :  .:*     *:               
 
C                   10        20        30        40        50        60   
           ....|....|....|....|....|....|....|....|....|....|....|....| 
HuNewORF   MQKTAWLTTNLSFPGNGLVEEQVAGLRLVDAVVWLRGAAEG-LEAVSRERRRRRGRVGLV  
HuSho      MNWAPATCWALLLAAAFLCDSGAAKGGRGGARGSARGGVRGGARGASRVRVRPAQRY---  
           *: :.     * :..  * :. .*     .*    **...*  ...** * *   *      
 
                    70        80        90       100       110       120   
           ....|....|....|....|....|....|....|....|....|....|....|....| 
HuNewORF   AGGAPAP---VAAAAGAGRHAAALLPGSAEALCMHTNTVSARTPACPGMVQWGNGSLGST  
HuSho      --GAPGSSLRVAAA-GAAAGAAA---GAAAGLAAGSGWRRAAGPGERGLEDEEDGVPGGN  
             ***..   **** **  .***   *:* .*.  :.   *  *.  *: :  :*  *..  
 
                   130       140       150       160          
           ....|....|....|....|....|....|....|....|....| 
HuNewORF   PVKPPQPSQSSATAGYVSFCSIYTPPPKSHIVVYKHLIILTS---  
HuSho      GTGPGIYSYRAWTSG-----AGPTRGPRLCLVLGGALGALGLLRP  
            . *   *  : *:*     :  *  *:  :*:   *  *        
Figure 5-7 Analysis of new human ORF with sequence similarities to Sho. (a) The human 
sequence found by homology search using chicken Sho sequence with the possible N-glycosylation 
sites highlighted. (b) Alignment with Chicken Sho and (c) Human Sho 
A search was performed using the huNewORF sequence in the chimp, rat and 
mouse genomes. Although a similar region was found, the sequence in rat and 
mouse had premature stop codons. In summary, the observed sequence 
conservation is more likely due to the ZNF exon rather than indicating a new gene.  
b 
c 
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Figure 5-8 Genomic environment of the new (Sho-like) ORF in human. This ORF overlaps exon 
6 of ZNF in the opposite direction. Also note the pseudogene CDC28 which spans the intron of ZNF 
and is oriented in the same direction.  
5.5 Summary 
M. domestica and platypus genomes were search for PrP family genes. All three 
genes were discovered in M. domestica and experimental characterization 
revealed chimeric PRND transcripts. One of the PRNP transcript variants had an 
intron in the 3’ end of the ORF resulting in an altered C-terminal signal sequence. 
However, this did not alter the predicted cleavage site for GPI attachment. This 
splicing may be a result of a weak splice signal. 
Searching the platypus trace sequence database for PrP family genes revealed 
full/partial length sequences for PrP, Dpl and Sho.  
Homology-based searches for PrP family members in C. Intestinalis for which 
genome data are available, and axolotl species (Ambystoma mexicanum) did not 
reveal any homologous sequence. Human PrP EST database was searched to 
look for any undiscovered variants. This search revealed ESTs which had fewer 
repeats probably as a result of a SNP signaling as a splice acceptor site. Some 
other EST sequences showed frame-shift mutations which may be a result of 
sequencing error. These variants were not reported in the literature before. The 
human genome was also searched for undiscovered PrP family genes. This search 
revealed an ORF sequence homologous to chicken Sho. However, this region is 
not seen even in closely related species (Chimp, rat and mouse) suggesting that 
this is not a functional ORF. 
1  2      3     4           5       6  7                  ZNF                                                               8
CDC28 NewORF 
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6 Comparative sequence and structure analysis of prion 
protein and doppel 
6.1 Background 
 
Comparative sequence analyses offer powerful approaches to infer conserved 
amino acid motifs that are likely of general importance. Conserved motifs can then 
be located on the three-dimensional structure which may give additional 
information on binding sites, DNA binding domains and protein-protein contact 
regions.  
The rate of evolution varies within and among lineages in that different proteins 
evolve at different rates. The rate of evolution varies among amino acid sites with 
some regions being highly conserved and other regions showing large variations. 
Hence, the evolutionary rate of change at an amino acid site is indicative of how 
conserved this site is and, in turn, allows evaluation of its importance in maintaining 
the structure or function of the protein. 
PRNP and PRND are gene duplicates which have been retained over time. 
Apparently, this gene duplication occurred between amphibians and fish before the 
radiation of tetrapods (Figure 7-2). Genes that have been duplicated are normally 
lost over long evolutionary timescales because of lower selective pressure. More 
rarely, duplicate genes may be retained. In some such cases, the functions and 
expression patterns of the gene pairs may diverge substantially giving rise to novel 
functions or specialization in the organism.  Force et al. (1999) have suggested 
that gene duplication may allow sub-functionalization to take place if a gene 
performing more that one function is duplicated. Lynch and Conory (2000) have 
suggested that following duplication, a time-dependent manner of selective 
pressure comes into play with the gene duplicate evolving in a nearly neutral way 
immediately after duplication but becoming more constrained as it becomes more 
divergent from its copy. The evolution of novel function may be related to changes 
in the coding and/or regulatory regions after gene duplication. 
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My main purpose in this chapter is to describe the variation in the rate of molecular 
evolution of PRNP and PRND. My other aim is to derive functional information from 
comparative sequence analysis.  
6.1.1 Methods 
Sequence alignment for predicting critical amino acids: The sequences 
included for identification of conserved residues are human, mouse, rat, sheep, 
cow, M. domestica, tammar wallaby, platypus, chicken, turtle, X. laevis and X. 
tropicalis (Table 6-1). 
Table 6-1 Identifiers of known sequences used in the analysis. 
 
Species Source 
PrP 
Human ref|NP_001009093.1| 
Mouse ref|NP_035300.1| 
Rat ref|NP_036763.1| 
Sheep ref|NP_001009481.1| 
Cow ref|NP_851358.1| 
Tammar wallaby gb|AAT68001.1| 
Possum gb|AAA61833.1| 
Turtle emb|CAB81568.1| 
Chicken gb|AAC28970.1| 
X. laevis ref|NP_001082180.1| 
Dpl 
Human ref|NP_036541.2| 
Mouse ref|NP_075530.1| 
Rat ref|NP_001095901.1| 
Sheep ref|NP_001009261.1| 
Cow ref|NP_776583.1| 
M. domestica ref|XP_001381721.1| 
 
The N-terminal signal sequence, C-terminal signal sequence, N-terminal repeats in 
PrP and the C-terminal domain regions in PrP and Dpl were aligned independently. 
These individual alignments were assembled to obtain the final alignment. 
Alignment of the C-terminal domain: Pairwise structural alignments were generated 
using DaliLite (Holm and Park 2000). Mouse PrP (1AG2) and mouse Dpl (1I17) 
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were used as templates for all the alignments, enabling generation of a multiple 
structure-based sequence alignment using mouse sequence as a reference.  
Alignment of the signal sequence: The predicted signal sequences among different 
lineages in PrP and Dpl were aligned using ClustalW.   
Calculation of rate of evolution: The rate of evolution of amino acid sequence 
was calculated by the Rate4Site algorithm (Pupko et al. 2002). Rate4Site makes 
use of topology and branch lengths of the phylogenetic trees constructed from 
multiple sequence alignments (MSA) of proteins and estimates conservation rates 
of amino acids based on the empirical Bayesian rule. A site-specific rate, r, 
indicates how fast a particular site evolves relative to the average evolutionary rate 
across all sites in the MSA and, hence, is unit less. A rate of 2.0 indicates that a 
site evolves two times faster than the average. 
The species included for calculating the rate of evolution are: human, mouse, rat, 
cow, sheep, M. domestica, and X. tropicalis. As there is no information available for 
the existence of reptilian PRND and as PRND is absent in chicken, these two 
vertebrate branches were eliminated from the analysis. Platypus sequence was not 
included in the analysis due to its current poor sequence quality. The average 
values of different structural components were calculated separately to compare 
the rate of evolution within different segments of the protein sequence. The graphs 
were plotted using Microsoft Excel.  
Analysis of distribution of conserved amino acids in 3D space: ConSurf is a 
web server (http://consurf.tau.ac.il/) for mapping the level of evolutionary 
conservation of each of the amino acid positions of a protein (based on multiple 
sequence alignment) onto its 3D structure (Glaser et al. 2003). The degree of 
residue conservation is translated into a coloring scale that is projected on to a 
known structure. Comparisons for PrP and Dpl were made as follows (reptile and 
avian sequence are not included for Dpl) 
1. Within eutherian mammals (human, mouse, rat, cow, sheep, dog).  
2. Eutherian mammals and marsupial (tammar wallaby and M. domestica). 
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3. Eutherian mammals, marsupial, avian (chicken), and reptile (turtle). 
4. Eutherian mammals, marsupial, avian, reptile and amphibian (X. tropicalis). 
All illustrations of protein structure were generated using PyMOL (DeLano 2002). 
Polydot:  A dotplot is a graphical representation of the regions of similarity 
between two sequences. Where the two sequences have substantial regions of 
similarity, many dots align to form diagonal lines. It is therefore possible to see at a 
glance where there are local regions of similarity. Polydot (Rice et al. 2000) 
compares all sequences in a set of sequences and draws a dotplot for each pair of 
sequences by marking where words (tuples) of a specified length have an exact 
match in both sequences. The Dotplot for PrP was based on a window size of 4 
and that for Dpl on a window size of 6.  
6.2 Results and discussion 
6.2.1 Rate of evolution of amino acid sequence 
The rate of evolution of amino acid sequence was measured among human, 
mouse, cow, sheep, M. domestica and X. tropicalis based on the MSA shown in 
the Figures 6-5 and 6-6. The N-terminal signal sequence in PrP is evolving at a 
slightly faster rate compared with the other regions of the protein (Figure 6-1). The 
middle hydrophobic region is likely to be under selective pressure and is evolving 
at the slowest rate compared with the other regions. The repeat region and the C-
terminal domain are evolving at a similar rate to each other. In Dpl, except for the 
C-terminal signal sequence which is evolving at a higher rate, other regions shows 
similar rates of evolution (Figure 6-1) (see Appendix 6 for rate of evolution of 
individual sites).  
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Figure 6-1 The rate of evolution (r) at each of the amino acid sites averaged across different 
sequence regions in PrP and Dpl. SS- signal sequence, BR- basic repeats, H- Hydrophobic 
region, C- C-terminal domain, B- basic (refer to Figure 5-3). 
 
6.2.2 Distribution of conserved residues on the protein structure 
The degree of conservation was analyzed among different lineages using ConSurf. 
PrP showed greater conservation compared with Dpl across different lineages 
(Figure 6-2). This suggests that Dpl is evolving at a faster rate compared with PrP 
in an attempt to acquire a specialized function in higher vertebrates. The 
evolutionary constraint on PrP may be related to the greater number of functions it 
carries out.  
PrP
Dpl
r
r 
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Predicting critical amino acid residues for structural stability: PrP and Dpl 
share a similar structural fold. To analyse the residues involved in the fold 
formation, the sequences from PrP and Dpl were compared among different 
lineages (Figure 6-7). A number of common conserved residues were found 
between PrP and Dpl which are listed below with the numbers corresponding to 
mouse sequence.  
PrP: F141, Y149, Y150, N153, P158, Y163, F175, C179, N181, T183, C214 
Dpl: F71, Y78, Y79, N82, P87, Y92, L105, C109, N111, T113, C143. 
The Leu residue at position105 in mouse Dpl is uniquely different from other 
lineages within Dpl and PrP where Phe is dominant at that position (Figure 6-7).  
These residues conserved between the two proteins are distributed at similar 
positions in 3D space indicating  significance in the fold formation and structural 
stability (Figure 6-3). 
Predicting critical amino acid residues for function: Comparison of PrP and 
Dpl sequences were made among different lineages (Figure 6-5, Figure 6-6) to 
identify evolutionarily conserved residues. The numbering of the amino acid 
residues in the following section corresponds to mouse sequence. 
PrP: Residues that are conserved among mammal, marsupial, avian and 
amphibian species (excluding those that are common between PrP and Dpl) are 
G126, G127, Y128, G131,F141, E146, R148,V161, R164,Y169, V176, D178, and 
M213. Residues those are conserved among mammal, marsupial and amphibian 
but missing in avian are A133, R136, P165, I182 and V209. Residues that are 
conserved among mammal, marsupial and avian but missing in Xenopus species 
are S135, Glu152, R156 and Y157 (Figure 6-5). The distribution of these residues 
in 3D space is shown in Figure 6-4. Most of the conserved residues are on the 
outer surface and possibly play a role in protein-protein interactions. 
Dpl: Residues (constituting the mature protein) that are present in all mammals 
and at least in one marsupial and one of the amphibian species (excluding those 
that are common between PrP and Dpl) are E24, F36, D38, N49, E53, N67, and 
 
 104 
V84. Residues that are present in all/most of the mammal and marsupial 
sequences compared (missing in amphibian species) are G22, G25, N26, Y33, I40, 
C45, T51 and L88 (Figure 6-6, Figure 6-4). One of the major structural distinctions 
between PrP and Dpl is the presence of a kink in helix B in Dpl. Dpl shows two 
different kinks. The first kink (kink1) is in helix A at position N82 (Figure 6-3) and 
the second (kink2) is in helix B at position N117 (Figure 6-4). Mo et al. (2001) 
proposed that N117 is possibly involved in the kink formation. This residue is 
conserved within Dpl in all species compared indicating it is critical to differentiate 
between PrP and Dpl (Figure 6-4). In both cases, Asn was preceded by Ala (A81 
and A116). The equivalent of Dpl N82 in PrP is N153 in helix A (Figure 6-3). 
However, this residue did not produce a kink in PrP. This may indicate that the 
sequence Ala-Asn is needed to produce the kink. Interestingly, the equivalents of 
mouse Dpl A81 and N82 are missing in M. domestica and tammar wallaby (Figure 
6-6) which may suggest this region is structurally different in marsupial species. 
Although the equivalent of mouse N117 is present in Xenopus species, the 
equivalent of mouse Dpl A116 is replaced by Arg in Xenopus species (Figure 6-6). 
This suggest that the kink in helix B may be missing in Xenopus species.  Similar 
to PrP, most of the conserved residues are on the surface of the protein. 
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Figure 6-2 Distribution of conserved residues on mouse PrP and Dpl based on sequence 
conservation. Comparison was made among different lineages.  
 
  
Eutherian mammal Mammal+
Marsupial
Mammal+ 
Marsupial+Avian+Reptile 
Eutherian mammal Mammal+Marsupial Mammal+Marsupial+
Amphibian 
Variable      Average   Conserved 
Mammal+Marsupial+ 
Avian+Reptile+Amphibian 
PrP
Dpl 
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Figure 6-3 Identical residues in PrP and Dpl among mammals, marsupial and amphibian 
species shown in blue. The evolutionary and interprotein conservation indicates that these 
residues are critical for fold or structural stability. 
 
Figure 6-4 Distribution of evolutionarily conserved residues in PrP and Dpl. Sequence 
information from mammal, marsupial, avian and amphibian was used for PrP and mammals, 
marsupial and amphibian species was used for Dpl. Residues in Red are present in all lineages, 
Green residues are those  missing in amphibian, and Blue (applicable to PrP only) missing in avian 
and/or reptile. 
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                 10        20        30        40        50        60        70        80        90       100       110       120       130       140       150       160       170       180  
        ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|.. 
                                                               
HuPrP   ----MAN--LGCWMLVLFVATWSDLGLCKK----RPKP--GGW---NTGG-S------RYPGQ-GS-PGGNRYP------------PQGGGG-WGQPHGGG--WGQPHGGG--WGQPH-GGG-WGQPHGGG--WGQ-------------------------------------------GGG 
MoPrP   ----MAN--LGYWLLALFVTMWTDVGLCKK----RPKP--GGW---NTGG-S------RYPGQ-GS-PGGNRYP------------PQGGT--WGQPHGGG--WGQPHGGS--WGQPH-GGS-WGQPHGGG--WGQ-------------------------------------------GGG 
DoPrP   ----MVKSHIGGWILLLFVATWSDVGLCKK----RPKP--GGW---NTGGGS------RYPGQ-GS-PGGNRYP------------PQGGGG-WGQPHGGG--WGQPHGGG--WGQPH-GGG-WGQPHGGGG-WGQ-------------------------------------------GGG 
BoPrP   ----MVKSHIGSWILVLFVAMWSDVGLCKK----RPKP-GGGW---NTGG-S------RYPGQ-GS-PGGNRYP------------PQGGGG-WGQPHGGG--WGQPHGGG--WGQPH-GGG-WGQPHGGG--WGQPHGGGGWGQ-----------------------------------GG 
ShPrP   ----MVKSHIGSWILVLFVAMWSDVGLCKK----RPKP-GGGW---NTGG-S------RYPGQ-GS-PGGNRYP------------PQGGGG-WGQPHGGG--WGQPHGGG--WGQPH-GGG-WGQ----------PHGGGGWGQ-----------------------------------GG 
MdPrP   ----MGKIHLGYWFLALFIMTWSDLTLCKK---PKPRP-GGGW---NSGG-------NRYPGQSG-----------------GWGHPQGGGTNWGQPHAGGSNWGQPRPGGSNWGQPHPGGSNWGQPHPGGSNWGQ------------------------------------------AGSS 
PoPrP   ----MGKIQLGYWILVLFIVTWSDLGLCKK---PKPRP-GGGW---NSGG-S-----NRYPGQPGS-PGGNRYP--------GWGHPQGGGTNWGQPHPGGSNWGQPHPGGSSWGQPH-GGSNWGQ------------------------------------------------------GG 
TwPrP   ----MAKIQLGYWILALFIVTWSELGLCKK---PKTRP-GGGW---NSGG-S-----NRYPGQPGS-PGGNRYP--------GWGHPQGGGTNWGQPHPGGSSWGQPHAGGSNWGQPH-GGSNWGQ-----------------------------------------------------GGG 
PlPrP   MWPHWGKSPVHHWIIDICVVHLERRCRGHLH--PNPCP-GGGW---NSG--------NRYPGQPAN--------------PGGWGHPQGGGASWGHPQGGGASWGHPQGGGSNWGHPQGGGASWGHPQGGG--------------------------------------------------- 
ChPrP   ----MARLLTTCCLLALLLAACTDVALSKK---GKGKPSGGGW----GAG-S-----HRQPSY-----------------------PRQPG--Y--PHNPG--Y--PHNPG--Y--PHNPG--Y--PHNPG--Y--PHNPG-Y--PQNPGYPHNPGYPGWGQGY--------NPSSGGS-YH 
TuPrP   ----MGRYRLTCWIVVLLVVMWSDVSFSKK---GKGKGGGGG----NTG--S-----NRNPNY-----------------------PSNPG--Y--PQNPG--Y--PRNP-S-Y--PHNPA--Y--PPNPA--Y--PPNPG-Y--PHNPSYPRNPSYPQN-PGYPGGGGQHYNPAGGGTNFK 
XlPrP1  ----MPQSLWTC-LVLISLI-CTLTVSSKKSGGGKSK-TG-GW---NTG--S-----NRNPNYPGGYPG-NTGG--------SW-----------------------------------------------------------------------------------GQQPYNPSG----Y- 
XtPrP   ----MLRSLWTS-LVLISLV-CALTVSSKKSGSGKSK-TG-GW---NSG--S-----NRNPNYPGGY-GWNTGG---NTGG-SW-----------------------------------------------------------------------------------G-QPYNPSGGN-NF- 
XlPrP2  ----MPRSLWTC-LVLVSLV-CTLTVSSKKSGSGKSK-TG-GWNNGNTGN-TGNTGNNRNPNYPGGY-GWNTG-NTGNTGG-SW-----------------------------------------------------------------------------------GQQPYNPSGG-SNF- 
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HuPrP   THSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYVLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEY--S---NQNNFVHDCVNITIKQHT--VTTTTKG--------EN--FTETDVKMMERVVEQMCITQYERESQAYYQ--RGSS-MVLFSS-PPV-ILLISFLIFLIVG  
MoPrP   THNQWNKPSKPKTNLKHVAGAAAAGAVVGGLGGYMLGSAVSRPMIHFGNDWEDRYYRENMYRYPNQVYYRPVDQY--S---NQNNFVHDCVNITIKQHT--VTTTTKG--------EN--FTETDVKMMERVVEQMCVTQYQKESQAYYDGRRSSS-TVLFSS-PPV-ILLISFLIFLIVG  
DoPrP   SHSQWGKPNKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPEQVYYRPVDQY--S---NQNNFVRDCVNITVKQHT--VTTTTKG--------EN--FTETDMKIMERVVEQMCVTQYQKESEAYYQ--RGAS-AILFSP-PPV-ILLISLLILLIVG  
BoPrP   THGQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGSDYEDRYYRENMHRYPNQVYYRPVDQY--S---NQNNFVHDCVNITVKEHT--VTTTTKG--------EN--FTETDIKMMERVVEQMCITQYQRESQAYYQ--RGAS-VILFSS-PPV-ILLISFLIFLIVG  
ShPrP   SHSQWNKPSKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPLIHFGNDYEDRYYRENMYRYPNQVYYRPVDQY--S---NQNNFVHDCVNITVKQHT--VTTTTKG--------EN--FTETDIKIMERVVEQMCITQYQRESQAYYQ--RGAS-VILFSS-PPV-ILLISFLIFLIVG  
MdPrP   YNQKW-KPDKPKTNMKHVAGAAAAGAVVGGLGGYMLGSAMSRPIMHFGNDYEDRYYRENQYRYPNQVMYRPIDQY-----NNQNNFVHDCVNITVKQHT--TTTTTKG--------EN--FTETDIKIMERVVEQMCITQYQNEYR------SAYS-VAFFSA-PPVTLLLLSFLIFLIVS  
PoPrP   -YNKW-KPDKPKTNLKHVAGAAAAGAVVGGLGGYMLGSAMSRPVIHFGNEYEDRYYRENQYRYPNQVMYRPIDQY-SS----QNNFVHDCVNITVKQHT--TTTTTKG--------EN--FTETDIKIMERVVEQMCITQYQAEYEAAAQ--RAY-NMAFFSA-PPVTLLFLSFLIFLIVS  
TwPrP   SYGKW-KPDKPKTNLKHVAGAAAAGAVVGGLGGYMLGSAMSRPVMHFGNEYEDRYYRENQYRYPNQVMYRPIDQY-GS----QNSFVHDCVNITVKQHT--TTTTTKG--------EN--FTETDIKIMERVVEQMCITQYQNEYQA-AQ--RYY-NMAFFSA-PPVTLLLLSFLIFLIVS  
PlPrP   -YSKY-KPDKPKTGMKHVAGAAAAGAVVGGLGGYMIGSAMSRPPMHFGNEFEDRYYRENQNRYSNQVYYRPVDQY-GS----QDGFVRDCVNITVTQHT--VTTTEGK---------N--LNETDVKIMTRVVEQMCGSTTWN-LQ--------W-----FG---------VSFN-F----  
ChPrP   NQKPW-KP--PKTNFKHVAGAAAAGAVVGGLGGYAMGRVMSGMNYHFDSPDEYRWWSENSARYPNRVYYR--D-Y-SS-PVPQDVFVADCFNITVTEYSIGPAAKKNTSEAVAAANQT--EVEMENKVVTKVIREMCVQQY-REYRLA-------SGIQLHPADTWLAVLLLLLTTLFAMH  
TuPrP   NQKPW-KPDKPKTNMKAMAGAAAAGAVVGGLGGYALGSAMSGMRMNFDRPEERQWWNENSNRYPNQVYYK--E-Y-NDRSVPEGRFVRDCLNITVTEYKIDP--NEN---------QN--VTQVEVRVMKQVIQEMCMQQYQQ-YQLA-------SGVKLLSD-PSL-MLIIMLVIFFVMH  
XlPrP1  N-KQW-KPPKSKTNMKSVAIGAAAGA----IGGYMLGNAVGRMSYQFNNPMESRYYNDYYNQMPNRV-YRPM--YRGEEYVSEDRFVRDCYNMSVTEYIIKP--TEGK--------NNSELNQLDTTVKSQIIREMCITEYRR-----------GSGFKVLSN-PWL-ILTITLFVYFVIE  
XtPrP   NNKQW-KPPKSKTNMKAVAVGAAAGA----IGGYMLGNAMGRMSYHFSNPMEARYYNDYYNQMPERV-YRPM--YRGEEHVSEDRFVTDCYNMSVTEYIIKP--AEGK--------NTSEVNQLETRVKSQIIREMCITEYRR-----------GSGFKVLSN-PWL-ILTITLFVYFVIE  
XlPrP2  NNKQW-KPPKSKTNMKAVAVGAAAGA----IGGYMLGNAVGRMNHHFDNPMESRYYNDYYNQMPDRV-YRPM--YRSEEYVSEDRFVTDCYNMSVTEYIIKP--SEGK--------NGSDVNQLDTVVKSKIIREMCITEYRR-----------GSGFKVLSN-PWL-ILTITLFVYFVIE   
Figure 6-5 Multiple sequence alignment of PrP sequences. The secondary structural units are shown above the sequence (L- loop, E- sheet, H- 
helix). Cleavage sites are represented by    . The C-terminal domain region shows a number of conserved residues among all the species compared. The 
most highly conserved region corresponds to the hydrophobic region numbered between 200 and 220. The N-terminal repeats show the maximum 
number of variations. The Cys involved in disulphide bridge formation are indicated (*). 
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                            10        20        30        40        50       60        70        80        90       100       110       120      
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....|....| 
                                                                            llLLLLLLEEELLLLLLLLLLLH.HHHHHHHHHHHHLLLEEELLLLLLLL..LLHHHHHHHHH  
                                                                                                                         *               # 
HumDpl         1   ------MRKHLSWWWLATVCMLLFSHLSAVQTRGIKHRIKWNRKALPSTA--QITEAQVAENRPGAFIKQGRKLDIDFGA-EGNRYYEANYWQFPDGIHYNGCSEAN--VTKEAFVTGCI 109  
MusDpl         1   ------MKNRLGTWWVAILCMLLASHLSTVKARGIKHRFKWNRKVLPSSGG-QITEARVAENRPGAFIKQGRKLDIDFGA-EGNRYYAANYWQFPDGIYYEGCSEAN--VTKEMLVTSCV 110  
RatDpl         1   ------MKNRLGTWGLAILCLLLASHLSTVKARGIKHRFKWNRKVLPSSG--QITEAQVAENRPGAFIKQGRKLDIDFGA-EGNKYYAANYWQFPDGIYYEGCSEAN--VTKEVLVTRCV 109  
DogDpl         1   ------MRKHLGGCWLAIVCVLLLSQLSAVEARGIKHRIKWNRKALPGTS--QVTEARSAEIRPGAFIRQGRKLDIDLGP-EGNRYYEANYWQFPDGIHYNGCSEAN--VTKEKFVTGCI 109  
BosDpl         1   ------MRKHLGGCWLAIVCILLFSQLCSVKARGIKHRIKWNRKVLPSTS--QVTEARTAEIRPGAFIKQGRKLDIDFGV-EGNRYYEANYWQFPDGIHYNGCSKAN--VTKEKFITSCI 109  
OviDpl         1   ------MRKHLGGCWLAIVCVLLFSQLSSVKARGIKHRIKWNRKVLPSTS--QVTEAHTAEIRPGAFIKQGRKLDINFGV-EGNRYYEANYWQFPDGIHYNGCSEAN--VTKEKFVTSCI 109  
MdpDpl         1   ------MRRHLGICWIAIFFALLFSDLSLVKAKTTRQRNKSNRKGLQTNRT-NPTTVQPSEKLQGTFIRNGRKLVIDFGE-EGNSYYATHYSLFPDEIHYAGCAESN--VTKEVFISNCV 110  
TwaDpl         1   --------------------------------------------------------------LQGTFIRQGRELSIDFGE-EGNSYYETHYQLFPDEIHYVGCTESN--VTKDIFISNCM 55   
PlaDpl         1   MMTVRRRRRSGGARWLLVFLVLLSGDLSSLQARGPRPRNKAGRKPPPSNAGPDSPAPRPPAGARGTFIRRGGRLSVDFGP-EGNGYYQANYPLLPDAIVYPDCPTAN--GTREAFFG--- 114  
XtDpl          1   ------MGRQNLFSCLILLLLILYCSLSSPRRAAS-SKKISKTTDLSRGAKRRPKVTNSP--ALGDLSFRGRALNVNFNLTEESELYTANLYSFPDGLYYPRPAHLSGAGGTDEFISGCL 111  
XlDpl          1   ------MERQNVFSCLILLVLILYCGLSCPRRSGSGIKKYFKISDLSRGAKKRSKVAHSP--VLGHLFFRSKELDVNLNFTEEYELYTENLYRFPDGLYYPWRSQLNDAAGTEEFMNGCL 112  
 
                           130       140       150       160       170       180       190       
                   ....|....|....|....|....|....|....|....|....|....|....|....|....|....|... 
                   HHHHHHLHHHHHhhHLLL..HHHHHHHHHHHHHHHHHLLLLLLLll                           
                                                     #    *       
HumDpl         110 NATQAANQGEFQ--KPDN--KLHQQVLWRLVQELCSLKHCEFWLER-GAGLRVTMHQPVLLCLLALIWLTVK- 176  
MusDpl         111 NATQAANQAEFSREKQDS--KLHQRVLWRLIKEICSAKHCDFWLER-GAALRVAVDQPAMVCLLGFVWFIVK- 179  
RatDpl         110 NATQAANQAEFSREKQDS--KLHQRVLWRLIKEICSTKHCDFWLER-GAALRITVDQQAMVCLLGFIWFIVK- 178  
DogDpl         110 NATQVANQEELSREKQDN--KLHQRVLWRLIRELCSVKRCDFWLER-GAGPRVAGAQPVLLCLLAFIWFIVK- 178  
BosDpl         110 NATQAANQEELSREKQDN--KLYQRVLWQLIRELCSTKHCDFWLER-GAGLRVTLDQPMMLCLLVFIWFIVK- 178  
OviDpl         110 NATQVANQEELSREKQDN--KLYQRVLWQLIRELCSIKHCDFWLER-GAGLQVTLDQPMMLCLLVFIWFIVK- 178  
MdpDpl         111 NATRVINKLEPLEEQNIS--DIYSRILEQLIKELCALNYCEFRTGK-GTGLRLSLDQYVMVYLVILTCLIVK- 179  
TwaDpl         56  NATHAANNLETLEEKNAS--DIHSRVLEQLIKELCALKYCELETET-GAGLKLSLDQSVMVYLLIL------- 118  
PlaDpl         114 ------------------------------------------------------------------------- 114  
XtDpl          112 NTTIERNKVWISQLEDDEEGDIYMSVATQVLQFLCMEN---YVKPTNGAVTCTGGLWVFIGVMHFFFLFRKGD 181  
XlDpl          113 NTTVERNKVWISGLEEEDEGETYMSVGMQVLQFLCYEN---YVKPTNGAVTCTGGLWVFIGVIHLLFFTQKGS 182  
 
  
Figure 6-6 Multiple sequence alignment of Dpl sequences. The secondary structural units are shown above the sequence (L- loop, E- sheet, H- 
helix). Cleavage sites are represented by    . The C-terminal domain region shows fewer conserved residues compared with PrP. The highly conserved 
region corresponds to the Cysteines involved in disulphide bridge formation and the N-glycosylation sites. The Cys involved in disulphide bridge 
formation are indicated (*, #). Note the absence of the second disulphide bridge in Xenopus species. The Asn involved in Kink formation is indicated by   . 
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PrP     ...LLLL.EELLLLLLLLLLLLLH.HHHHHHHHHLLLLLLLLEEL.LLLLL..L...LLHHHHHHHHHHHHHHHH..HHLHH..HL......LL..LL..HHHHHHHHHHHHHHHHHHHHHHHHHHHH. 103  
HuPrP   VGGLGGY-VLGSAMSRPIIHFGSD-YEDRYYRENMHRYPNQVYYR-PMDEY--S---NQNNFVHDCVNITIKQRT--VTTTT--KG------EN--FT--ETDVKMMERVVEQMCITQYERESQAYYQ- 106  
MoPrP   VGGLGGY-MLGSAVSRPMIHFGND-WEDRYYRENMYRYPNQVYYR-PVDQY--S---NQNNFVHDCVNITIKQHT--VTTTT--KG------EN--FT--ETDVKMMERVVEQMCVTQYQKESQAYYDG 107  
DoPrP   VGGLGGY-MLGSAMSRPLIHFGND-YEDRYYRENMYRYPEQVYYR-PVDQY--S---NQNNFVRDCVNITVKQHT--VTTTT--KG------EN--FT--ETDMKIMERVVEQMCVTQYQKESEAYYQ- 106  
BoPrP   VGGLGGY-MLGSAMSRPLIHFGSD-YEDRYYRENMHRYPNQVYYR-PVDQY--S---NQNNFVHDCVNITVKEHT--VTTTT--KG------EN--FT--ETDIKMMERVVEQMCITQYQRESQAYYQ- 106  
ShPrP   VGGLGGY-MLGSAMSRPLIHFGND-YEDRYYRENMYRYPNQVYYR-PVDQY--S---NQNNFVHDCVNITVKQHT--VTTTT--KG------EN--FT--ETDIKIMERVVEQMCITQYQRESQAYYQ- 106  
MdPrP   VGGLGGY-MLGSAMSRPIMHFGND-YEDRYYRENQYRYPNQVMYR-PIDQY-----NNQNNFVHDCVNITVKQHT--TTTTT--KG------EN--FT--ETDIKIMERVVEQMCITQYQNEYR---   102  
PlPrP   VGGLGGY-MIGSAMSRPPMHFGNE-FEDRYYRENQNRYSNQVYYR-PVDQY-GS----QDGFVRDCVNITVTQHT--VTTTEG-K--------N--LN--ETDVKIMTRVVEQMCGSTTWN-LQ----- 100  
PoPrP   VGGLGGY-MLGSAMSRPVIHFGNE-YEDRYYRENQYRYPNQVMYR-PIDQY-SS----QNNFVHDCVNITVKQHT--TTTTT--KG------EN--FT--ETDIKIMERVVEQMCITQYQAEYEAAAQ- 106  
TwPrP   VGGLGGY-MLGSAMSRPVMHFGNE-YEDRYYRENQYRYPNQVMYR-PIDQY-GS----QNSFVHDCVNITVKQHT--TTTTT--KG------EN--FT--ETDIKIMERVVEQMCITQYQNEYQA-AQ- 105  
ChPrP   VGGLGGY-AMGRVMSGMNYHFDSP-DEYRWWSENSARYPNRVYYR---D-Y-SS-PVPQDVFVADCFNITVTEYSIGPAAKKNTSEAVAAANQT--EV--EMENKVVTKVIREMCVQQY-REYRLA--- 113  
TuPrP   VGGLGGY-ALGSAMSGMRMNFDRP-EERQWWNENSNRYPNQVYYK---E-Y-NDRSVPEGRFVRDCLNITVTEYKIDP--NEN---------QN--VT--QVEVRVMKQVIQEMCMQQYQQ-YQLA--- 103  
XtPrP1  ---IGGY-MLGNAVGRMSYQFNNP-MESRYYNDYYNQMPNRV-YR-PM--YRGEEYVSEDRFVRDCYNMSVTEYIIKP--TEG-K-------NNSELN--QLDTTVKSQIIREMCITEYRR-------- 100  
XtPrP   ---IGGY-MLGNAMGRMSYHFSNP-MEARYYNDYYNQMPERV-YR-PM--YRGEEHVSEDRFVTDCYNMSVTEYIIKP--AEG-K-------NTSEVN--QLETRVKSQIIREMCITEYRR-------- 100  
XlPrP2  ---IGGY-MLGNAVGRMNHHFDNP-MESRYYNDYYNQMPDRV-YR-PM--YRSEEYVSEDRFVTDCYNMSVTEYIIKP--SEG-K-------NGSDVN--QLDTVVKSKIIREMCITEYRR-------- 100 
 
Dpl     LLLLLLLLEEELLLLLLLLLL.LH.HHHHHHHHHHHHLLLEEELLLLLLLL..L...LHHHHHHHHHHHHHHHL...HHHHHHHH..........LLL..HHHHHHHHHHHHHHHHHLL...LLLLLLL 104  
MoDpl   RVAENRPGAFIKQGRKLDIDF-GA-EGNRYYAANYWQFPDGIYYEGCSEAN--V---TKEMLVTSCVNATQAAN---QAEFSREK----------QDS--KLHQRVLWRLIKEICSAKH---CDFWLER 104  
HuDpl   QVAENRPGAFIKQGRKLDIDF-GA-EGNRYYEANYWQFPDGIHYNGCSEAN--V---TKEAFVTGCINATQAAN---QGEF-Q-K----------PDN--KLHQQVLWRLVQELCSLKH---CEFWLER 102  
RaDpl   QVAENRPGAFIKQGRKLDIDF-GA-EGNKYYAANYWQFPDGIYYEGCSEAN--V---TKEVLVTRCVNATQAAN---QAEFSREK----------QDS--KLHQRVLWRLIKEICSTKH---CDFWLER 104  
DoDpl   RSAEIRPGAFIRQGRKLDIDL-GP-EGNRYYEANYWQFPDGIHYNGCSEAN--V---TKEKFVTGCINATQVAN---QEELSREK----------QDN--KLHQRVLWRLIRELCSVKR---CDFWLER 104  
BoDpl   RTAEIRPGAFIKQGRKLDIDF-GV-EGNRYYEANYWQFPDGIHYNGCSKAN--V---TKEKFITSCINATQAAN---QEELSREK----------QDN--KLYQRVLWQLIRELCSTKH---CDFWLER 104  
OvDpl   HTAEIRPGAFIKQGRKLDINF-GV-EGNRYYEANYWQFPDGIHYNGCSEAN--V---TKEKFVTSCINATQVAN---QEELSREK----------QDN--KLYQRVLWQLIRELCSIKH---CDFWLER 104  
MdDpl   QPSEKLQGTFIRNGRKLVIDF-GE-EGNSYYATHYSLFPDEIHYAGCAESN--V---TKEVFISNCVNATRVIN---KLEPLEEQ----------NIS--DIYSRILEQLIKELCALNY---CEFRTGK 104  
TwDpl   -----LQGTFIRQGRELSIDF-GE-EGNSYYETHYQLFPDEIHYVGCTESN--V---TKDIFISNCMNATHAAN---NLETLEEK----------NAS--DIHSRVLEQLIKELCALKY---CELETET 99   
PlDpl   RPPAGARGTFIRRGGRLSVDF-GP-EGNGYYQANYPLLPDAIVYPDCPTAN--G---TREAFFG----------------------------------------------------------------- 57   
XtDpl   NSP--ALGDLSFRGRALNVNF-NLTEESELYTANLYSFPDGLYYPRPAHLSGAG---GTDEFISGCLNTTIERN---KVWISQLE----------DDEEGDIYMSVATQVLQFLCMEN------YVKPT 104  
XlDPl   HSP--VLGHLFFRSKELDVNL-NFTEEYELYTENLYRFPDGLYYPWRSQLNDAA---GTEEFMNGCLNTTVERN---KVWISGLE----------EEDEGETYMSVGMQVLQFLCYEN------YVKPT 104  
 
Figure 6-7 Comparison of C-terminal domain of PrP and Dpl among different lineages. The conserved residues among the two proteins may 
indicate critical residues in the fold for structural stability.  
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6.2.3 Dotplot analysis 
The amino acid sequences from various species were analysed using dotplots. 
The N-terminal repeat region in PrP appears to be evolving gradually from 
amphibian to eutherian mammals (Figure 6-8). This region is very distinct among 
the mammalian species and chicken, whereas it is less pronounced in turtle and 
absent in amphibian. The other feature is that the repeat region is clustered among 
the eutherian mammals, and marsupial species indicating that the composition of 
the repeats is lineage specific. The middle stretch of hydrophobic region is very 
well conserved among the species compared.  
Dpl showed lesser sequence similarity compared to PrP between eutherian 
mammals and marsupial species. Xenopus sequence in both PrP and Dpl showed 
little similarity compared to rest of the sequences.  
  
 
Figure 6-8 Pairwise sequence comparison for PrP and Dpl using Dotplot. PrP: Evolution of the 
N-terminal repeats can be seen from Xenopus to human. The repeat region (circled in green) is 
lineage specific. Note the conserved hydrophobic region (circled in red) in most of species 
compared. Dpl: Note the conservation of sequence among mammals and the minimal sequence 
match between Xenopus and other species. [Md=M. domestica; Xen =Xenopus] 
 
PrP  
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6.2.4 Evolution of functional elements in 3’UTR 
The 3’UTR in mammalian PRNP sequences was reported to have a number of 
conserved sequence motifs (Cytoplasmic polyadenylation element (CPE), nuclear-
specific polyadenylation signal site) (Premzl et al. 2005). These sequence 
elements are also found to be conserved in the platypus sequence (Figure 6-9A). 
However, these motifs elements are not seen in other lower vertebrate (chicken 
and amphibian) indicating that they evolved in higher vertebrates. The 3’UTR 
regions in Xenopus, chicken and turtle were also compared. There were no 
common conserved elements in these sequences but, interestingly, separate 
conserved elements were detected between turtle and chicken (Figure 6-9B), and 
between Xenopus and turtle 3’UTRs (Figure 6-9C). Whether these conserved 
elements are just a random match or due to evolutionary selective pressure is not 
known. 
6.3 Conclusion 
Comparative sequence analysis of PrP and Dpl among different lineages indicates 
Dpl is evolving at a faster rate than PrP. This may be due to Dpl, a recently 
duplicated gene, trying to acquire a specialized function in higher vertebrates. 
Analysis of the rate of evolution within PRNP and PRND showed apparently 
different evolutionary constraints acting on different regions of the protein 
sequences. The signal sequences which are cleaved to form the mature protein 
are evolving at a higher rate compared with other regions of the mature protein. 
Through comparative sequence analysis, I could identify the critical residues 
involved in the structural stability of the C-terminal domain fold of PrP and Dpl. 
Comparisons made within PrP and Dpl among different species indicated a 
number of conserved residues. These residues may be critical for function and 
protein-protein interactions as most of the residues are on the surface of the 
protein. The unique N-terminal repeats in PrP gradually evolved, from Xenopus 
where they are almost absent to mammals, and show lineage specificity. The 
conserved 3’UTR elements in PRNP, known to play a role in the post-
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transcriptional regulation, appear to be a modern feature which are present in 
monotremes but absent in the other lower vertebrates.  
a                          10        20        30        40        50        60            
             ....|....|....|....|....|....|....|....|....|....|....|....|....| 
                                                     CPE 
Human        GGTCTTTGAAATATGCATGTACTTT-----------ATATTTTCTATATTTGTAACTTTGCATGT  
Mouse        GGTCTTTG-AATCTGCATGTACTTC-----------ACGTTTTCTATATTTGTAACTTTGCATGT  
Cow          GATATTTGAAATACGCATGTGCTTA------------TATTTTCTATATTTGTAACTTTGCATGT  
Sheep        GATATTTGAAATACGCATGTGCTTA------------TATTTTTTATATTTGTAACTTTGCATGT  
Tammar       -GTCTTTGAAATTTGCATGCACTTAGTAATGTAAGGACATTTTATAGATTTGTAACTTCGCACGT  
Monodelphis  AGTCTTTGAAATTTGCATGCACTTAGTAATATAAAGATGTTTTATAGATTTGTAACTTTGCACGT  
Platypus     GGTCGTCGGAA-GTGCATGAACTTTGTGCTGTAAGAACATTTTCTATATTTGTAACTTTGCATGT  
               *  * * **   *****  ***               **** ** *********** *** ** 
                      70        80        90       100       110       120         
             ....|....|....|....|....|....|....|....|....|....|....|....|.. 
                                                             Polyadenylation 
Human        TCTT-GTTTTGTTATATAAAAAAATT-GTAAATGTTTAATATCTGACTGAA-ATTAAACGAG   
Mouse        ATTTTGTTTTGTCATATAAAAAGTTT-ATAAATGTTTGCTATCAGACTGAC-ATTAAATAGA   
Cow          ACTT-GTTTT---GTGTTAAAAGTTT-ATAAATATTTAATATCTGACTAAA-ATTAAACAGG   
Sheep        ACTT-GTTTT---GTGTTAAAAGTTT-ATAAATATTTAATATCTGACTAAA-ATTAAACAGG   
Tammar       ACTT-GTTTTGATGTATTAAAAATTT-ATAAATGTTTAATATCTGACTAAAAATTAAACAGG   
Monodelphis  ATTT-GTTTTGATGTATTAAAAATTT-ATAAATGTTTAATATCTGACTAAAAATTAAACAAA   
Platypus     ATAT-GTTTTGAGGTGCAGAAAGTTTTATAAATGTTCACTATCTAACTAAA-ATTAAAGAGA   
                * *****    *    ***  **  ***** **   ****  *** * * *****        
 
                    
b                          10        20        30        40        50        60            
             ....|....|....|....|....|....|....|....|....|....|....|....| 
Turtle   1   GAAAGCAGTCTCAGCCTGAACTG----TGCTGCTGATCTGTGCAAACGTT-CAGAGGGAA 55   
Chicken  1   TGGAACTATTGCTTCTTGTGCTTCAGTTGCTGCTGATGTGTACATAGGCTGTAGCATATG 60   
                * *  *  *  * **  **     ********** *** ** * * *  **        
 
                      70        80        90       100       
             ....|....|....|....|....|....|....|....|.... 
Turtle   56  TAATCT-ATATAAAACAGCCTCTCTGT----TGGAGGTCTCTCA 94   
Chicken  61  TAAAGTTACACGTGTCAAGCTGCTCGCACCGCGTAGAGCTAATA 104  
             ***  * * *     **  **    *      * **  **   *  
 
 
c                          10        20        30        40        50        60            
             ....|....|....|....|....|....|....|....|....|....|....|....| 
Xenopus  1   TCACCGAGTACAGGAGAGGATCGGGATTCAAAGTGCTCTCTAACCCTTGGCTGATCCTTA 60   
Turtle   1   TCAGCAA-TACCAGCTGGCCTCTGGTGTCAAACTACTCTCTGACCCCTCGCTCATGCTGA 59   
             *** * * ***  *   *  ** **  ***** * ****** **** * *** ** ** *  
 
                      70        80        90       100       110       120         
             ....|....|....|....|....|....|....|....|....|....|....|....| 
Xenopus  61  CTATCACTCTCTTTGTTTACTTTGTGATAGAGTGATCAAAGGAAATATTAATAAAAAG-- 118  
Turtle   60  TTATCATGCTTGTCATTTTTTTTGTAATGCATTAA--GAAAGCAGTCTCAGCCTGAACTG 117  
              *****  **  *  ***  ***** **  * * *   ** * * * * *     **       
 
                     130       140       150       160       170           
             ....|....|....|....|....|....|....|....|....|....|....|.... 
Xenopus  118 -GCCA--AATGTATGTATATATAGAGAGAGTATAAACCGATTCTGAACTGTTCCGTCTC 174  
Turtle   118 TGCTGCTGATCTGTGCAAACGTTCAGAGGGAATAATCT-ATATAAAACAGCCTCTCTGT 175  
              **     ** * ** * *  *  **** * **** *  **    **      *       
Figure 6-9 Conserved sequence elements in PRNP 3’UTR. (a) Demonstration of the presence of 
the PRNP 3’UTR sequence elements in platypus as reported in Premzl et al. (2005). Conserved 
sequence elements in the 3’ UTR between (b) turtle and chicken and (c) Xenopus and turtle.  
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7 Phylogenetic footprinting and transcription factor 
binding analysis of prion-protein family genes 
 
7.1 Background 
The publication of draft sequence of newly sequenced genomes gives enormous 
potential for characterizing functional elements by using comparative genomic 
approaches. One of the key functional elements are proteins termed transcription 
factors (TFs) which play a central role in RNA-polymerase II- mediated 
transcriptional regulation of gene expression by binding to specific short DNA 
sequence motifs known as transcription factor-binding sites (TFBSs) or cis-
regulatory elements. These regulatory sequence elements at the DNA level 
include: promoters; enhancers; silencers; locus control regions; and matrix 
attachment regions/scaffold attached regions (Figure 7-1). Predicting the binding of 
TFs to a particular gene gives an opportunity for deeper understanding of the 
potential functions of the genes regulated.  
Identifying regulatory modules: When a gene is to be expressed in a number of 
different circumstances in a developing organism, it is usually found that separate 
cis-regulatory sub-elements carry out different parts of the overall regulatory job. 
These sub-elements are referred to as regulatory modules. Individual modules are 
always found to contain multiple TF target sites, and these contribute in various 
ways to overall regulatory output. The most remarkable cases are found among 
genes encoding TFs that are expressed in complex spatial patterns and at different 
times. Target sites for the set of TFs required to generate a given spatial regulatory 
output are often found clustered together more or less contiguously, within a given 
sequence region of the cis-regulatory DNA. 
Experimental detection of TFBSs is widely done but is time consuming and 
expensive if prior binding information is not available. A number of reliable 
computational methods have been developed to predict TFBSs, which are 
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economical both in terms of time and resources and can produce useful predictions 
for experimental validation. As TFBSs are under greater selective pressure than 
other non-protein-coding DNA, the reliability of predicting them is greatly improved 
by use of comparative genomics to filter out sequence noise. Identifying such 
conserved sequence elements in non-coding regions of homologous genes from 
phylogenetic comparison is called ‘phylogenetic footprinting’ (PF) (Tagle et al. 
1988). 
The aim of this study was to develop a systematic high throughput screening 
pipeline to first search for conserved motifs using two different PF methods (motif-
discovery and alignment-based) , and then to rapidly evaluate the motifs as 
potential TFBSs for members of the PrP family. The results are displayed in an 
interactive graphical user interface, FactorScan, which integrates three separate 
complementary databases (conserved sequence motifs, TFBS motifs, 
TRANSFAC). This pipeline was applied to TFBS analysis of the orthologous gene 
regions of PrP family genes from vertebrate lineages, taking account of the gene 
annotations. Some initial insights into the functions of these genes, which are not 
well understood, were gleaned from the TFs predicted to be involved in regulating 
their tissue expression. (Please note that in the following sections, the term 
mammal refers to eutherian-mammal). 
                               
Figure 7-1 Schematic representation of (a) promoter, (b) enhancer, (c) silencer and (d) locus 
control region (LCR); [TSS= transcription start site] 
  
+
-
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7.2 Motivation for developing the pipeline 
 
Several programs implement PF but only a few combine it with TFBS analysis, for 
example, ConSite (Sandelin et al. 2004) and rVISTA (Loots et al. 2002) that allow 
only pairwise comparison; there are currently no programs which perform this 
analysis on multiple sequences. Another restriction is that they use databases of 
position weight matrices (PWM), TRANSFAC public and JASPAR respectively, 
neither of which is as comprehensive as TRANSFAC professional. Finally, rVISTA 
and ConSite do not provide a facility to customize display of the results to make the 
maximum use of the output, for example, display of clusters of TFs.  
While there are several online resources which can perform PF, none provides the 
flexibility for combining the conserved sequence-motif data with TFBS analysis 
and, at the same time, allowing the flexibility to customize the searches based on 
gene annotation information. To address this deficiency, I developed a two-step 
procedure which combines PF with TFBS analysis. This automated pipeline 
enables us to carry out rapid screening and evaluation of the phylogenetically 
conserved motifs for potential TF binding affinity. To perform the most 
comprehensive searches, TRANSFAC professional database was included in the 
pipeline.  
The current approach overcomes the restrictions listed above, by providing various 
options for customizing searches for both pairwise and multiple sequences, for 
incorporating flexibility in visualizing the output, and for using databases of PWMs 
of choice. 
7.3 Software and Hardware  
Standalone versions of AVID (version 2.1), LAGAN (version 1.21) and FootPrinter 
(version 2.1) were used for the PF analysis. The TRANSFAC database version 9.2 
and Match version 6.1 were used for TFBS analysis. The web form was 
implemented using HTML running on an Apache web server on a Linux operating 
system at valera.anu.edu.au that hosts the web page and can be accessed locally 
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with the web address http://valera.anu.edu.au:8080/factorScan.html. The graphical 
package Perl GD and Common Gateway Interface package Perl CGI were used for 
the web interface development. Additional pipelining and analysis modules were 
written in Perl. All analysis was performed on a PC but some of the more memory 
demanding FootPrinter analyses was performed on the Dell Linux cluster at the 
APAC (Australian Partnership for Advanced Computing) National Facility. 
7.4 Development of the pipeline 
 
7.4.1 Criteria for species selection 
An essential first step in PF is to identify orthologous genes in different species. At 
relatively close evolutionary distances (40-80 million years ago), it can be difficult 
to distinguish between functional or non-functional conserved sequences because 
there may not have been enough evolutionary time for accumulation of mutations. 
Hence, comparison with distantly related species can improve the ability to 
distinguish the conserved sequence that is a result of functional constraint from 
that retained due lack of divergence time (Frazer et al. 2003). The comparison of 
orthologous DNA sequences between evolutionarily distant species with greater 
divergence time would enable the prediction of the non-coding sequences with 
greater confidence. However, if the species being compared are too distant, then 
detecting conserved elements will be difficult because they would have diverged 
too much to show any conservation or they may have evolved different regulatory 
processes.  
Duret and Bucher (1997) suggested that any sequence conservation between 
species that diverged 300 Myr (million years) ago indicates a strong selective 
pressure based on the rate of substitution of neutral bases, estimated to be around 
0.5% every Myr (Li et al 1985). They also suggested that the species should be 
selected so that the cumulative length of branches of the phylogenetic tree uniting 
them to their last common ancestor represents >200 Myr. Stojanovic et al (1999) 
suggested that each lineage diverge independently after separation from a 
common ancestor which results in additive effect of their evolutionary distances. 
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Multiple mammalian sequences were selected as this would improve the resolving 
power. The timescale of evolution for these species is shown in Figure 7-2 with fish 
at the bottom of the timescale which is separated from human by 450 million years 
of evolution (Kumar and Hedges 1998).  Alignment of chimp DNA sequence with 
human showed more than 90% sequence similarity; hence, chimp was not 
included for analysis (Figure 7-6). 
To improve the signal-to-noise ratio, representative species for which genomic data 
for PRNP and PRND are available were selected. This comprises several 
mammalian species, and all those available for lower vertebrates; marsupial 
mammals M. domestica (South American opossum) and tammar wallaby, chicken, 
and the frog X. tropicalis. Platypus was not included in the analysis as complete 
genomic sequence information for the PRNP gene locus is not available. There are 
significant differences in the lengths of the intronic and intergenic regions of these 
genes, both among mammals and among the vertebrate lineages due to the high 
frequency of insertion of transposable elements (Premzl et al. 2004). 
 
Figure 7-2 Timescale of evolution of vertebrate species of interest with the time shown on 
the horizontal bar in millions of years (Kumar and Hedges 1998). 
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A database of annotated gene sequences was created by mapping the PRNP and 
PRND cDNA sequence obtained from either experiment or public databases onto 
the genome sequence obtained from various genome sequencing projects. The 
EMBOSS application (Rice, Longden & Bleasby 2000) “est2genome” was used to 
annotate the exon-intron boundaries, and transcription start site (TSS), while 
“getorf” was used for detecting the coding regions which were then masked. 
Enhancers and silencers are reported to act at a distance from the TSS (Donoghue 
et al. 1988; Schachat and Briggs 2002). Hence, genomic sequence covering 2 kb 
upstream of the TSS, the whole of exon-intron region, and 2 kb downstream from 
the transcription stop site was included in the PF analysis. The sequences (other 
than ORF) were not masked as the aim was to look for conserved motifs by 
sequence comparison. The sequence dataset was divided into independent gene 
regions (PRNP and PRND) and one region containing PRNP, PRND together with 
its intergenic sequence (Figure 7-3). 
 
 
Figure 7-3 Annotated gene sequence information for (a) PRNP, (b) PRND and (c) PRNP plus 
PRND including intergenic region. 2kb upstream to the TSS, 2 kb downstream to the 3’ UTR and 
all sequence between TSS and transcription stop site except ORF was included for analysis.  
 
 
 
 
 
 
 
 
PRNP PRND 
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7.4.2 Conserved-sequence motif detection 
Conserved sequence motifs were identified by several PF methods which are 
categorized into two groups, alignment-based and motif-discovery-based. Separate 
pipelines for each, were developed. 
7.4.2.1.1 Global alignment with AVID/LAGAN 
To perform end-to-end comparisons, the global pairwise-alignment methods AVID 
(Bray et al. 2003) and LAGAN (Brudno et al. 2003) were used independently to 
generate pairwise alignments.  
7.4.2.2 Search strategy for alignment-based methods 
The input sequences are in FASTA format with the sequence identifier format as 
specieGene (example humDpl). Each sequence is in a separate file and the 
sequence identifier must match with the filename to enable processing of the 
sequence using the filename programmatically.  
AVID performs the pairwise alignments of two input sequence files (example: file1 
and file2) and generates three different outputs with filenames file1_file2.info, 
file1_file2.minfo, file1_file2.out. The pairwise alignment is written to the .out file 
which is needed for downstream processing.  
LAGAN also generates pairwise alignments by taking two input sequence files. It 
performs local alignment first and then joins the aligned regions with gaps. The 
option for translate anchor was used enabling the protein coding regions to be 
anchored for a better alignment. Binary output format was selected which would 
allow downstream processing. Unlike AVID, LAGAN does not generate the output 
file name automatically and it needs to be specified. To maintain consistency and 
to make the programming step simpler, the same filename format as in AVID was 
specified.  
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Both the AVID and LAGAN alignments for all possible pairwise combinations 
(Figure 7-4) of sequences in the annotated gene sequence database were 
performed using the Perl script “doAlign.pl”. 
 
 
Figure 7-4 Summary of pairwise sequence comparisons (all grey cells) performed with AVID 
and LAGAN between the species on the X and Y axes. H, human; M, mouse; R, rat; D, dog; C, 
cow; S, sheep; Md, M. domestica; Tw, tammar wallaby; Ch, chicken; X, Xenopus. 
 
 
7.4.2.3 Annotation with VISTA 
 
VISTA is a program for visualization and annotation of global alignments of 
arbitrary length (Frazer et al. 2004). It is efficient in annotating the alignments 
based on user-defined parameters. VISTA plots are based on sliding a user-
defined window over the entire alignment and calculating the percent identity at 
each base pair in the window. Conserved regions are reported based on the user 
defined percentage and length cutoffs. VISTA can be configured by changing 
several parameters (e.g. percentage identity and length), which can be defined in 
the input Plotfile. 
Global pairwise alignments generated by AVID and LAGAN were annotated using 
VISTA.  
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7.4.2.3.1 Plotfile 
 
VISTA executes the information specified in the Plotfile. The file path of the input 
alignments, percent and length cutoffs for plotting are specified in the Plotfile. To 
facilitate trialing of several combinations of percent identity (range: 75% to 100%) 
and length (range: 8 to 15 bp) values, a Perl script “runVista.pl” was developed to 
generate corresponding Plotfiles for percent identity and length values passed as 
command line arguments. In order to annotate the genes, it needs another input 
file containing details of the annotation (Figure 7-5). The annotation file contains 
information about the start and end base numbers for exon, intron, untranslated 
and coding regions. The annotation file for each of the sequences was made in the 
format suitable for VISTA. 
 
 
 122 
7.4.2.3.2 Output files 
 
VISTA generates three different output files: VISTA plot, alignment, and region 
files. VISTA plot contains graphical representation of the conserved regions (Figure 
7-6).  
 
 
Figure 7-5 Flow chart showing the steps involved in PF using AVID/LAGAN pairwise 
alignments and annotation with VISTA. The final result of the analysis is the conserved sequence 
motif database. The background input and output files are shown with dotted arrows. 
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Figure 7-6 VISTA plot of pairwise alignments (AVID) between human and the remainder of the sequences on the X-axis. The alignments 
constituted the PRNP and PRND gene regions and the intergenic region. Tammar wallaby sequence lacked the PRND region.  Some of the intergenic 
sequence information between PRNP and PRND is also missing in cow and sheep. The Y-axis represents the percentage identity using a window size of 
10bp. The gene annotation information corresponds to human sequence as specified in the input annotation file.
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7.4.2.3.3 Region file 
 
This output file contains details of those regions which satisfied the user specified 
length and percentage cutoffs (Figure 7-7).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7-7 VISTA region file. The first line shows the cutoffs used for the analysis. The second line 
contains the details of the sequences in the pairwise alignment. The rest of the report contains the 
annotation information (column numbers labeled in red font). Column 1 shows the start number of 
the region which satisfied the user specified criteria. Column 2 consists of the start number of the 
corresponding match in the second sequence. Column 4 and 5 corresponds to the end number of 
the first and second sequence respectively. Column 7 indicates the size of the matched region with 
the percentage identity in column 9. If the gene annotation file is supplied, it reports the region in 
column 10 to which the match corresponds. Query sequences values are shown within brackets.  
 
This alignment annotation file was processed using a Perl script “extractseq.pl”. 
Based on the start and end numbers, the subsequences were extracted using the 
EMBOSS application “extractseq” integrated in “extractseq.pl”. This process was 
repeated for all the region files obtained for the various combinations of 
alignments. The Perl script finally generates a multiple FASTA file of all the 
conserved subsequences (Figure 7-8) which are stored in a conserved sequence 
database. The identifier of each sequence stored contains the information about 
the pair involved in the alignment, the position of the conserved sequence in both 
  Criteria: 90% identity over 10 bp 
 
  *************** Conserved Regions - cow (mouse) *************** 
 
   35      (62)  to       43      (70)  =        9bp  at 100.0%  noncoding 
   56     (749)  to       66     (759)  =       11bp  at  90.9%  noncoding 
  165     (919)  to      180     (934)  =       16bp  at 100.0%  noncoding 
  249    (1003)  to      262    (1015)  =       14bp  at  85.7%  noncoding 
  290    (1066)  to      307    (1083)  =       18bp  at  88.9%  noncoding 
  332    (1108)  to      340    (1116)  =        9bp  at 100.0%  noncoding 
  470    (1199)  to      488    (1217)  =       19bp  at  89.5%  noncoding 
  501    (1230)  to      510    (1239)  =       10bp  at  90.0%  noncoding 
  514    (1243)  to      525    (1254)  =       12bp  at  91.7%  noncoding 
  636    (1376)  to      645    (1384)  =       10bp  at  90.0%  noncoding 
  734    (1432)  to      745    (1443)  =       12bp  at  91.7%  noncoding 
  802    (1507)  to      811    (1516)  =       10bp  at  90.0%  noncoding 
  822    (1526)  to      832    (1536)  =       11bp  at  90.9%  noncoding 
 1341    (1633)  to     1349    (1641)  =        9bp  at 100.0%  noncoding 
 1487    (1736)  to     1496    (1745)  =       10bp  at  90.0%  noncoding 
 1692    (1852)  to     1701    (1861)  =       10bp  at 100.0%  noncoding 
 1921    (1883)  to     1937    (1899)  =       17bp  at  94.1%  noncoding 
 1954    (1917)  to     1964    (1927)  =       11bp  at  90.9%  noncoding 
 1981    (1953)  to     1999    (1971)  =       19bp  at  94.7%  noncoding 
 2060    (2024)  to     2069    (2033)  =       10bp  at  90.0%  UTR 
1 2 3 4 5 6 7 8 9 10
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the sequence and the region to which it belongs. This enables the exact position of 
the conserved sequence to be tracked for further analysis. For those motifs which 
are shorter than 15 bp, continuous stretches of five “N” were added to both the 5’ 
and  3’ ends of the motif to facilitate the TFBS analysis. 
 
 
 
 
Figure 7-8 Final output of “extractseq.pl” in multiple FASTA format. The identifier contains all 
the details of the sequence motif ; its position in relation to the main sequence, the sequence to 
which it is aligned together with its subsequence position, and the region to which it corresponds to 
such as non-coding, UTR, coding. These sequences occur in pairs corresponding to the region of 
the alignment which satisfies the user cutoffs of percent identity and size. 
 
7.4.2.4 Drawbacks of alignment method 
In a study conducted by Chapman et al (2004) it was shown that although some 
pairwise alignments perform well, success largely depends on species selected for 
pairwise comparison. The other factor is that the rate of sequence divergence 
between two species is not uniform across the genome (Li and Miller 2002). The 
use of multiple sequences was shown to be far superior in predicting functionally 
conserved regions in comparison with pairwise sequence alignment, by increasing 
the signal-to-noise ratio (Chapman et al. 2004). A multiple sequence alignment 
version of LAGAN called Multi-LAGAN (Brudno et al. 2003) which performs a 
progressive multiple alignment is also available and was trialled. However, 
theoretical considerations suggest the alignment approach may not be suited to the 
PRNP and PRND gene problem. 
>cowPrPDpl_align_cowPrPDpl_469_527_vs_humPrPDpl_3_61 region = noncoding 
ACAATTCATGGGCATAATAAAATGGTGGTTTCTTTAAACCATTAAGTTTTGGAGTAGTT 
>humPrPDpl_align_cowPrPDpl_469_527_vs_humPrPDpl_3_61 region = noncoding 
ACAATCCATTGGCATAATAAAATGGTAGTTGTTTTAAACCACCTAAGTTGTGGGGTATT 
>cowPrPDpl_align_cowPrPDpl_541_562_vs_humPrPDpl_76_97 region = noncoding 
AATAGCCAGAATAGGACAAAAG 
>humPrPDpl_align_cowPrPDpl_541_562_vs_humPrPDpl_76_97 region = noncoding 
AATAACCAGAATAGGTCATAAG 
>cowPrPDpl_align_cowPrPDpl_572_582_vs_humPrPDpl_107_117 region = noncoding 
NNNNNTTTCGTTCCCTNNNNN 
>humPrPDpl_align_cowPrPDpl_572_582_vs_humPrPDpl_107_117 region = noncoding 
NNNNNTTTGGTTCCCTNNNNN 
>cowPrPDpl_align_cowPrPDpl_587_596_vs_humPrPDpl_126_136 region = noncoding 
NNNNNCCCTCACGAANNNNN 
>humPrPDpl_align_cowPrPDpl_587_596_vs_humPrPDpl_126_136 region = noncoding 
NNNNNCCCTCCAAGAANNNNN 
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DNA has potential to undergo various rearrangement events, such as 
translocations (a subsegment is removed and inserted in a different location but 
the same orientation), inversions (a subsegment of DNA is removed from the 
sequence and then inserted back in the same location but in opposite orientation), 
duplications (a copy of a subsegment is inserted into the sequence, the original 
subsegment is unchanged), or a combination of the above. Global alignment 
algorithms are suitable with the assumption that the highly similar regions in the 
sequences appear in the same order and orientation. These are useful when the 
comparison is made within related organisms where the order and orientation is 
conserved across sufficient small regions. As the dataset is from different lineages, 
further work with multiple global alignments was not pursued. 
 
7.4.2.5 Phylogenetic footprinting using motif-discovery approach 
FootPrinter (Blanchette and Tompa 2003) uses the motif-discovery approach in 
identifying conserved motifs in a collection of homologous sequences (see section 
2.1.2.2). FootPrinter takes as input a set of orthologous sequences and a 
phylogenetic tree relating the sequences used (Figure 7-9). It then reports the 
motifs based on the user-defined motif size and maximum number of mutations, 
which is represented by parsimony score. The option subregion_size divides the 
input sequence into subregions of defined size. This helps in eliminating those 
motifs whose locations vary too much. The following are some of the other options, 
which were used to refine the search. 
Position change cost: Is the cost for a motif to change its subregion position.  
Maximum number of mutations per branch:  This option allows a fixed number 
of mutations per branch of the tree. 
Triplet filtering and post filtering: This filtering eliminates those motifs that do 
not have a good pair of matching motifs in the other input sequence compared. 
This mainly reduces the memory used by the program. 
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Sequence type: For upstream sequence type, the 3’ ends of the sequence are 
assumed to be aligned and for downstream, the 5’ ends are assumed to be 
aligned. 
Inversion cost: Is the cost for a motif to undergo inversion. 
A locally installed version (FootPrinter version 2.1) was used for the analysis as it 
gives more options compared with the web version and also simplifies the 
processing of output files. FootPrinter generates a number of output files with 
different file formats (Figure 7-9). For programmatic processing, only html output 
format was used; this contains the information about the motifs which satisfied the 
user criteria/cutoffs.  
7.4.2.5.1 Search strategy 
Regulatory elements that have been acquired very recently in evolution may not be 
easily detectable through PF if the comparisons are made across diverse lineages. 
Hence, the analysis was divided into different categories. Importance was given to 
understanding mammalian-specific regulation; this was achieved by comparing 
sequences within the mammalian species and with other lineages. PF using 
multiple mammalian sequences has been shown to have better resolution at 
individual TFBSs compared with pairwise alignments (Cooper et al. 2003). 
• Category 1: Mammal 
• Category 2: Mammal+marsupial 
• Category 3: Mammal+marsupial+amphibian 
• Category 4: Mammal+marsupial+avian 
• Category 5: Mammal+marsupial+avian+amphibian 
Category 4 and 5 are not applicable for phylogenetic footprinting analysis related to 
PRND as chicken lacks PRND. 
The sequences were not divided across the TSS into upstream and downstream 
sequence region, as the idea was to include the sequence as a whole in single 
analysis rather than performing two independent motif searches on upstream and 
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downstream sequence regions. This would enable us to identification of those 
motifs which have undergone rearrangement across the TSS.  
The output motif file (motif.html) contains the information about the motifs and their 
positions. A comprehensive search was performed using different FootPrinter 
options (Table 7-1) (subregion- 1000 to 3000bp; motif size- 6 to 10bp; parsimony 
score- 0 to 2). Using a Perl script “motifextract.pl”, the “motif.html” output file was 
converted to a single multi-FASTA file. Each analysis was performed twice using 
upstream and downstream (FootPrinter: sequence type) option on the same input 
sequence. The multi-FASTA files from both analyses were combined using a Perl 
script, “compileTFBS.pl” to produce a non-redundant single multi-FASTA file 
(similar to Figure 7-8). These multi-FASTA files relating to different subregion sizes 
were stored in a conserved sequence database. Each sequence-motif position was 
registered in the sequence identifier 
Table 7-1 The options used to run FootPrinter and the value range used for the analysis. 
Option Value range 
subregion_size 2000-3000 
position_change_cost 2 
Size 8-10 
max_mutations 0-1 
max_mutations_per_branch 1 
triplet_filtering  N/A 
post_filtering  N/A 
inversion_cost 1 
sequence_type upstream 
and 
downstream 
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Figure 7-9 Flow diagram summarizing the steps in PF using FootPrinter. The end result of the 
analysis is the conserved sequence motif database. 
. 
 
7.4.3 Searching against the TRANSFAC database for TF-binding 
specificity 
The TRANSFAC database of eukaryotic transcriptional regulation comprises data 
on TFs, their target genes and regulatory binding sites (Matys et al. 2003). 
TRANSFAC is available as a commercial version and a public version with the 
commercial version having more data. To enable a comprehensive analysis, the 
commercial version, TRANSFAC professional (version 9.2), was used. Match is a 
tool which uses the weight matrices in the TRANSFAC database for searching for 
putative TFBSs (Kel et al. 2003). The advanced version, Match professional 
(distributed with TRANSFAC professional), was used.  
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7.4.3.1 Search strategy 
 
7.4.3.1.1 Optimization of Match search parameters 
Match provides several pre-defined optimized profiles. A profile is a selected 
subset of matrices including default user-defined cut-off values designed for 
searches. Match takes DNA sequence and profile as input, scores it against the 
PWMs based on the profile information, and outputs a list of potential sites. The 
scores that are calculated are the core similarity score and the matrix similarity 
score. These scores measure the quality of a match between the sequence and 
the matrix with values ranging from 0.0 to 1.0 where 1.0 denotes the exact match. 
The core of each matrix is the first five most conserved consecutive positions of a 
matrix and the matrix similarity score is the score calculated for all the positions of 
the matrix. In order to find putative TFBSs, choosing the appropriate cutoffs for 
core and matrix similarity plays a central role. To address this task, three different 
pre-calculated cutoffs for each matrix is provided with TRANSFAC license 
• Cut-offs minimizing false negative rate (minFN) 
• Cut-offs minimizing false positive rate (minFP) 
• Cut-offs minimizing the sum of both errors (minSum) 
Table 7-2 Details of the test data used to define optimal search parameters for the Match 
tool. 
TF Binding site Literature 
ETS ggtttcctccggggt (Chapman et al. 2003) 
GATA tccttatcaggcgc (Chapman et al. 2003) 
Oct1 tgcatatt (Premzl et al. 2005) 
NFAT attttcca (Premzl et al. 2005) 
 
Published TFBS information was used to optimize the Match search parameters, 
i.e. to predict maximum true positives and minimum false positives against the 
TRANSFAC professional database. From the literature, the binding information for 
ETS, GATA, Oct1, and NFAT (Table 7-2) was used to define the optimal search 
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parameters for the Match tool. The test either showed too few or too many hits for 
most of the profiles but the results obtained for minSUM profile was well balanced 
and predicted the appropriate TF-binding to the test data. Match can report more 
than one TF-binding in a given position but can be made to return unique best hits 
by using the options -b and -u. Match can take a multiple sequence FASTA file as 
input and writes to the user defined output file. For each of the sequences in the 
input file, it gives a search report (Figure 7-11) with the first line showing the 
sequence identifier which corresponds to the sequence identifier in the multiple 
FASTA sequence file. This is followed by a five-column search result if a TFBS is 
found; otherwise, it is left blank. The columns are the TRANSFAC identifier of the 
matching matrix, position and strand where the match was found followed by core 
similarity and matrix similarity score, with the last column indicating the matching 
sequence where the core match is in capital letters. As the input file contains 
multiple sequences, the TF-binding information for all of this is written to a single 
output file. The matrix library from the TRANSFAC database includes matrices from 
vertebrates, plants, insects, fungi, nematodes and bacteria which have identifiers 
which begin with V$, P$, I$, F$, N$, B$, respectively. Using Perl scripts, 
“motifExtract.pl” or “extractSeq.pl”, all sequences which did not show any binding 
affinity were eliminated and only those sequences which showed binding to the 
vertebrate TFs were retained.  
A systematic pipeline was developed to assess the specificity of TF binding to the 
conserved-sequence motifs identified by PF (Figure 7-10). The steps of the 
analysis were:  
• Starting inputs were the motifs identified by AVID/LAGAN/FootPrinter 
methods. 
• These motifs were scored against the TRANSFAC database using Match, 
which uses the information defined in the profile. 
• The output file generated by Match was processed to eliminate entries for 
motif sequences which did not correlate with any known binding affinity; only 
sequences showing putative binding to the vertebrate TFs were retained. 
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• The Perl scripts, “motifExtract.pl” and “extractSeq.pl” contain modules that 
process the Match output file. 
• The final output (same format as Match output) generated by these Perl 
scripts was stored in the TFBS database (Figure 7-11). 
• When conserved motifs were obtained by non-stringent criteria, e.g. for 
parsimony score value > 0 for FootPrinter or percent identity value < 100% 
for alignment methods, it is possible that TFs predicted to bind to the same 
set of conserved motifs in different input sequences could differ (Figure 
7-10). Such predicted TFs were eliminated. This criterion was implemented 
by two Perl scripts, “tfbsCons.pl” and “ultraTFBS.pl” which need to be run 
consecutively. 
• Altogether, the resultant predicted motifs were classified as either highly 
conserved or less highly conserved. Both sets were stored in the TFBS 
database. 
                 
Figure 7-10 Flow diagram showing the steps in the TFBS analysis. Dotted arrows indicate 
processes outside the TFBS analysis. Motifs identified by non-stringent criteria (e.g. 2 mismatches 
among 7 bases in the core region) can result in the predicted TF binding only to one of the 
sequences compared and not to the others. Such motifs were not stored in the TFBS database.  
 
OCT 
GATGCAAATATT 
GATCCTAATACT 
OCT 
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Figure 7-11 Final output of the TFBS analysis for conserved sequence motifs obtained from 
AVID/LAGAN (top) and FootPrinter (bottom).  
 
 
7.5 Visual front end for data analysis 
 
TFBSs specific for a particular gene occur in combinations of order, distance and 
strand orientation. Analyzing this organization is essential for understanding 
transcriptional regulation. A visual front end is necessary to make this process of 
viewing TFBSs intuitive and easy enough to facilitate proper judgment of the 
results. To achieve this, an interactive user interface, FactorScan was designed to 
give functional access to the results obtained from the PF and TFBS analysis.  
7.5.1 Interface development  
FactorScan is a web-based application accessible through a web browser. It links 
the TFBS information, conserved-sequence motif information predicted by 
AVID/LAGAN/FootPrinter and the TRANSFAC database (Figure 7-12). All the 
databases are in flat-file format. This interface enables access to the data 
(conserved-sequence motifs and TFBS) generated by the various pipelines (Figure 
AVID/LAGAN 
 
Inspecting sequence ID  
humPrPDpl_align_humPrPDpl_15_40_vs_mouPrPDpl_57_82 
 V$CEBP_Q3              |     14 (-) |  1.000 |  0.998 | gTTGCCaaagtt 
Inspecting sequence ID  
mouPrPDpl_align_humPrPDpl_15_40_vs_mouPrPDpl_57_82 
 V$CEBP_01              |     12 (-) |  1.000 |  0.988 | ttgttaCCAAAgt 
// 
 
FootPrinter 
 
Inspecting sequence ID   HUMDPL2137 
 V$PBX1_01              |        9 (-) |  1.000 |  0.855 | nTGATTtct 
// 
Inspecting sequence ID   DOGDPL2708 
 V$PBX1_01              |        9 (-) |  1.000 |  0.855 | nTGATTtct 
// 
Inspecting sequence ID   RATDPL3220 
 V$PBX1_01              |        9 (-) |  1.000 |  0.855 | nTGATTtct 
// 
i O 3311
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7-7, Figure 7-9, Figure 7-10): it is not dynamically generated during the 
visualization process. The web interface has three main components, the web 
form, the results page and the report page. 
 
 
 
 
Figure 7-12 The main functional flow of information from submitting the web form to the 
display of results. The programs involved with each of the tasks are indicated. 
 
7.5.1.1 Web form 
 
Input: The user input for the web form is categorized into mandatory and optional 
parameters (Figure 7-13). The mandatory parameters include the gene for which 
the results are to be displayed and the various options used for PF to generate the 
data (subregion size, sequence type, sequence dataset). The optional parameters 
are for customizing and controlling the display of the results. Some important 
features are (i) Transcription Factor Search, (ii) Core Similarity Score, (iii) Title, (iv) 
Tissue Source and (v) Line. The Transcription Factor Search is useful to display a 
subset of TFs of particular interest, either individually or in combinations. The latter 
is particularly useful for identifying and comparing TFBS ‘modules’ (clusters of 
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TFBS in a defined order) (Wasserman and Sandelin 2004). The Core Similarity 
Score can be used to visualize TFs which satisfy criteria set by the user. This value 
is in the range of 0-1; by default, this is set to 1 to display the statistically most 
significant hits. The “Title” option can be used to visualize the name of the TF 
matrices for the displayed TFs. Tissue-specific TFs can be searched according to 
tissue, such as brain and testis. The cell-positive and cell-negative information in 
the TRANSFAC database is used for this purpose. The conserved-sequence motif 
distribution can be viewed by selecting the “Line” option. The parameters specific 
for alignment-based and motif-discovery based method are listed below 
7.5.1.1.1 Options specific for alignment method 
 
PF in the genomic region relating to PRNP, PRND and the intergenic region were 
performed only with alignment-based methods and, hence, the parameter 
“PRNP+Intergenic+PRND” is valid only if either AVID/LAGAN algorithm is selected. 
Also, the results obtained from alignment methods are based on pairwise 
sequence comparison. The option “Choose organism” is for selecting the alignment 
pair for viewing. Selection can be made between a pair of species or between one 
species with the rest of its pairwise combinations. 
7.5.1.1.2 Options specific for FootPrinter 
 
FootPrinter analysis was performed using different dataset which includes intra-
mammalian species comparison and that between the mammalian and other 
lineages. The parameter “Select dataset” gives the combinations as analyzed in 
section 7.4.2.5.1 (categories 1-5) for user selection. 
The options used with FootPrinter include subregion and sequence_type. The user 
can view the results obtained using these combinations by selecting from the 
“Subregion” parameter which has values 2000, 2500 and 3000 and the “Sequence 
Type” parameter which has values upstream, downstream and combined (non-
redundant compilation of upstream and downstream results). 
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Figure 7-13 Webform for FactorScan where the user can submit the information for viewing 
the results.  
 
7.5.1.2  Results page 
Output: The submitted web form is processed by a CGI script 
“simpleImageReference.cgi” (Figure 7-12) and the results are displayed in the 
same window. The results page displays a schematic of relative organization of 
gene annotation, TF and conserved sequence motif information. Genomic 
sequence is represented, conventionally, as a horizontal line with exons mapped 
on as rectangular boxes, and with coding and non-coding regions of exons shaded 
in different colors (Figure 7-14 (a)). The TFs predicted to bind are represented as 
triangles, inverted and upright for the forward and reverse strands, respectively 
(Figure 7-14 (a)). Each TF is assigned a unique color; its name is displayed if the 
“Title” option is selected. The conserved-sequence motifs, identified by any of the 
methods, are represented as vertical bars (Figure 7-14 (a)); use of color is 
particularly helpful to discriminate these regions when they are very close to each 
other. Triangles representing TFs and vertical bars representing conserved-
sequence motifs are clickable areas. Clicking on the triangles invokes Perl script 
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“factorInfo.pl” for displaying a summary of TF information, which is obtained from 
the TRANSFAC database. Clicking on the vertical bar invokes the Perl script 
“seqInfo.pl”, which displays information about the conserved sequence motif by 
accessing the information from the conserved sequence motif database. This is 
particularly useful as the conserved-sequence motif can be examined for other 
purposes. For FootPrinter analyses, the schematic are drawn to scale within a 
species, but between species the scale is not normalized (Figure 7-14 (c)). For 
pairwise-alignment analyses, the scale (also shown; see Figure 7-14 (b)) is 
normalized between the pairs, and the results can be displayed either between 
specific pairs or for one against all others. The latter is useful to compare the 
conserved TFBS distribution among various lineages. Information about species, 
abbreviations used and the sequence length in base pairs is provided in table form 
at the bottom of the schematic. The results page also has a link to view the report 
of the TFs and their binding sites. Clicking this link invokes a Perl script 
“generateReport.pl” which pops up a window (enabled by Java Script) displaying 
the summary of the TFs, the strand to which it binds, core match, the conserved-
sequence motif identifier, the position of the TF relative to the TSS and the 
sequence which was used for TFBS analysis. The output is in a tabular format and 
includes the date and time stamp and a link to print the report (Figure 7-14 (c)).  
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Exons 
(+) 
(-) 
 
Figure 7-14 Display of results. (a) Features of the results page. (b) Display of results page for 
alignment-based method and (c) FootPrinter method. Note the differences in the display pattern 
between (b) and (c), the titles of the TFs are seen in (c). 
(a) 
(b) 
(c) 
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7.6 Results from application of the pipeline to the PrP family 
genes 
The TF-binding predictions obtained from the alignment method did not show 
consistent conservation patterns when the second sequence in the pair being 
compared was changed. This made judgment of the significance of the predicted 
TFBSs difficult. FootPrinter, which uses multiple sequences, reports conserved 
regions found in all the input sequences. Hence, efforts were focused on analyzing 
the results obtained from the FootPrinter analysis, this is discussed below. 
7.6.1 Selection criteria 
The FootPrinter results obtained by altering the values for the subregion option 
were manually compiled (for mammal+marsupial and mammal comparisons) by 
elimination based on the following:  
1) Overrepresented TFs for example TBP in “AT” and STAT in “TC” rich/repeat 
region.  
2) Variation in the TF position between 3’ UTR in one species and intron in the 
other. 
3) Variation in the occurrence of several of consecutive copies of the same 
TFBS in different species. In such cases, only the minimum number of 
copies found across all species compared is retained, based on their 
relative position with adjacent TFs. 
4) Neighboring TF positions were used to eliminate TFs which show large 
variation in position. 
The TFBS predictions based on FootPrinter results (FootPrinter search criteria; 
motif size 8 and parsimony score 0) are discussed below for PRNP and PRND.  
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7.6.2 Prion protein gene, PRNP 
Based on the PF and TF-binding predictions, the TFs predicted by intra-
mammalian species comparison and that from comparison between mammalian 
and other vertebrate species (Table 7-3 and Figure 7-15, Figure 7-16) are 
discussed below. 
7.6.2.1 Mammal+Marsupial+Avian+Amphibian 
The comparison made between all the four lineages resulted in very few motifs. 
With subregion value of 3000, only motif “gggagggg” which binds to 
SPZ1/MAZ/MZF (Figure 7-16 (a)) can be considered significant based on the 
selection criteria (section 7.6.1).  
7.6.2.2 Mammal+Marsupial+Amphibian 
Using a subregion value of 2000, sequence motifs binding to MEF2, CDXA/TBP, 
and FAC1 were predicted. Increasing the subregion value to 3000 produced 
another additional motif binding to MYB (Figure 7-16 (b)).  
7.6.2.3  Mammal+Marsupial+Avian 
Using a subregion value of 2000, only one TFBS binding to MAZ/SPZ1/MZF was 
predicted. With a subregion value of 3000, the additional TFBS YY1/STAT4 was 
found (Figure 7-16 (c)). 
7.6.2.4  Mammal+Marsupial 
The predictions made by comparing mammal with marsupial species are more 
reliable because the evolutionary distance separating them is relatively small. With 
a subregion value of 2000, MAF, XVENT1, CIZ, YY1 and STAT1 were predicted 
with good scores. Increasing the subregion value to 3000 added another TFBS 
corresponding to PAX2/MYB (Figure 7-16 (d)).  
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7.6.2.5 Mammal 
A number of TFs were predicted to bind, with most of them predicted in the intron. 
The only TF predicted upstream to the TSS is E4BP4. These predictions were 
made with a subregion option of 2000. Most of the predicted TFs show 
conservation in position and relative order with adjacent predicted TFs (Figure 7-16 
(e)). 
 
7.6.3 Doppel gene, PRND 
7.6.3.1 Mammal+marsupial+amphibian 
The conserved sequence motifs predicted among these lineages did not produce 
any TFBS of statistically significant score. The only TFBS observed was TBP but it 
does not satisfy the selection criteria 2 (section 7.6.1). 
7.6.3.2 Mammal+Marsupial 
Using a subregion value of 2000, three significant conserved sites binding to LEF1, 
PBX1/STAT4/STAT5, and XVENT1 were predicted. XVENT1 in marsupial is 
predicted to be in the first exon in contrast to the upstream region in the mammal 
sequences (Figure 7-17 (a)). 
7.6.3.3  Mammal 
In addition to the above predicted TFs, two additional conserved motifs binding to 
TFs, SPZ1/TFIII and CDXA were predicted in the upstream and intronic region, 
respectively (Figure 7-17 (b)).  
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7.6.4 Applying this pipeline to SPRN 
The pipeline tested on PRNP and PRND was tried on the SPRN gene. This 
analysis was performed by Dr Lorenzo Sangiorgio (Visiting Post Doc Fellow, 
University of Milan, Italy). SPRN is reported in several lineages (mammal, 
marsupial, avian, amphibian and fish). PF was performed in various combinations 
using three different fish species, zebrafish, Fugu, Tetraodon. The PF analysis was 
performed only with FootPrinter. Also, in addition to the combinations used for 
PRNP and PRND (Section 7.4.2.5.1), fish sequences were also used for the 
analysis. A number of TFs were predicted which are conserved in order and 
orientation. The results are not discussed here as this was done as a part of a 
separate project.  
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Table 7-3 Summary of (predicted ) TFs, binding motifs, and position in various species. Bases downstream to the TSS begin with “+” and that 
upstream to the TSS begins with “-” for (a) PRNP and (b) PRND.  Base underlined is either an overlapping motif or motif at a different location. Hum- 
Human, Mou- Mouse, Md- M. domestica, Tw- Tammar wallaby, Chick- Chicken, Xen- Xenopus.* indicates not included in manual curation for mammal 
and marsupial results as these results are from subregion 3000. 
 
TF Motif Hum Dog Rat Mou Cow Sheep Md Tw Chick Xen 
PAX2/MYB TTCAGTTT +3670 +6634 +6593 +6735 +7035 +7083     
TBP/GATA1 TTTATCAA +2680 +7534 +2244 +2200 +2455 +2441     
HOXA4 AAAATTAG +2168 +1773 +1725 +1674 +2071 +2057     
NF1 TAGCCAAG +4673 +5106 +4314 +5429 +9339 +9367     
HMGIY AGAAAATT +2222 +3765 +782 +1723 +1672 +1354 +1350     
STAT1/HMGIY/
NFAT ATTTTCCA +5991 +4486 +4917 +4804 +6701 +6749     
DBP CAGCAACC +1808 +1339 +894 +875 +1669 +1665     
Ap3 TCTAAAAT +2165 +1770 +4498 +2044 +4381 
+2068 
+4378 
+2054 
+4355     
MEF2 TAAAAATA +3051 +3417 +2955 +2555 +2364 +2349     
OCT1 TGCATATT +3247 +4419 +3701 +3503 +1702 +1698     
OCT1 CTTTGCAT +15082 +16835 +15516 +28391 +28606 
+20152 
+20877 
+20569 
+21234     
PAX2/MYB AAACTGAC +2304 +1548 +1779 +1729 +1862 +1859     
PBX1 TGATTTGT +5924 +6460 +8031 +21082 +11849 +11909     
E4BP4 TTATGTAA -311 -396 -260 -266 -1109 -1103     
GEN_INI2 CTTCATTT +12775 +10896 +10392 +24791 +15459 +15921     
ETS/STAT6 TTCTTCCT +6264 +4012 +5540 +7162 +3920 +3898     
STAT1 CTTTCCTT +10155 +9971 +8166 +6312 +7346 
+8262, 
+11835 +11895 
+6737,+11820
+11888 +9648   
MAF TCTGACTC +3986 +10507 +6023 +19279 +10746 +12324 
+10783 
+12759 +6679 +10042   
YY1 TTGCCATT +4075 +6452 +7743 +7761 +4176 +4153 +4550 +6779   
XVENT1 ACAAATAT +1429 +6350 +5191 +12513 +14836 +5656 +5694 
+4338 
+4825 +4509   
CIZ TTTTTTCT +7723 +7601 +8698 +19987 +12657 +11662 +11709 +12048   
*PAX2/MYB TACAGTTT +9953 +7154 +7510 +7522 +1765 +9324 +3517 +2821   
MEF2 TATTTTTA +8044 +10683 +6048 +8586 +21639 
+14029
+14708 
+15864 
+15171 
+16324 +9415 +10453  +4797 
CDXA/TBP ATTTATTT +4250 +6017 +5479 +5538 +8122 + 80 48 +4775 +6986  +3482 
FAC1 TTTGTTGTT +2697 +2295 +4148 +2267 
+2629 
+2224 +3788 
+ 37 66 
+968 
+3655,+6651 
+6654 
+7530,+6697 
+6700  +5692 
*MYB TTACAGTT +9952 +7153 +7509 +7521 +12827 +13262 +12488 +12548  +8256 
*YY1/STAT4 TCCATTTC +7730 +5354 +3542 +5645 +6499 + 54 75 +7474 +9020 +1955  
SPZ1/MAZ GGGGAGGGG +500 +204 -150 +2365 +2375 + 8 9 9 + 8 8 8 
+1789 
+2980 
+610,+1722 
+1816 
+1450 
+2407 +6333 
 
(a) PRNP 
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TF Motif Hum Dog Mou Rat Cow Sheep Md 
SPZ1/ TFIII CCTCCCCC -47 +537 -48 -48 -20 -21  
CDXA TTATTTAA +386 +936 +377 +368 +413 +400  
LEF1 ACAAAGAA +1726 -582, 
+4354 
+1998 -1140 +759 +706 +3041 
PBX1/ 
STAT4/ 
STAT5 
TGATTTCT +137 +708 +1311 +1220 +172 +172 +4584 
XVENT1 TATTTGGA -72 +512 -81 -82 -44 -45 +150 
 
 
 
Figure 7-15 Venn diagram illustrating the TFs predicted by comparing different species for 
(a) PRNP and (b) PRND. For PRND the comparisons were only made between marsupial and 
mammals. As mammalian sequences were used for all the comparisons, it forms the outermost 
circle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(b) PRND 
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(a) PRNP: Mammal+Marsupial+Avian+Amphibian 
 
 
(b) PRNP: Mammal+Marsupial+Avian 
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(c) PRNP: Mammal+Marsupial+Amphibian 
 
 
(d) PRNP: Mammal+Marsupial 
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(e) PRNP: Mammal 
 
 
Figure 7-16 PF and TFBS predictions in PRNP as displayed by the image drawing program. 
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(a) PRND: Mammal+Marsupial 
 
 
(b) PRND: Mammal 
 
 
Figure 7-17 PF and TFBS predictions in PRND. (a) Between mammal and marsupial, and (b) 
within mammalian species as displayed by the image drawing program. 
 
7.7 Discussion of the results 
The number of conserved sequence motifs and TFs predicted to bind to PRNP is 
greater than that predicted for PRND (Figure 7-15). This likely is consistent with 
evolution of PRND at a faster rate in comparison with PRNP, which is likely under 
greater selective pressure as it has an established function in the mammalian 
lineage resulting it evolving at a slower rate. Some TFBSs showed variation 
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between upstream in a few species to downstream in the rest of the species 
compared, for example, LEF1 in PRND (Figure 7-17 (a)) and MAZ/SPZ1/MAF in 
PRNP (Figure 7-16 (a)). This may be related to the (stringent) parsimony score of 0 
(or no mismatches) being used which does not take into account the degenerate 
nature of the TFBSs (Figure 7-20). The core binding bases which are shorter than 
the searched motif size of 8, may be conserved in the expected position. Either the 
comparison of the pairwise alignments in these circumstances or repeating the 
FootPrinter analysis with a higher parsimony score may prove useful.  
For PRND analysis, the occurrence of X-VENT1 in the exonic region for marsupial 
in contrast to the upstream region in mammalian species is interesting. This raises 
the issue of the validity of masking the exonic sequences for PF analysis, which is 
the most common practice. The rationale behind masking the exonic sequences is 
that they are under greater selective pressure. If that was the case, many more 
conserved motifs and TFBSs in the exonic region should have been predicted but 
this was not observed. TFBSs have been shown to be present in the 5’UTR 
(Calhoun et al. 2002) and even the coding exons (Neznanov et al. 1997). One 
possible explanation for predicting a higher number of conserved motifs in PRNP 
may be related to the use of unmasked sequences. However, masking the repeat 
regions which are phylogenetically conserved and statistically show binding 
potential to TFs may indeed have significance in binding to TFs and this 
information would have been lost by using masked sequences for the analysis. 
Some of the sites showed binding potential to multiple TFs and the judgment of the 
significance was based on understanding the biological function of these TFs and 
their tissue specificity. The input genomic sequence was not split into upstream 
and downstream sequence datasets allowing the possibility of rearrangement 
events occurring across the TSS. Comparisons made with avian and amphibian 
sequences did not produce many TFBSs which may be a result of different 
regulatory mechanisms in these lineages.
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7.7.1 Known vs predicted TFs 
The use of this combinatorial PF approach (i.e. both alignment-based and motif-
discovery-based methods) predicted most of the known TFs for the PRNP and 
PRND genes.  
PRNP: The Sp1 TF has been shown experimentally to play a role in transcriptional 
regulation of PRNP (Saeki et al. 1996; Baybutt and Manson 1997; Inoue et al. 
1997; Mahal et al. 2001). Mahal et al. (2001) also found Ap1 and Ap2 binding sites 
in the human promoter region. Both Sp1 and Ap1/Ap2 TFBSs were predicted using 
the pairwise-alignment method in most pairs of sequences compared (Figure 
7-18), but these TFs were not identified using FootPrinter analysis (motif absence 
in any sequence was not allowed). Premzl et al. (2005) reported several regulatory 
regions in PRNP using PF (FootPrinter method) with the then-available sequences 
(mammals and one marsupial only): most of the TFs (MEF2, Oct- 1, MyT1 and 
NFAT) were predicted in the intra-mammal comparison.  
 
 
Figure 7-18 Ap1, Ap2, Ap3 and Sp1 sites identified in PRNP using LAGAN alignments with 
the search criteria of 100% identity over 10 bp. (human (H), mouse (M), rat (R), dog (D), cow 
(C), sheep (S), M. domestica (Md)). 
PRND: Nagyova et al (2004) experimentally validated the role of USF-1 and NF-Y 
in PRND promoter activity. The NF-Y region was predicted using both alignment-
based and FootPrinter methods (Figure 7-19, Figure 7-20). The USF-1 binding site 
was predicted in comparisons of some sequence pairs using alignment-based 
methods but not using FootPrinter: this indicates either that the USF-binding site is 
H
H
M
R
H
D
H
C
H
H
S
Md
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short and degenerate or that it is not phylogenetically conserved among the 
species compared.  
 
 
Figure 7-19 Result of a search for NF-Y and USF-1 in PRND in the AVID generated pairwise 
alignments using human (H) as a reference sequence. NF-Y was not predicted in rat (R) and 
USF-1 was not predicted in cow (C), sheep (S) and dog (D) with the VISTA search criteria of 100% 
identity over 8 bp. 
  
 
 
Figure 7-20 Repetition of the FootPrinter analysis of PRND with motif size of 8 bp, parsimony 
score of 1 and subregion size of 1000. Search made for NF-Y USF-1 and LEF1. Note the 
improvement in the positioning of LEF in rat and dog compared with the previous search criteria 
(Figure 7-17). 
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Several new TFBSs were predicted for PRNP and PRND, (PRNP: E4BP4, DBP, 
FAC1, MYB; PRND: Spz1, Ap3, CDXA, LEF1) which are phylogenetically 
conserved for both genes, and which correlate well with physiological behavior 
consistent with operation of these TFs in regulating other genes (e.g. tissue 
specificity, specific physiological role) (See Appendix 5). 
E4BP4 and DBP binding sites in PRNP: The mRNA for PRNP is regulated in a 
circadian manner in the rat brain (Cagampang et al. 1999). The TFs involved in 
circadian regulation are referred to as “clock related” and include E4BP4 and DBP. 
They both have antagonistic roles in circadian oscillatory mechanisms (Mitsui et al. 
2001), where the former helps in repression and the latter helps in activation of 
transcription. Recent studies demonstrated that fatal familial insomnia which is a 
condition characterized by marked changes in many physiological rhythms, is an 
inherited prion disease (Fiorino 1996). Based on the conserved TFBS analysis, 
E4BP4 and DBP are shown to be conserved in order, orientation and position in all 
the mammalian species compared (Figure 7-21). This association appears very 
significant considering the circadian regulation of PRNP.  
 
 
Figure 7-21 Comparison within mammals has shown two TFBS, E4BP4 and DBP, conserved 
in position in PRNP. 
 
PRND core promoter: None of the earlier studies reported the possible role of 
Spz1 and Ap3 in transcriptional regulation of PRND; my analysis shows statistically 
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significant binding for these two TFs which are phylogenetically conserved in 
mammalian species in position and orientation. Their position relative to the TSS 
makes them strong candidates for transcriptional regulation. However, 
computational predictions made by Nagyova et al. (2004) indicated a possibility of 
the Sp1 (Cys2His2 zinc finger domain) TF binding to a motif at -48 of the Prnd 
promoter (mouse). Based on my TF-binding analysis by Match, the statistical score 
obtained for the -48 motif for Sp1 (core similarity =0.95) was lower than that of 
Spz1 (core similarity = 1). A tantalizing finding is the identification of a Spz1 binding 
site. Spz1 (spermatogenic zip1) plays an important role in transcriptional regulation 
of genes involved in spermatogenesis and is highly expressed in testis (Hsu et al. 
2001). As USF-1 and NF-Y are ubiquitous TFs, the tissue specific expression of 
PRND in testis is likely controlled by some tissue specific TFs. Spz1 is strong 
candidate to play a critical role in transcriptional regulation of PRND in testis in 
association with other TFs. Luciferase assays in reporter constructs made from a 
combination of mutations to the USF-1, NF-Y, Ap-3, and Spz1 binding motifs have 
been used to test the functional importance of each of these predictions (Figure 
7-22) (see Chapter 8).  
 
Figure 7-22 Schematic representation of mouse Prnd promoter. USF-1 and NF-Y are known to 
bind and showed transcriptional activation. The sites for Ap3 (TATTTGGA) and Spz1/Sp1 
(CCTCCCC) are phylogenetically conserved and new predictions from my analysis for 
transcriptional regulation of PRND. 
-186                           -112              -81                  -48
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7.8 Application and Conclusions  
The development of a graphical web interface has facilitated evaluation of results 
from the PF and TFBS analysis pipelines. An application of the pipeline and web 
interface has been illustrated by an analysis of PRNP and PRND genes. This 
revealed several new conserved TFBSs, in addition to detecting already published 
and experimentally validated TFs for regulating these genes. Detection of the latter 
serves as a confidence test for the pipeline analysis. Several of the newly predicted 
TFBSs are consistent with the known functions of these genes, providing strong 
starting points for follow up experimental studies. A combinatorial approach of 
predicting conserved motifs using FootPrinter and AVID/LAGAN methods followed 
by TF binding analysis significantly improved the confidence in the predicted 
TFBSs. This pipeline was also tested on the newly discovered PrP family gene, 
SPRN, providing us with valuable initial functional predictions of a gene whose 
function is not known. The development of a pipeline which incorporates both 
alignment-based and motif-discovery based methods with TFBS analysis is novel, 
and provides a powerful new tool for high throughput, robust analysis. The 
concurrent development of the graphical-display module to this pipeline greatly 
enhances its usefulness by facilitating intuitive and interactive analysis of the 
results.  
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8 Experimental validation of predictions 
8.1 Background 
While doppel and prion protein share similar structural properties, their tissue 
expression patterns differ significantly. Prnp is expressed widely with the highest 
concentration in neurological tissues whereas Prnd is expressed mainly in the 
testis of adult mice. This indicates a tighter transcriptional regulation of Prnd. The 
core Prnd promoter (mouse) has been identified to be in the region -185/+27 with 
respect to the transcription start site (TSS) (Nagyova et al. 2004).  Based on the 
TF-binding predictions made by PF, two evolutionarily conserved regions (100% 
conservation in 8 bp across human, mouse, rat, cow, sheep and dog) for 
spermatogenic zip (Spz1) and activating protein (Ap3) were predicted to bind in the 
Prnd core promoter. It has been experimentally shown that the upstream 
stimulating factor (USF-1) and nuclear factor-Y (NF-Y) also play a functional role in 
the transcriptional regulation of Prnd (Nagyova et al. 2004; Sepelakova et al. 2005) 
which are also the part of the core promoter.  
The mouse promoter was used for this study because previous published 
functional studies for Prnd were on mouse promoter. This allows the data to be 
compared across studies. In this work, a particular focus is placed on studying the 
influence of the Spz1 TF on the promoter activity. Spz1 belongs to the bHLH-Zip 
family and is exclusively expressed in mouse testis and epidydimis. It plays a role 
in cell proliferation and differentiation and is involved in spermatogenesis (Hsu et 
al. 2001). The Spz1 binding motif, “CCTCCCCC” is situated at -48 bps upstream to 
the TSS in mouse and is conserved in position and orientation among the 6 
mammalian sequences compared (Chapter 7: Table 7-3b). As the current literature 
supports the idea that Prnd is expressed in testis and that it has a role in male 
fertility, this predicted TF was considered as of particular interest. Nagyova et al. 
(2004) indicated a possibility of the Sp1 TF binding to a motif at -48 of the Prnd 
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promoter (mouse). However, in silico binding analysis results presented in Chapter 
7 (section 7.7.1) indicates that Spz1 is more likely to bind to this motif than Sp1. 
 
Figure 8-1 Schematic representation of the mouse Prnd promoter. (* Confirmed, # Predicted) 
 
The aim of this work was to study the mouse Prnd promoter for transcriptional 
regulation encompassing the four binding sites (Figure 8-1): USF-1, NF-Y, Ap3 and 
Spz1 and to validate the predictions made in Chapter 7 for PRND core promoter. 
To elucidate the significance of Sp1 and Spz1 in transcriptional regulation of the 
mouse Prnd, functional studies were performed on the Prnd promoter. The role of 
Ap3 and Spz1 binding sites in Prnd core promoter were studied for the first time.  
 
8.2 Materials and Methods 
8.2.1 Database searches 
NCBI Gene Expression Omnibus (GEO) profiles were searched for analyzing the 
gene expression of USF-1 (gene ID: 1426164_a_at), NF-Y (1452560_a_at), Ap3, 
Spz1 (1450653_at) Sp1 (1448994_at) and to compare with Prnd (1425681_a_at). 
The NCBI GEO dataset GDS565 (platform GPL339) which is designed for 
analyzing sex-specific transcription in somatic and reproductive tissues was used 
for this purpose.  
8.2.2 Cell lines 
The cell lines GC-2spd (ATCC: CRL-2196) (provided by Dr. Kate L. Loveland, 
Monash Institute of Medical Research) and bEnd.3 (ATCC: CRL-2299) (provided 
by Professor Carolyn Geczy, Inflammatory Diseases Research Unit School of 
-186                           -112                -81                    -48 
  *                           *                 #                    # 
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Medical Sciences, University of New South Wales) were used to study Prnd 
promoter activity. The GC-2spd cell line is of testicular origin that corresponds to 
primary spermatocytes. bEnd.3 is a mouse brain endothelial cell line. Both cell 
lines were maintained in DMEM with 10% fetal bovine serum, 1% glutamine and 
1% penicillin. They were grown in a humidified incubator at 37 oC and 5% CO2.  
8.2.3 Plasmids 
A luciferase construct containing the four TFBS of the mouse Prnd gene was made 
and is referred to as mDpl230 (-197/+27) (Figure 8-2).  A second luciferase 
construct containing only the Spz1 binding region was made which is referred to as 
mDpl90 (-67/+27) (Figure 8-2). These constructs were made by amplifying the 
Prnd promoter region by PCR from mouse genomic DNA using primers lmDpl and 
rmDpl (Table 8-1). The PCR product was digested with HindIII and BglII restriction 
enzymes for the mDpl230 construct and by HindIII and SacI for mDpl90 and cloned 
into the corresponding sites of the pGL4 reporter vector (Promega) upstream of the 
firefly luciferase gene.  
Table 8-1 Primers used in this study. *Published mutant site (Nagyova et al. 2004) 
 
Luciferase construct 
lmDpl GAGGTTGGGTCTTGATGGTC 
rmDpl GCTGGAAGGGAAGTCACAAG 
Luciferase construct with mutated binding site (underlined) 
Spz1-mut GGTAGAGAGGCCCCgatCCCCTGCAGCGCCTATAT 
Ap3-mut GAAGGGCTACCCTAggTGaAGGGTTGGAGCTCGGT 
NFY-mut* ATGCAGGAGCCCTTttTTGGTCCTGCTGTGGAGGGA 
USF-mut ATCAAGATCTTCAagaGGTTTTATCAGTGAAG 
Tissue expression 
lmex1Dpl TCAGAGGCCACAGTAGCAGA 
rmex2Dpl GCTTGCTATCCTGCTTCTCC 
lspz1 CATCTGCTCTCCCTGGACTC 
rspz1 CTGGCGACTTCTACCGAAAG 
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Figure 8-2 Two Luciferase constructs mDpl230 and mDpl90 were made. * indicates the 
mutated core binding site with the mutated bases underlined.  
Plasmids for expression of TF Spz1 cloned into pCI-neo vector (provided by Dr. 
Jack Hsu, Kaohsiung Medical University) and Sp1 cloned into pCR3.1 vector 
(provided by Dr Mark Hulett, John Curtin School of Medical Research) were 
obtained. pcDNA was used as a control plasmid (a gift from Dr. Alison Shield 
JCSMR). The nucleotide sequence of all the plasmids and luciferase constructs 
were confirmed by automated sequencing. Plasmid DNAs for use in transfection 
were prepared using the Invitrogen Midiprep kit. 
 
8.2.4 Transfection and luciferase reporter assays 
1 x 105 cells were seeded per well of a 12-well plate, in serum free and antibiotic 
free media. Transfection for the luciferase reporter assay was performed using 
FuGENE™ 6 (data in Figure 8-5, Figure 8-6). The ratio between the DNA (1μg) 
and transfection reagent used was 1:3. After growing overnight to ~90% 
confluence, cells were transiently transfected according to the manufacturer’s 
instructions. A constant amount of total DNA was used by adjusting with the 
pcDNA. The cells were trypsinised and transferred to a 96-well plate for 
measurement of luciferase activity. Gene expression was evaluated using the 
Dual-Luciferase Reporter Assay System (Promega). The luciferase activity was 
normalized against the Renilla expression produced by the pRL-TK renilla vector 
(Promega). All assays were repeated at least twice in triplicate. Luciferase assays 
to evaluate the effect of Sp1 and Spz1 were performed at two different 
concentrations of luciferase construct and TF plasmids (1:1 and 1:3) (Table 8-2).  
Luciferase 
Luciferase
USF-1 NF-Y AP3 Spz1
/Sp1
CACGTG            GATTGG      TATTTGGA      CCTCCCC 
CAAGAG*           TTTTGG*     TAGGTGAA*     CGATCCC* 
CCTCCCC
mDpl230 
mDpl90 
Spz1
/Sp1
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Table 8-2 Concentrations of luciferase vector and TF plasmids used to compare the 
promoter activity induced by Sp1 and Spz1. 
 
 
 
8.2.5 Endogenous gene expression: RNA extraction and PCR 
analysis 
Endogenous Prnd expression was analyzed by semi-quantitative PCR in GC2 and 
bEnd.3 cells transfected with Spz1 expression plasmid and pcDNA. The test was 
performed with three different transfection reagents: FuGENE™ 6, Metafectamine 
and Lipofectamine 2000. 1 μg of Spz1 and pcDNA plasmids were transfected into 
GC2 and bEnd.3 cells as described in section 8.2.4.  
24 hours after transfection, the cells were trypsinised and collected in 1.5 ml tubes 
which were briefly spun to separate cells from the media. These cells were either 
used directly for RNA extraction or stored in RNAlater until used. Total RNA was 
extracted using the RNeasy® plus Mini kit (Qiagen) as described by the 
manufacturer. 1 μg of total RNA was used for cDNA synthesis using the 
SuperscriptTM III First-Strand cDNA Synthesis (Invitrogen) kit. For amplification of 
Prnd, primers were designed spanning the intron (lmex1Dpl and rmex2Dpl) (Table 
8-1). Success of transfection was checked using Spz1 primers (lspz1 and rspz1). 
β-actin was used as a control. Amplification reactions were performed using 
Platinum®Taq DNA polymerase (Invitrogen); PCR conditions were 15 min at 95 °C, 
followed by 30-35 cycles of 30 s at 94 °C, 30 s at 56 °C, and 30 s at 72 °C.   
8.2.6 Mutation of TF binding sites 
Each of the binding sites for Spz1, Ap3, NF-Y, and USF-1 were mutated using the 
PCR-based technique. Before the mutants were made, computational analysis was 
performed by substituting several different bases in the core binding region and 
each of these combinations was tested against the TRANSFAC database using 
 Sp1 Sp1 Spz1 Spz1 
Luciferase vector 800ng 500ng 800ng 500ng 
TF plasmid/pcDNA 800ng 1500ng 800ng 1500ng 
Renilla 300ng 300ng 300ng 300ng 
Cell line GC2 GC2 bEnd.3 bEnd.3 
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Match to make sure that the mutated region did not bind any other known TFs. 
Once the right mutations were determined, forward and reverse primers with 
mutations were designed (Table 8-1). High fidelity Platinum® Pfx DNA polymerase 
(Invitrogen) was utilized and the manufacturer’s protocol was followed. PCR was 
performed for 18 cycles [94 °C for 2 min; 94 °C for 15s; 55 °C for 30s; 68 °C for 5 
min.30s]. PCR product was digested with DpnI restriction enzyme. 1 μl of digested 
PCR product was transfected into TOPO10 cells and the clones sequenced to 
confirm successful mutation.  The successful mutants were then digested with BglII 
and HindIII and sub-cloned back into pGL4 to ensure the integrity of the vector.  
This generated four different luciferase vectors each with one of the four binding 
sites mutated (mDpl230-USFmut, mDpl230-NFYmut, mDpl230-Ap3mut and 
mDpl230-Spz1mut).  
The mutant luciferase vectors were transfected into GC2 and bEnd.3 cells and the 
luciferase activity produced by endogenous TFs was measured to study the effect 
of the mutated site on promoter activity.  
 
8.3 Results 
8.3.1 Spz1 is only expressed in testis 
The NCBI GEO database was searched for the expression profiles of TFs of 
interest and these were compared with those for Prnd (Figure 8-3). Sp1, USF-1 
and NF-Y are widely expressed whereas Spz1 shows expression specific to testis. 
The data for Ap3 was not available from GEO profiles. Consistent with the tissue 
expression profile of Spz1, Prnd also showed localized tissue expression in testis. 
The other finding supporting my prediction that Spz1 may have more affinity for the 
-48 binding site than Sp1 is that the consensus binding site of Spz1 
(“GG(G/A)GGG(G/A)(A/T)T”) (Hsu et al. 2001) is more similar to the conserved -48 
motif (“CCTCCCCC”) than to that of the Sp1 consensus (“CCGCCC”) (Tamaki et 
al. 1995).  
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Figure 8-3  Mouse tissue expression profiles of USF-1, NF-Y, Spz1, Sp1 and Prnd obtained 
from the NCBI GEO database. The red bars represent relative measure of abundance of each 
transcript. The blue squares represent the percentile ranked value of a spot compared to all other 
spots within that Sample 
 
 
8.3.2 Endogenous Prnd expression analysis in GC2 and bEnd.3 
cells 
Prnd and Spz1 transcripts are expressed endogenously in GC2 and b.END3 cells. 
Cells (GC2 and bEnd.3) transfected with Spz1 expression plasmid did not show 
any changes in endogenous Prnd levels compared with the untransfected or cells 
transfected with pcDNA (Figure 8-4). This was confirmed by transfection assays 
performed using Lipofectamine2000, and FuGENE™ 6. However, the endogenous 
Prnd levels varied based on the transfection reagents used as Prnd transcript was 
not detected (after 30 cycles of PCR) after transfection with Metafectamine.  
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Figure 8-4 Endogenous gene expression of Prnd using RT-PCR. (a) Lipofectamine2000. Spz1 
product has stronger intensity in the Spz1 transfected cells compared with pcDNA or untransfected 
cells (control) indicating successful transfection (30 PCR cycles for Spz1 and 35 PCR cycles for 
Prnd). (b) Cells transfected using FuGENE™ 6 (30 PCR cycles) and (c) cells transfected using 
Metafectamine (30 PCR cycles for Spz1 and 35 PCR cycles for Prnd). Spz1 did not have any 
influence on Prnd levels in all of the tests. The data shown are from GC2 cells (bEND.3 data not 
shown as it was similar to GC2 cells).  
 
8.3.3 Test for Prnd core promoter 
The activity of mDpl90 compared with mDpl230 (Figure 8-5) was low, in accord 
with the observations of Nagyova et. al. (2004). This indicates that other TFs in the 
-197 region are required for maximum activity, which is consistent with the core 
promoter region spanning -185 to +27 bp as reported previously. The significance 
of the Spz1 binding site (-48 region) was tested by comparing the luciferase 
experimental results from mDpl90 (containing only the Spz1 binding site) with 
mDpl230 (containing the four binding sites of interest). Co-transfecting Spz1 
expression plasmid and luciferase construct (mDpl230 or mDpl90) showed that 
Spz1 induced expression from the Prnd promoter in both GC2 and bEnd.3 cells 
(Figure 8-5). 
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Figure 8-5 Comparison of luciferase activity between mDpl230 and mDpl90 luciferase 
constructs in GC2 and bEnd.3 cell lines. Note the increase in the activity of the promoter in cells 
transfected with Spz1 TF for both the luciferase constructs with short (mDpl90) and long (mDpl230) 
promoters. 
 
8.3.4 Effect of Spz1 and Sp1 on promoter activity 
Sp1 and Spz1 expression plasmids were co-transfected with the mDpl230 
luciferase construct in GC2 and bEnd.3 cells to compare their effect on promoter 
activity. This was tested at two different concentrations of the mDpl230 luciferase 
construct and TF plasmid (1:1 and 1:3) (Figure 8-6). Both Spz1 and Sp1 plasmid 
had a slight positive effect (25% and 15% respectively) on luciferase promoter 
activity at the ratio of 1:1. Increasing the Spz1 concentration by three times (1:3) 
did not give any additional increase in promoter activity suggesting that the site is 
saturated. However, the same increase in Sp1 concentration reduced the promoter 
activity (from +15% to -15%), possibly by competitively binding to some other 
important TFBS thereby reducing the transcriptional efficiency. In both the tests, 
Spz1 showed more activity compared with Sp1. This data shows that Spz1 is a 
better TF than Sp1 for the -48 region. 
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Figure 8-6 The effect of Spz1 and Sp1 TF on mDpl230 luciferase vector using different 
concentrations of TF plasmid in GC2 and bEnd.3 cells. 
 
8.3.5 Mutation of Spz1 and NF-Y binding sites decreases promoter 
activity 
Luciferase assays using mutant promoter constructs were performed in GC2 and 
bEnd.3 cells to evaluate the significance of each of the four binding sites under the 
influence of endogenous TFs. However, the endogenous expression of USF-1, NF-
Y and Ap3 was not tested in these cells, but based on the data from GEO 
database they are expressed in a wide range of tissues (Figure 8-3). Mutation of 
the the Spz1 binding site (mDpl230-Spzmut) reduced the promoter activity by 40-
60% (Figure 8-7 (a), (b)) compared with the cells transfected with unmutated 
Luciferase vector : TF plasmid = 1:1 
Luciferase vector : TF plasmid = 1:3 
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luciferase vector (mDpl230). Co-transfecting Spz1 expression plasmid with 
mDpl230-Spzmut showed no additional changes in the promoter activity indicating 
that Spz1 does not bind to the mutated plasmid (Figure 8-7 (b)). This confirms that 
the increase in the promoter activity (Figure 8-6) observed in the mDpl230 
luciferase vector cotransfected with the Spz1 expression plasmid was an effect 
produced by targeting the -48 region.  
The most significant effect was seen in luciferase vector (mDpl230-NFYmut) with a 
mutation in the NF-Y binding site, consistent with the experimental results of 
Nagyova et al. (2004) (Figure 8-7). Mutation of the Ap3 binding site showed only a 
minor reduction of promoter activity by 15-20% (Figure 8-7). Interestingly, mutation 
of the USF-1 binding site (mDpl230-USFmut) showed an increase in activity in both 
GC2 and bEnd.3 cells indicating repression of Prnd expression by USF-1. This is 
contrary to the findings of Nagyova et. al. (2004) showing a marked reduction in 
the promoter activity in luciferase vector with a different mutation (Figure 8-8) on 
the USF-1 binding site in GC1 and bEnd.3 cells. It should be noted that a search 
against the TRANSFAC database using Match did not show any binding affinity to 
the USF-1 mutated site I used in this study. However, the USF-1 binding site 
mutation created by Nagyova et. al. (2004) showed binding to various TFs (Figure 
8-8). This may explain the contradictory findings between the two studies. My 
results suggest that mutation of the USF-1 binding site has removed the repressor 
action by USF-1, which has been reported in other genes (Hadjiagapiou et al. 
2005) thus producing the positive effect. 
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Figure 8-7 Luciferase assays using mutant promoter constructs. (a) Analysis of the promoter 
activity using luciferase vector with mutant TFBSs in GC2 and bEnd3 cells (no TFs were co-
transfected). (b) Effect of cotransfection of Spz1 on expression from mutant luciferase vector, Spz-
mut in bEnd.3 cells. 
 
 
 
 
 
 
Figure 8-8 USF-1 mutation created by Nagyova et. al. (2004). Analysis using Match against 
TRANSFAC data indicated several possible TFs which might bind to the mutated region.  
USF-1 mutation site: TCTTCAttaGGTTT 
Search results against TRANSFAC using Match: 
 
V$OCT1_03      |   1 (-) |  0.985 |  0.982 | tcttcATTAGgtt 
V$SRY_01       |   8 (-) |  0.894 |  0.871 | taGGTTT 
V$GEN_INI2_B   |   2 (+) |  0.977 |  0.968 | cttCATTA 
V$GEN_INI3_B   |   2 (+) |  0.979 |  0.965 | cttCATTA 
V$Ap3_Q6       |   1 (+) |  0.882 |  0.907 | tCTTCAtt 
a 
b 
p
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8.4 Discussion 
The aim of this work was to validate the significance of predicted Ap3 and Spz1 
binding sites in the Prnd core promoter with a particular emphasis on the Spz1 
binding site located at -48 bp upstream to the TSS. The results suggest that the -
48 region is crucial for Prnd promoter activity, validating the prediction of a Spz1 
binding site. This is evident by the increase in the promoter activity brought about 
by transfecting Spz1 expression plasmid and the fact that mutating this site down 
regulated the promoter activity by 40-60%. Further work (electrophoretic mobility 
shift assay) could be done to prove whether Spz1 binds directly to this region.  
Lack of a many-fold increase in promoter activity in the Spz1-transfected cell may 
be related to already maximal activity of promoter due to high endogenous levels of 
Spz1 in these cells. Further work could involve knockdown experiments with siRNA 
(small interfering RNAs) and shRNA (short hairpin RNA) to validate this 
hypothesis.  
The current study supports the finding of Nagyova et al. (2004) that NF-Y is the 
most significant TF for Prnd promoter activity. The minimal (15%) changes in 
promoter activity for the Ap3-mutated site may be related to lack of endogenous 
Ap3 in this tissue. Experimental data regarding Ap3 and testis was not available 
from GEO (Figure 8-3) so this would need to be confirmed for these cells/tissue 
type. This site may be significant in other tissues, or may be that it needs some 
other cofactors which are not present in the test cells. NF-Y and USF-1 are 
ubiquitous TFs, and the testis-specific expression of Prnd may be due to Spz1. The 
experimental data for Spz1 serves to validate the computationally predicted TFBS. 
Also note that while Nagyova et al (2004) predicted Sp1 binding site in the 
promoter, the expression level of Sp1 is much lower in testis than in other tissues, 
therefore more likely that Spz1 binds to the promoter in vivo than Spz1. I have now 
demonstrated a functional Spz1 element in the promoter of Prnd. It seems highly 
likely, given the level of expression of Spz1 in testis and the evolutionary 
conservation of this site, that this TF is responsible for the testis specific 
expression of Prnd in the mouse.
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9 Human Doppel gene polymorphisms in male infertility 
9.1 Background 
PRND shows testis-specific expression in adult human (and mice). Several 
published studies have demonstrated its role in spermatogenesis. This which is 
supported by my new finding of the presence of a conserved Spz1 binding site 
(Chapter 7 and Chapter 8) which is known to play a role in regulating the genes 
involved in spermatogenesis. As Prnd knockout mice were shown to be infertile, 
PRND might be important for fertility in human. The purpose of this study is (a) to 
search for rare mutations which might cause infertility and (b) to study the possible 
association of polymorphisms in human PRND with infertility. Polymorphisms in the 
promoter region together with the ORF were studied, as they may affect the gene 
expression. 
Earlier polymorphism studies focused on studying the genetic variation in PRND in 
the etiology of prion disease. This led to the detection of a few polymorphic 
genotypes in the PRND coding region: M26T, P56L and T174M (Peoc'h et al. 
2000). There was considerable interest in studying the influence of these 
genotypes on prion disease. The implications of polymorphic codon 174 showed 
contradictory results (Schroder et al. 2001; Infante et al. 2002). Several studies 
showed no significant association between T174M with sCJD (Schroder et al. 
2001; Croes et al. 2004; Jeong et al. 2005; Vollmert et al. 2006). Similar 
conclusions were drawn for polymorphic codon 26 (T26M) and codon 56 (P56L) 
(Mead et al. 2000; Schroder et al. 2001; Infante et al. 2002). The association of 
these polymorphisms with other neurodegenerative diseases such as Alzheimer’s 
disease disclosed no significant difference in the frequency of PRND genotype 
betweens cases and controls was found (Golanska et al. 2004). 
Although PRND polymorphisms have been studied to ascertain an association with 
prion disease, there have been no reports on PRND mutations or polymorphism 
investigating a possible association with male infertile populations. In this study, 
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the promoter and ORF regions of the human PRND gene region were screened for 
variations in 96 control and 96 infertile male samples.  
 
9.2 Materials and methods 
9.2.1 Study population 
The patients in this study were diagnosed with male infertility. The following DNA 
samples were obtained from Dr. Moira O'Bryan (Centre for Reproduction and 
Development, Monash Institute of Medical Research). The ethnic background of 
these samples is not known. 
• 96 infertile men 
• 96 controls comprising 53 fertile men (proven fathers) and 43 healthy men 
with normal semen analysis 
The sperm concentration, motility and morphology associated with infertile samples 
ranged from normal to a combination of poor concentration, motility, and 
morphology in varying degrees. The control population contained fertile men or 
proven fathers and healthy individuals where the fertility factor is not known but 
have normal semen analysis parameters and hormone levels. All DNA samples 
were diluted in water and were supplied at a concentration of 50 ng/μl. A volume of 
20μl of each sample was supplied. These samples were further diluted by using 10 
μl from each sample and adding 30 μl of water.   
9.2.2 Genotyping  
Two methods were tested for detecting polymorphisms in the PRND promoter and 
ORF 
• LightScanner® (using LCGreen® dye) 
• Big-Dye sequencing 
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9.2.2.1 Idaho technology LightScanner® 
The LightScanner hi-res melting technique (refer section 2.1.4.1) was assessed for 
its suitability for analyzing the PRND gene. The LCGreen dye was incorporated in 
the PCR mix and double the normal quantity of magnesium was used to 
compensate for any loss of sensitivity by incorporation of the dye. The DNA 
samples were amplified using primers lorfDpl and rorfDpl for ORF and lprDpl and 
rprDpl for promoter region (Table 9-1, Appendix 8). PCR was performed using 
Platinum®Taq DNA polymerase (Invitrogen) (4pmol of primer and 50 ng of DNA as 
template). The PCR conditions were optimized based on a number of test runs. 
The final PCR protocol was as follows: 94 °C for 5 min; denaturation at 94 °C for 
30 s; annealing at 66 °C for 30 s; extension at 72 °C for 20 s; and a final extension 
72 °C for 5 min; amplification for 45 cycles. The LCGreen dye does not interfere 
with the amplification process but is known to increase the melting temperature by 
2-4 °C.  The PCR amplified product was transferred to the LightScanner for the 
melting analysis using the LightScanner software.  
Out of the 24 test samples (infertile male) on which PCR (ORF) was performed, 13 
samples showed good quality product as analyzed from the melting curves. The 
melting curves were normalized by defining regions in the pre- and 
postdenaturation parts of the curve, and the value was set for the melting. The 
melting curve shows the decrease in the fluorescence against increasing 
temperature (Figure 9-1). Variations in the melting curves were observed among 
the 13 samples. Because of the large number of variations within the PCR 
amplicon, it was decided that this approach may not be appropriate for analyzing 
this gene and, hence, further work was not carried out by this method. As the 
sample set was relatively small and the number of expected SNPs large (high 
resolution is best applied to single SNPs with a PCR amplicon), it was decided that 
direct sequencing would be the best approach to search for novel mutations.  
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Figure 9-1 Melting curves for Dpl ORF (Infertile male population) showing a number of 
variations obtained using LightScanner.  
 
9.2.2.2 Big-Dye sequencing 
PCR was performed in 96-well plates using the DNA Engine Tetrad® thermocycler. 
Genomic DNA from infertile and control population samples was amplified using 
promoter primers lprDpl and rprDpl and ORF primers lorfDpl and rorfDpl. The 
amplified product was then sequenced using lprDpl for promoter and a nested 
forward primer lorfSeqDpl for ORF product.  
PCR. Platinum®Taq DNA polymerase (Invitrogen) was used for the analysis (12 ng 
genomic DNA template and 4 pmols of the forward and reverse primers) with PCR 
conditions: 94 °C for 5 min; denaturation at 94 °C for 30 s, annealing at 66 °C for 
30 s; extension at 72 °C for 20 s; and a final extension 72 °C for 5 min; 
amplification for 35 cycles. 
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Table 9-1 Primers used to amplify the promoter and ORF regions of human PRND gene. (See 
Appendix 8 for primer map). 
Primer name Primer sequence Comment 
lprDpl CTTGCCCTCTTTTTGAGCTG Left promoter 
rprDpl CGTACCTTGGCTCTCTCTGG Right promoter 
lorfDpl TAGCAAAGGAGCTCGGTGTT Left ORF 
rorfDpl GCTGCTGCACTCTGTACTGC Right ORF 
 
lorfSeqDpl TAACCCTGCACAACCCAAAC Nested primer for 
ORF sequencing 
 lDplrflp GGGGAGTTCCAGAAGCCAGAC Left RFLP 
 rDplrflp TCAGAACGCAGGCACATACCAG Right RFLP 
 
SAP-Exo digest. Shrimp alkaline phosphatase (SAP) removes the phosphate 
groups from the excess dNTPs left over from the PCR reaction. Exonuclease I 
(EXO) digests the single-stranded PCR primers into dNTPs and the phosphate 
groups are removed by the SAP. 
SAP (1 µl, 1 U/µl) and 10X SAP buffer (0.9 µl) (New England Biolabs), EXO 
(0.15ul, 20U/µl) and 10X EXO buffer (1.5 µl) (Roche) was added to the PCR 
reaction and incubated at 37°C for 1 h. SAP was denatured for 10 min at 80°C. 
The PCR product was verified on an agarose gel by loading 3 μl of the PCR 
product from 13 random samples each from the infertile and the control population 
(Figure 9-2). This was done to ensure that the PCR product was of good quality for 
direct sequencing and that the samples were free of contamination.  
 
Figure 9-2 Agarose gel electrophoresis of randomly picked samples to check the quality of 
the ORF PCR product in control and infertile samples. The PCR product matched the expected 
product size of 740 bp. A negative control (water) was included in each set of PCR amplifications. 
The sequencing protocol specified by the Biomolecular Resource Facility at the 
JCSMR was used as a starting point for sequencing. Several trial runs were made 
to modify the protocol to suit the needs for sequencing on 96-well plates. The final 
H20 H20 Control Infertile 
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volumes of the reagents used are: BigDye 4 µl, PCR product 4 µl, 5X buffer 4 µl, 
water 7 µl, and primer 1 µl in a 20 µl reaction. Sequencing reaction protocol: 
Precipitation - for each of the samples add 100% ethanol 60 µl, 125uM EDTA 1 µl, 
and 3M Sodium acetate 1 µl. Spin at room temperature for 40 min at 4000 rpm, 
discard and then remove residue by spinning for 2 min at 400 rpm; Wash - for each 
of the samples add 70% ethanol 200 µl and spin for 10 min at 4000 rpm. Discard, 
wash and submit pellet for analysis 
9.2.3 PCR-RFLP assay for analysis of C521T polymorphism 
Restriction fragment length polymorphism (RFLP) was used to identify SNPs that 
alter or create a site where a restriction enzyme cuts. C521T genotypes were 
determined by means of PCR and RFLP analysis for the samples which could not 
be confirmed through sequencing. In total, 14 samples of known genotype were 
used as controls and 20 test samples whose genotype was ambiguous from the 
chromatogram were analyzed (see Appendix 10). The C521T polymorphism alters 
a Nla III restriction site. Genomic DNA was subjected to standard PCR (PCR 
conditions were 94oC for 30 s, 65oC for 30 s, 72oC for 30 s, 35 cycles) using 
primers lDpl-rflp, and rDpl-rflp. The PCR product was digested with Nla III (10 µl of 
PCR product, 0.5 µl Nla III, 1.5 µl NEB4 buffer, 0.15 µl BSA, 2.85 µl water) for 4 
hours at 37oC and samples were electrophoresed on a 2.5% agarose gel. 
9.2.4 Statistical analysis 
Sequencher 4.7 (http://www.genecodes.com/) was used to analyze the 
chromatograms obtained from sequencing reactions. To reduce the risk of missing 
novel SNPs, especially as the dataset was relatively small, a manual approach was 
used for SNP screening. A reference sequence for the ORF and promoter regions 
was used to align the sequences (NM_012409 and NW_927317.1, respectively). 
The option “Matching Bases as Dashes” was used to screen for any 
mutations/SNPs. The regions with mutation/SNPs were further analyzed visually to 
rule out any sequencing errors. The criterion for identifying homozygous or 
heterozygous is shown in Figure 9-3. Further visual analysis of the aligned 
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chromatograms was made to detect any mutations not reported by the first 
approach.  
The results of the genotyping were analyzed by Chi-square test and Fischer’s 
Exact Test (FET) (GraphPad Prism, 4.0) on each of the control and infertile groups 
separately to determine if each SNP was in Hardy-Weinberg Equilibrium. The allele 
frequencies in the control and infertile populations were compared by FET for 
association with infertility. Probabilities of haplotypes and their frequencies were 
calculated using PHASE program version 2 (Stephens and Donnelly 2003; 
Stephens and Scheet 2005). Chi-square test was used to determine the p-value of 
the haplotypes for promoter and ORF regions separately. Population frequencies 
were analyzed from the HAPMAP (http://www.hapmap.org/) project for some of the 
known SNPs. 
 
Figure 9-3 Snapshot from Sequencher showing region homozygous for T and C and 
heterozygous C/T at the same position from different sequences. 
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9.3 Results  
9.3.1 Analysis of promoter and ORF for infertility-associated 
mutations 
Direct sequencing of the PCR product identified four nucleotide substitutions in the 
promoter and five nucleotide substitutions in the coding region (See Appendix 9 for 
SNPs in each sample tested). The only sequence variant that was unique to the 
infertile population was C210T (rs34966363) in the ORF, which was present in only 
1 individual. This SNP has a reported frequency of 0.013 in African Americans 
(Appendix 11) and causes no change in amino acid sequence (Table 9-2). It is 
therefore not likely to be a cause of infertility, but rather a low frequency 
polymorphism. Therefore, no mutations in PRND were identified which might cause 
infertility in these men. 
9.3.2 Analysis of SNPs in PRND 
9.3.2.1 SNPs in promoter 
The region corresponding to -282 from the TSS covering the core PRND promoter 
was analyzed for SNPs. Four SNPs: G-259A, G-206A, C-202A, and G-171A were 
identified in this region (Figure 9-4(a)). SNPs at position -259 and -206 are 
reported in the ENSEMBL dbSNP (the number representing the SNPs for promoter 
is the relative position of the nucleotide from the TSS) (Table 9-2). SNPs at 
position -202 and -171 are novel and have a minor allele frequency of 1.6% and 
2.6%, respectively, a likely reason for them not having been reported previously. 
The SNP G-171A corresponds to the 3’ end of the USF-1-binding site. The G-259A 
SNP also shows large frequency variation in different ethnic groups with minor A 
allele frequency ranging from 0.07 in African Americans to 0.44 in Japanese 
(Appendix 11). Again, the variation in the allele frequencies between control and 
infertile samples may be related to the ethnic composition of the control and 
infertile samples. 
 
 176 
9.3.2.2 SNPs in ORF 
All five SNPs (C77T, C167T, C210T, C521T, and G522A) identified in the ORF 
region were previously reported (Peoc'h et al. 2000). The SNP at nucleotide 
position 210 was found only in one infertile sample and the SNP at nucleotide 
position 167 was found only in 2 control samples (Table 9-2). All of the SNPs 
except at nucleotide position 210 and 522 produce a change in the amino acid 
residue (Table 9-2).  
 
 
Figure 9-4 SNPs in ORF and promoter among control and infertile samples. (a) Distribution of 
SNPs shown on a schematic representation of human PRND gene. The four TFBSs in the core 
promoter are also shown. (Figure not drawn to scale). (b) Genotype comparison of control (C) and 
infertile (I) samples. The genotypes of all 9 SNPs of control and infertile were compared. Results 
are given in percent.. 
Infertile
Control
-259       -206       -202   77                    210                                              521    522 
-259       -206      -202     -171   77       167                             521     522 
-282 
USF-1    NF-Y  Ap3   Spz1 
a 
b 
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Table 9-2 Genotype, allele frequencies and Fisher’s Exact Test (FET) for nine different SNPs. 
in control and infertile human samples. The frequency range for the reported alleles (dbSNP or 
published data) corresponds to the minor allele of control samples (See Appendix 11 for detailed 
information about the source of data). ENSEMBL dbSNP ID is shown for some of the SNPs. 
 
SNP Genotype Allele 
frequency
FET Reported allele 
frequency range 
dbSNPID/ 
Comment 
G-259A GG GA AA G A  
Control 67 27 2 0.84 0.16  0.095
Infertile 57 33 6 0.77 0.23  
 
A: 0.07-0.44 
 
rs6133157 
    
G-206C GG GC CC G C  
Control 79 17 0 0.91 0.09 0.708
Infertile 82 14 0 0.93 0.07  
 
C:0-0.22 
 
rs12481509 
    
C-202A CC CA AA C A  
Control 93 3 0 0.98 0.02 0.723
Infertile 91 5 0 0.97 0.03  
  
    
G-171A GG GA AA G A  
Control 92 4 0 0.98 0.02 0.123
Infertile 96 0 0 1 0  
 3' end of 
USF-binding 
site 
    
C77T CC CT TT C T  
Control 92 4 0 0.98 0.02 0.751
Infertile 90 6 0 0.97 0.03  T: 0-0.04 M26T 
    
C167T CC CT TT C T  
Control 94 2 0 0.99 0.01 0.499
Infertile 96 0 0 1 0  T: 0-0.02 
Rs35453518 
P56L 
    
C210T CC CT TT C T  
Control 96 0 0 1 0 1 
Infertile 95 1 0 0.99 0.01  T: 0-0.01 
Rs34966363 
Synonymous
    
C521T CC CT TT C T  
Control 24 49 23 0.51 0.49 0.101
Infertile 29 56 11 0.59 0.41  T: 0.23-0.65 
Rs2245220 
M174T 
    
G522A GG GA AA G A  
Control 95 1 0 0.99 0.01 1 
Infertile 95 1 0 0.99 0.01   Synonymous
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9.3.2.3 Association analysis 
Comparison of the allele frequencies between control and infertile populations by 
FET found no significant association of any of the SNPs with infertility (Table 9-2). 
However, suggestive association was seen (p~0.1) for SNPs G-259A, G-171A and 
C521T. Comparison of the genotype was performed for these SNPs (Table 9-3). 
This analysis revealed there were significantly fewer TT individuals for the C521T 
SNP in the infertile group than in the control group, that is, individuals homozygous 
for the T allele were less likely to be infertile (relative risk=0.86; 95% confidence 
interval= 0.75-0.98; p=0.036). 
Table 9-3 Genotype analysis of significant SNPs 
Genotype Analysis p-val Test 
G-259A GG/GA/AA 
GG/GA+AA 
0.182    
0.174 
Chi2       
FET 
G-171A GG/GA+AA 0.121 FET 
C521T CC/CT/TT 
CC+CT/TT 
0.075    
0.0365
Chi2       
FET, 
 
9.3.3 Analysis of association of SNPs with infertility 
The frequency of SNPs in the control and infertile populations were compared 
(Table 9-2) to look for association between any of these SNPs and infertility. Initial 
sequencing results found that all SNPs were in Hardy-Weinberg equilibrium, 
except for SNP C521T. This prompted closer examination of the sequencing traces 
in this position and it was found that 20 samples had very ambiguous sequencing 
results for this SNP only. These samples were re-genotyped by PCR-RFLP (Figure 
9-5, Appendix 10), and all were unambiguously genotyped; 4 as CC, 9 as CT and 7 
as TT. After correctly assigning these genotypes, this SNP was also in Hardy-
Weinberg equilibrium. This SNP is also reported in the dbSNP (rs2245220) and 
showed varied distribution of alleles in different ethnic groups analyzed. The 
frequency range for the T allele varied from 0.25% in Chinese population to 0.65% 
in Youroba population (Appendix 11). Earlier studies indicated that there is no 
association of this polymorphism with Prion or Alzheimer’s disease. The SNPs at 
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nucleotide positions 521 and 522 lead to 3 different combinations for the 
polymorphic codon 174 which codes for either Threonine (T) or Methionine (M): 
ACA (T), ACG (T), and ATG (M). 
 
Figure 9-5 PCR-RFLP analysis for the C521T polymorphism. Restriction enzyme NlaIII was 
used to digest the PCR product. Homozygosity for thymine is revealed by a 185-bp, 107-bp and 40 
(not shown here) bp fragment. Heterozygosity for cytosine and thymine generates 230-bp, 185-bp, 
107-bp and 40-bp fragments. Homozygosity for Cytosine generates 185-bp, 107-bp and 40-bp 
fragments. 
9.3.4 Genotype analysis 
No significant difference in genotype distribution or allele frequency was observed 
between the control and infertile populations (Figure 9-4 (b) and Table 9-2). A 
minor distribution in the allele frequency was observed for the C521T 
polymorphism with the infertile population showing a lesser allele frequency for T.  
The allele frequencies of all the identified SNPs in the control and infertile samples 
are within the range of the population frequencies observed in various ethnic 
groups (Table 9-2, Appendix 11). 
9.3.5 Haplotype analysis 
Independent haplotype analysis was performed on promoter and ORF  
regions. A summary of the different possible haplotypes for control  
and infertile populations is listed in Table 9-4. No significant  
association of infertility with the promoter haplotypes was found when  
considering all 5 promoter haplotypes (p=0.11), or when pooling the rare (< 5%) 
haplotypes (i.e. combining Hap-pr4 and 5, p=0.3). Similarly, no significant 
association with haplotypes of the ORF was found, considering all 6 haplotypes 
(p=0.2) or when pooling the rare haplotypes (i.e. Hap-orf3 – 6, p=0.2). 
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Table 9-4 Distribution of major haplotypes in control and infertile humans. Haplotype 
analysis was performed independently for ORF and promoter region. 
 
Name Haplotype Control Frequency Infertile Frequency  
Hap-pr1    GGCG 144 0.750 133 0.693 
Hap-pr2    AGCG 31 0.161 45 0.234 
Hap-pr3    GCCG 10 0.052 9 0.047 
Hap-pr4    GCCA 4 0.021 0 0.000 
Hap-pr5    GCAG 3 0.016 5 0.026 
      
Hap-orf1 CCCTG 95 0.495 77 0.401 
Hap-orf2   CCCCG 90 0.469 107 0.557 
Hap-orf3 TCCCG 4 0.021 6 0.031 
Hap-orf4 CTCTG 2 0.010 0 0.000 
Hap-orf5   CCCCA 1 0.005 1 0.005 
Hap-orf6   CCTTG 0 0.000 1 0.005 
 
 
 
9.4 Discussion 
The PRND promoter and ORF was studied for polymorphisms in the infertile 
population for the first time. Nucleotide substitutions at four sites in the promoter 
and five sites in the ORF were identified. Out of the 192 samples screened, only 
one polymorphism G-171A was found within 185 bp upstream to the TSS which 
was proposed to be the core promoter region (Nagyova et al. 2004). This 
observation supports the significance of this region by showing only one 
polymorphic site. The effect of the SNP G-171A at the 3’end of the USF-1 binding 
site was analyzed using Match against the TRANSFAC database. The 
polymorphism did not alter the statistical score for USF-1 and may not affect it 
binding potential. All of the ORF SNPs found in this study were reported either in 
the literature or in the HAPMAP project. The C521T polymorphism showed 
different allele frequencies in the control and infertile population in which the TT 
genotype was more common in the control than in the infertile population. As this 
SNP showed a large variation in the allele frequency among different ethnic 
groups, it cannot be established whether the observed variation has any functional 
significance, i.e. individuals homozygous for the T allele are less likely to be fertile, 
or is due to the mixed ethnic population in Australia (ethnic information for the 
samples is unknown). The C521T polymorphism produces an amino acid change 
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M174T, which is a part of the C-terminal signal peptide that is cleaved to form a 
mature protein. However, this amino acid change does not alter the potential of the 
C-terminal end to act as a signal (as predicted by big-PI). No significant differences 
between infertile and control were found in the frequency of genotype distribution 
of other polymorphisms.  
In summary, no mutations in the PRND gene which are specific to human infertile 
population were found. The slight variation in the genotype frequency observed 
between control and infertile population may be related to size of the dataset 
screened and the ethnic composition of the two test groups.   
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Summary and Final Remarks 
The main objectives of my PhD were to understand the function and evolution of 
PrP family genes, predicting TFBS involved in the regulation of these genes and to 
explore a possible association of Dpl with human male infertility. To this end, I 
applied several computational and experimental methods to identify and 
characterize the genes of interest in various vertebrate lineages. The results 
revealed a plethora of interesting information on the evolution of these genes. A 
dominant chimeric PRND transcript encoded by a dicistronic transcript in Xenopus 
species supports the hypothesis of a PRNP gene duplication event. The co-
existence of monocistronic PRND and PRNP transcripts, although at a lower tissue 
concentration, indicates a drive towards evolution of an independent promoter 
which would enable PRNP to evolve a separate specialized function. I also 
discovered a retained duplicate of PRNP designated as PRNP2 in X. laevis which 
has a tetraploid genome. The pattern of co-existence of dicistronic and 
monocistronic transcripts was also observed in a marsupial species (M. 
domestica). Although the chimeric transcript has been reported in mammalian 
species (mice), it is found at a very minimal level in adult mice brain and is possibly 
due to a leaky ancestral promoter. In this scenario, it is interesting to note that 
PRND is missing in the chicken genome. Instead, a novel gene with sequence 
similarities to Sho was discovered downstream and in opposite orientation to 
PRNP, in a similar organization to that in fish. The findings from the various 
species indicate that the PRNP locus is dynamic and rapidly evolving. This is 
consistent with the observation that when genes are duplicated, one of the genes 
evolves at a higher rate in an attempt to find a novel function. 
The comparative sequence analysis identified conserved residues within PrP and 
Dpl, and those that are conserved between PrP and Dpl. These residues may be 
critical in function and maintaining the structural fold. PF revealed conserved 
TFBSs for PRNP and PRND. The number of conserved TFs predicted for PRNP 
was much larger compared with that for PRND. This may account for the wide 
range of functions performed by PrP and also to its widespread tissue distribution. 
One of the most interesting TF-binding predictions for PRNP was that of E4BP4 
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and DBP which are both clock-related proteins and may be involved in the 
regulation of PRNP, which is associated with fatal familial insomnia, in a circadian 
manner. These predictions provide a good starting point for planning experimental 
validations and may help in better understand this prion disease. The testis-specific 
TF Spz1 was predicted in the core promoter of Prnd. Spz1 in association with the 
other experimentally validated ubiquitous TFs, USF-1 and NF-Y, may play a role in 
testis-specific expression of Prnd. Functional studies were performed to validate 
the significance of the Spz1 binding site. Co-transfection of Spz1 expression 
plasmid with the luciferase vector containing the core Prnd promoter showed a 20-
25% increase in the promoter activity. Mutating the same site reduced the activity 
by about 40%. However, I did not directly test the binding of Spz1 to the predicted 
binding site. Another conserved TFBS in the core promoter region is that of Ap3. 
Mutating the Ap3 binding site produced a very minor reduction in promoter activity 
by about 15%. This binding site may play a more significant role in other cell types. 
Prnd knockout mice have been shown to be infertile. Motivated by this observation, 
I investigated the possible association of SNPs/mutations in PRND among the 
human male infertile population. Genotyping of the core promoter and ORF were 
performed by the direct sequencing method on 96 infertile male and 96 controls. 
This identified five already known SNPs in the ORF. None of the four SNPs in the 
promoter region is in the core binding sites of the known TFBS. Interestingly, some 
of the control samples had a SNP at the 3’end of the USF-1 binding site (G-171A) 
which was not detected in the infertile samples, indicating that it may not have a 
significant effect on the TF binding. However, one of the allele frequencies (C521T) 
was different among the control and infertile population. Further sequencing of 
more samples needs to be done to validate the significance of this finding.  
Although Sho was predicted to be present in the different species studied, 
experiments to characterize this gene and comparative sequence analysis were 
not performed (mainly due to time factors).  
During my PhD studies, I have explored various species for prion-protein family 
genes and performed comparative sequence analysis using a series of 
computational tools. I hope that the results I have presented highlight the 
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importance of comparative genomics in the analysis of function and evolution of 
genes. The computational predictions significantly helped in planning the 
experimental studies. Ever increasing computational power and constant 
development of new algorithms in computational biology and bioinformatics will 
open up exciting new capabilities to address complex biological systems, such I 
have studied. 
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Appendix 
 
Appendix 1: Sequence information of primers used by Tatiana Vassilieva for the Xenopus 
project. GSP indicates gene specific primers. 
 PRNP, X. tropicalis 
5’GSP-R ACCGAGCATGTAGCCCCCGATAG 
5’nested GSP-R TGGGAGGTTTCCATTGCTTGTTGTTG 
3’GSP-F CCAGATGCCAGAGCGTGTTTACAG 
3’nested GSP-F AGGGAAGAACACCAGCGAGGTAAAC 
 PRND, X. tropicalis 
5’GSP-R GGTCACTGCCCCATTGGTAGGCTT 
5’nested GSP-R AGCTCAGATTCCTCGGTAAGGTTAAAG 
3’GSP-F CTTCAGAGGCAGGGCACTCAATGTG 
3’nested GSP-F GGTGCTGGTGGGACTGACGAGTTT 
 PRNP1, X. laevis 
5’GSP-R CGACCCACTGCATTACCGAGCAT 
5’nested GSP-R TACTTTTCCCACCACCGCTCTTCTTG 
 PRND, X. laevis 
5’GSP-R CTCCTCCGTGCCGGCAGTATCATT 
5’nested GSP-R GCTGGGAGCGCCATGGGTAGTAAA 
3’GSP-F TCCTGTCCTCGGACACCTATTCTTCA 
3’nested GSP-F CTGTACAGATTCCCGGACGGACTTT 
 PRNP1, X. laevis 
F4 CTCACTGCTTTCCCGATCAC 
R4 GTTGCTCCCTGTGTTCCATC 
 PRNP2, X. laevis 
R6 CCAAGCATGTAGCCTCCAAT 
 PRND, X. laevis 
F4 CTCACTGCTTTCCCGATCAC 
F10 GGAAGAAACAGCAGCAAAGG 
R7 GTGCCGGCAGTATCATTCA 
 GAPDH, X. laevis 
F11 AACTGTCTGGCTCCTCTTGC 
R10 ACTTTGCAGGCTTCTTCAGG 
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Appendix 2: Emu Sholike 
>EmuSlike 
ALFSNTAGGRRGAGGRAGGRGGGGGGGGGGLRGGFRSISRGGNTAGRGSKMASAITAGAAAGYGMGLLGRPRP
PRLGHGPPAQRQPPPAGGFHAAAWPDLGAKRGSPNQAPKGPCGGIVPTLLL 
 
Amino acid sequence alignment 
 
chickSLike      MRPRDAWCWVAMLLLALFSNTAGGRRGAGGRAGGRGGGGGGGGGGLRGGFRSISRGGNTA 60 
emuSlike        ---------------ALFSNTAGGRRGAGGRAGGRGGGGGGGGGGLRGGFRSISRGGNTA 45 
                               ********************************************* 
 
chickSLike      GRGSKMASAIAAGAATGYGMGLLGRPRPPRLGHGPPAQRQPPPAGGFHAAAWPDLGAKRG 120 
emuSlike        GRGSKMASAITAGAAAGYGMGLLGRPRPPRLGHGPPAQRQPPPAGGFHAAAWPDLGAKRG 105 
                **********:****:******************************************** 
 
chickSLike      SPNQAPKGPCGGIVPTLLLANAICWVNHGM 150 
emuSlike        SPNQAPKGPCGGIVPTLLL----------- 124 
                *******************       
 
 
Appendix 3: M. domestica alternatively spliced 3’end. Grey portion corresponds to the ORF. 
ORF2 variant underlined. Note the possible splice donors and acceptors boxed. Bases in red 
background corresponds to exon 
GTACCAGAACGAGTACCGCAGTGCTTACAGCGTGGCGTTCTTCTCTGCCCCACCTGTGACCCTCCTCCTCCTC
AGTTTCCTTATTTTCCTGATTGTGAGCTAAGAAGCCTACCAATGTTTACTCTCTTCATGTTTCTTCTCTTAAT
CTTTGCAGAGAAGGAGGTCCTTCTGTCTGCAAGGGCAGCCCAAATAGCAGCAATTTCTCATTTCTATGTTTAT
CTGTCCCCCATAGGTTAAGGCACTAATGAGTACTGGTGAATGTACAGTAGACCCTAGATGCCAGGCCACCACT
CTTCCCCCGAACCATTTTGATCATGCATCCATCAGGGCAATGCCATACTTGTCAGTATCCTTTACAAGAGAGG
AGACCATTAAGTAACTTCTGGTCCATCAAGACACTTCTATAGTATAGCAGATTAAGGCCAAAACAGAAATGAT
TTCAAACTACATTTTCCAAATAGACACAACCATGGGCCCTTTTGCTTCCTGAAATGCCACCTAAATCTTTCTC
CCTGCTTGTATAGTCAATTAATGAGTAGATAAAGAATTAGCTAATTTAGAGCCCCATCTCTTCTTTGGCTTTA
CCAGCTGTGATATCATAGCCAGTTAAATATCTTTAGGAAACTCATTCATACATTTCAATACATCCTGATGCAT
TTTCCTCTTCAAATAGAAATTTTCATCATTAGGAAAGAAAGACTAGAGACCATCTAGGCAAACTATAGAAATC
ATCCGACCATGTGGGTCCAGGCTCGAGCTGCTGAATCAAGCGTAGCTACACCACAGAGAACTGGGACTACTGT
CTTGAATTTTATAAATGGGACACACTCAGTAGAGGCTGCACCAAAAATATATCCGGCCCAGGGGCTGGGTCTA
TTTGTCAACAGTGGAATGAGCATCGAGCATCATTGCGTGAGCTTTATCCTGTGCTACAGAGACTGTTCTTCTG
GGTAACCTACAATTTGGAAAGTAGTATTACTATGGGTATGATTTGTCATCTCAGACCATTTTGGTGTGTACAT
ATTGTTCAATACCAGTGTAAACTATTTCTACCAGAGCATTCCACCCAGGAATATGAAAATGCAAAGCAGATAC
TCCCGGATAACGAAGGAATCCCTCTCCAATGTTAGCAAATAATCCAAGACTGGCAGGCAGCACTTGGCTAGGC
CTCTTTGCCTGGAAGCCCACAAAGGTGCCAGCATTGTTAGAGTTACAGCAGGAGGCTGGTTAGCTCAGAGGAA
TCAGCAACTGGTTAAATTGCAATTTTAGGAATTAATGAGATAGTTTGGTGAGTTTATAAGCAAAAGAAGCACT
TCTTTTTTTCATGTCTCAAGATAAAGCAGTACCTAACTATACTGGATGAGCCCTTAAAGTCAGATTAGAAGAA
GAATCATTCAGATGGAGGAAGCCAGCCTGTTGATTTTTGGATTTAATCCAATCTTCAAAAACAATGTCTCAGA
AAAGGAGGAGAGGAGGGGAGGAGAAGACGGGGAGATGATCTGTCTGTATAAGTGATTTTTGTATTGAGTTGTG
AAAAAGTTGTTCTCATAGAATAAATTATTACTTTTTTCTTGTCACTATTTTGCATTGTGATGGGCTTGCAGTC
TTTGTAATCAGTAAATATCAGATATGATAAACTAGAAATTCTGCTCAGAACAATTCACCCAGAGTAGTATCCA
ATGTATTCTGTGTCTTTCCAAGATCCCAGATGCCCATTCCGTGGAAGCAATATCCTGAGGCTTACGGCACCAC
ATGCTGAATGGACTCCTGCTTGAGTCCCCAGTGCACCAGGGAAAGTAGTCTTTGAAATTTGCATGCACTTAGT
AATATAAAGATGTTTTATAGATTTGTAACTTTGCACGTATTTGTTTTGATGTATTAAAAATTTATAAATGTTT
AATATC 
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Appendix 4: Platypus PRNP and PRND ORF as obtained from trace sequence archive. Note 
the GC rich region in PRND ORF 
>PlatypusPrP_ORF 723211856 
ATGTGGCCACATTGGGGAAAATCCCCTGTACATCACTGGATAATAGACATCTGTGTGGTACACCTGGAGCGCA
GATGCCGTGGACACCTACACCCAAATCCCTGCCCCGGCGGGAGGTGTGTGCAACAGCAGCCAAACAGATACCC
AGGCCAGCCGGACCACCCCCGGCGGATAGGGTCACCCCCAGAGCGGGGGGGTCCAGATGGGGCCACCCCCAGG
GCGGGGGAGCCAGCTGGGGTCACCCCCAGGGGCGGGGGCTCCAACTGGGGTCATCCGCAGGGCGGGGGGGCCA
GCTGGGGTCACCCCCAGGGCGGGGGCTATAGCAAGTACAAGCCGGACAAGCCCAAGACCGGCATGAAGCACGT
GGCCGGGGCGGCGGCGGCCGGGGCGGTGGTGGGGGGCCTGGGGGGCTACATGATCGGCAGCGCCATGAGCCGG
CCCCCCATGCACTTCGGCAACGAGTTCGAGGACCGCTACTATCGGGAGAACCAGAACCGCTATTCCAACCAGG
TTTACTACAGGCCCGTGGACCAGTACGGCAGCCAGGACGGCTTCGTCCGCGACTGCGTCAACATCACCGTCAC
CCAGCACACCGTCACCACCACCGAGGGGAAGAACCTCAACGAGACCGACGTCAAGATCATGACCCGCGTCGTG
GAGCAGATGTGCGGATCCACCACATGGAACCTCCAGTGGTTCGGAGTAAGTTTCAATTTC 
 
>PlatypusPrP 
MWPHWGKSPVHHWIIDICVVHLERRCRGHLHPNPCPGGRCVQQQPNRYPGQPDHPRRIGSPPERGGPDGATPR
AGEPAGVTPRGGGSNWGHPQGGGASWGHPQGGGYSKYKPDKPKTGMKHVAGAAAAGAVVGGLGGYMIGSAMSR
PPMHFGNEFEDRYYRENQNRYSNQVYYRPVDQYGSQDGFVRDCVNITVTQHTVTTTEGKNLNETDVKIMTRVV
EQMCGSTTWNLQWFGVSFNF 
 
>PlatypusDpl 
ATGATGACGGTGAGGAGGAGGAGGAGGAGCGGAGGAGCCCGGTGGCTCCTGGTCTTCCTGGTCCTGCTGAGCG
GCGACCTGTCCTCCCTCCAGGCTCGGGGGCCGAGGCCGAGGAACAAGGCCGGCCGGAAACCCCCCCCGTCCAA
CGCCGGGCCCGACTCTCCGGCCCCCCGGCCCCCGGCGGGAGCCCGGGGGACTTTCATCCGGCGAGGCGGGAGG
CTTTCCGTCGATTTCGGGCCCGAGGGCAACGGCTACTACCAGGCCAACTACCCGCTCTTGCCCGACGCCATCG
TCTACCCGGACTGCCCGACGGCCAACGGGACCAGAGAGGCCTTCTTCGGGGACTGCGTCAACGCCACCCACGA
GGCCAACCGGGGCGAGCTGACGGCCGGCGGGAACGCCAGCGACGTCCACGTCCGGGTGCTCCTCAGGCTGGTC
GAAGAACTCTGCGCCCTCCGGGACTGCGGCCCGGCGCTCCCGACGGGGCCGGCGCCGCGGCCCGGACCGCCGG
GCCCGCCCGCCGCGCTCGCCCTGCTGACCCTCGTCCTCCTCGGGGCCCAGTGA 
 
 
>PlatypusDpl 
MMTVRRRRRSGGARWLLVFLVLLSGDLSSLQARGPRPRNKAGRKPPPSNAGPDSPAPRPPAGARGTFIRRGGR
LSVDFGPEGNGYYQANYPLLPDAIVYPDCPTANGTREAFFGDCVNATHEANRGELTAGGNASDVHVRVLLRLV
EELCALRDCGPALPTGPAPRPGPPGPPAALALLTLVLLGAQ 
 
Appendix 5: Human PRNP EST sequences (GenBank gi) used for the analysis 
45857930, 34889317, 15490243,13980625, 13994109, 15494325, 13976124, 
15495677, 19370296, 34479361, 15440431, 13967872, 15492735, 15440704, 
5433432, 15490584, 15580878, 13976743, 15493048, 15434125, 15583207, 
15438103, 15440700, 15490764, 15496140, 13976202, 66264383, 15583400, 
11002886, 15494802, 22705803, 47372420, 21857720, 46921643, 46925984, 
51481408, 10202561, 14001854,45749230, 22285044, 22271655, 22659989, 
31446754, 45751517, 22697249, 45703565, 21855704, 15433349, 18520023, 
20405989 
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Appendix 6: The rate of evolution (r) at each of the amino acid site in PrP and Dpl. The 
different region of the protein sequence is shown on top of the graph. (SS- signal sequence, 
HP- Hydrophobic region). 
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Appendix 7: Known information about some of the TFs of interest 
Transcription factor Important function Information 
CDXA1: caudal type 
homeobox 
transcription factor 1 
Early expression in developing organs derived from the three germ layers, and a late expression 
confined to organs of endodermal origin. Cdx-1 and Cdx-2 homeobox genes belong to the 
regulatory network that controls intestinal development and homeostasis. They participate in the 
definition of positional information along the intestinal A–P axis, they are involved in the regulation of 
the continuous renewal of the digestive epithelium, and they are key actors of the reciprocal 
epithelial–mesenchymal cell interactions. 
 
CIZ: Cas-associated 
zinc finger protein 
Potential role in the regulation of neurodevelopment or neuroplasticity  
DBP: D site albumin 
promoter binding 
protein 
Classification: bZIP 
(proline and acidic 
amino acid-rich basic 
leucine zipper) 
Show high-amplitude circadian expression in the suprachiasmatic nucleus, the master circadian 
pacemaker in mammals. They are expressed at nearly invariable levels in most brain regions, in 
which clock gene expression only cycles with low amplitude. Show higher amplitude circadian cycles 
of expression in liver than in brain. 
 
E4BP4: Protein factor 
encoded by lambda-
P4 which binds to E4 
promoter 
 
Classification: bZIP 
Diverse range of processes including commitment to cell survival versus apoptosis, the anti-
inflammatory response and, most recently, in the mammalian circadian oscillatory mechanism 
(central circadian clocks reside in several neuronal tissues such as the suprachiasmatic nucleus 
(SCN), pineal gland and retina). E4BP4 appears to act antagonistically with members of the related 
PAR family of transcription factors with which it shares DNA-binding specificity.  
Interaction: 
Competitive 
binding site with 
PAR 
 
Transcriptional 
activity: 
Repression 
ETS: E26 
transformation-
specific 
Ets-1 is transcriptionally up-regulated by H2O2 via an antioxidant response element in tumor cell 
lines. Results suggest that Ets-1 might play an important role in carcinogenesis and/or the 
progression of human prostatic carcinomas. Ets-1 expression increases the transformed phenotype 
of HeLa cells, by promoting cell migration, invasion and anchorage-independent growth, while Ets-1 
downregulation reduces cell attachment. Ets-1 regulated angiogenesis through the induction of 
angiogenic growth factors 
 
FAC1: fetal 
Alzheimer antigen / 
fetal Alz-50 reactive 
clone 1 
Classification: Zinc 
Gene identified in brain homogenates from patients with Alzheimer's disease. High levels of FAC1 
were detected in fetal brain and in patients with neurodegenerative diseases. 
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finger domain 
GATA1: Globin 
binding protein 1 
Classification: 
Diverse Cys4 zinc 
fingers 
 
The protein plays an important role in erythroid development by regulating the switch of fetal 
hemoglobin to adult hemoglobin. Mutations in this gene have been associated with X-linked 
dyserythropoietic anemia and thrombocytopenia. Results are consistent with GATA1 regulating 
some but not all pathways of platelet activation. A multiprotein complex containing GATA-1, Oct-1, 
and other protein factors may contribute to the formation of a repressive chromatin structure that 
silences gamma-globin gene expression. GATA-1 has a role in erythropoiesis and 
megakaryocytopoiesis. GATA1 is likely to play a critical role in the etiology of myeloproliferative 
disorder and Down syndrome acute megakaryoblastic leukemia, and mutagenesis of GATA1 
represents a very early event in DS myeloid leukemogenesis. Roles of hematopoietic transcription 
factors GATA-1 and GATA-2 in the development of red blood cell lineage. 
Interaction: 
OCT1, Sp1 
 
 
GEN_INI2: General 
Initiator2 
 
  
HMGIY: High mobility 
group AT-hook 1 
Encoded protein preferentially binds to the minor groove of A+T-rich regions in double-stranded 
DNA. Might regulate lymphoid differentiation. Loss of Hmga1 expression, induced in mice by 
disrupting the Hmga1 gene, largely impaired insulin signaling and severely reduced insulin 
secretion, causing a phenotype characteristic of human type 2 diabetes. HMGA1 functions as a 
transcriptional enhancer co-activator in B cells through indirect association with DNA. HMGA1 as 
one of the first mediators in the development of human atherosclerotic plaques. Regulated dynamic 
properties of HMGA1a fusion proteins indicate that HMGA1 proteins are mechanistically involved in 
local and global changes in chromatin structure. HMGI-Y physically interacts with Sp1 and C/EBP 
beta and facilitates the binding of both factors to the insulin receptor promoter. 
 
HOXA4 Homeo box 
A4 
Classification: 
Homeo domain 
Expression of these proteins is spatially and temporally regulated during embryonic development. 
Involved in developmental and organogenesis. 
 
LEF1: lymphoid 
enhancer-binding 
factor 1 
Expressed in pre-B and T cells. LEF-1 is abundantly expressed in human tumors.  
MAF: v-maf 
musculoaponeurotic 
fibrosarcoma 
oncogene homolog 
(avian) 
High levels of c-maf mRNA is associated with multiple myeloma  
MAZ: MYC-
associated zinc finger 
protein 
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MEF2: myocyte 
enhancer factor 2 
 
Classification: 
MADS box (MCM1, 
AGAMOUS, 
DEFICIENS and 
SRF) 
Play a key role in the differentiation of muscle tissues and are important in the muscle-specific 
expression of a number of genes. Plays an important role in cardiac muscle development is the 
MEF2 protein family. MEF2 regulated neuronal survival by stimulating MEF2-dependent gene 
transcription. The protein, myocyte enhancer factor 2 (MEF2), turns on and off genes that control 
dendritic remodeling. That MEF2 activation leads to the inhibition of synapse formation, makes 
sense in light of what is known about the nervous system. In memory and learning, as well as 
development, activity leads to a sculpting, or cutting away, of synapses. What may be more 
surprising is the way activity causes MEF2 to switch from repressor to activator. 
 
MYB: v-myb 
myeloblastosis viral 
oncogene homolog 
 
Classification: 
Tryptophan clusters 
The c-myb proto-oncogene product (c-Myb) regulates both the proliferation and apoptosis of 
hematopoietic cells by inducing the transcription of a group of target genes. c-Myb activity is 
regulated during the cell cycle in hematopoietic cells. Involvement of c-myb in the regulation of 
intestinal nutrient absorption. Activation of c-MYC and c-MYB proto-oncogenes is associated with 
decreased apoptosis in tumor colon progression. c-Myb activity is regulated during the cell cycle in 
hematopoietic cells. It is generally believed that Myb proteins, including MybA and MybB, two 
additional vertebrate Myb proteins that are related to c-myb, play roles in the cell division cycle. c-
myb and MybB have been implicated in the G1/S transition, whereas MybA is more likely to be 
involved in cellular differentiaton. 
Interaction: 
GATA1 
Transcriptional 
activity: 
NF1: Nuclear factor 1 
Classification: Basic 
domain 
  
OCT1 Octamer-
binding transcription 
factor 1 
 
Classification: POU 
domain factors 
Oct-1 modulates the activity of genes important for the cellular response to stress. Oct-1 is widely 
expressed in adult tissues and is the only known POU family member not expressed in a specific 
temporal or spatial pattern. The Oct-1 transcription factor regulates a variety of tissue-specific and 
general housekeeping genes by recruiting specialized coactivators of transcription. 
 
PAX2: Paired box 
Gene2  
Classification: 
Paired box domain 
PAX2 is believed to be a target of transcriptional suppression by the tumor supressor gene WT1. 
Mutations within PAX2 have been shown to result in optic nerve colobomas and renal hypoplasia. 
Over expression of Pax2 is associated with apoptosis resistance and angiogenesis favoring renal 
tumor growth. Pax2 protein regulates expression of secreted frizzled related protein 2. The PAX2 
gene was frequently expressed in a panel of 406 common primary tumor tissues and endogenous 
PAX gene expression is often required for the growth and survival of cancer cells. PAX2 has a role 
in urogenital tract development and disease 
 
PBX1: pre B-cell 
leukemia transcription 
factor 1 
Data suggest that Pbx1 acts together with multiple Hox proteins in the development of the caudal 
pharyngeal region, but that some functions of Hox proteins in this region are Pbx1-independent. 
Early requirement for Pbx1 in urogenital development. is an essential regulator of mesenchymal 
function during renal morphogenesis. Development of pancreas. 
 
Interaction:  
Hox proteins 
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Spz1: spermatogenic 
Zip 1 
Highly expressed in adult testis; may play an important role in spermatogenesis and fertility in males 
in the humans. Spz1 has a regulatory role during spermatogenesis. 
Interaction: 
PP1cgamma2 
STAT1: Signal 
transducer and 
activator of 
transcription 1 
This protein mediates the expression of a variety of genes, which is thought to be important for cell 
viability in response to different cell stimuli and pathogens. These results imply that STAT-1 plays a 
crucial role in the DNA-damage-response by regulating the expression of 53BP1 and MDC1, factors 
known to be important for mediating ATM-dependent checkpoint pathways. STAT1 plays an 
important role in the regulation of erythropoiesis. Cells lacking STAT-1 show reduced apoptosis in 
response to heat or ischaemia. Expression of STAT-1 in these cells does not enhance cell death but 
restores sensitivity to stress-induced death. 
 
STAT4: signal 
transducer and 
activator of 
transcription 4 
Expression of Stat4 in connective tissue-type mast cellss plays an important role on Th1 immune 
responses. STAT4 is required for the generation of an effective innate host defense against bacterial 
pathogens of the lung. Play a role in Immunity and defense. STAT4 appears to be a critical 
transcription factor in defence against mycobacterial infection 
Interaction: Ap-1 
STAT6: signal 
transducer and 
activator of 
transcription 6 
 
STAT6 plays a protective role against hemodynamic stress in hearts. Role of STAT6 in late phase of 
allergic responses of mast cells 
 
 
YY1 
 
Classification: 
Kruppel class of zinc 
finger proteins 
The protein is involved in repressing and activating a diverse number of promoters. Contributes to 
vascular smooth muscle proliferation and differentiation in normal pulmonary artery development. 
YY1 may play a role in prostate cancer development. YY1 is involved in a positive feedback loop 
during apoptosis. 
 
 
Interaction:  
Ap2 
Sp1 
GATA4 
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Appendix 8: Primer map for mouse promoter and ORF. Bases highlighted in green 
correspond to UTR and bases in bold and underlined correspond to ORF. 
     lprDpl 
CTTGCCCTCTTTTTGAGCTGAACCTCCCCACAGAGGCTGTCAGCAAAGACTGCTTTGCTGTCCAAGGCCGGCC
TTTAGGTACAGGACACTATGCATGTCCAGCGAGGCTTGTTGAAGCCACATCTGTCATAGATATTGATGGGAAA
AGCATTTTCCTTCTAACACATCTCATTCCAATTCTAAAAGGCACCTCTGAAGCCTTGCTGAACTTCATCAAGA
TTTTCACGTGGTTTCCTTAGTAAAGTGTGATGAGAAGGTCCATCCTTCTCAGGATGAAGGAGTGGTCCAGGAA
GCCCTGATTGGTCTGCCGGGGAGGGAAGGGCTGCCTTATTTGGAGACCTGCAGGAATGCCACCTCCCCCGGCA 
                                   Exon1 
GCTCCTATATAGCTGGGCGGACCTGGCTGCCAAGAGGGTGTGCTGGGGGACTGTGCAGCTCGAGGCTCCAGAG 
       rprDpl         Intron1 
GCACACTCCAGAGAGAGCCAAGGTACGTGGGGG 
 
--------------------intronic region removed for brevity -----------------
---- 
  lorfDpl                     lorfseqDpl 
TAGCAAAGGAGCTCGGTGTTTGAGTTAACCCTGCACAACCCAAACATGGGGAAACAATTATGCTTTTGAGACC
ACATAAATAGCACAAGGATGCGATTCCTTCCTTAAAATCTCCTGCACTTGGGAGGGGGCAGGGGAGCCCAGGC 
                                         Exon2      ORF 
AGGCCTGGTGGGGAGCTGACCCACCGCCGTTTCTCTGGCAGGTTCTGACGCGATGAGGAAGCACCTGAGCTGG
TGGTGGCTGGCCACTGTCTGCATGCTGCTCTTCAGCCACCTCTCTGCGGTCCAGACGAGGGGCATCAAGCACA
GAATCAAGTGGAACCGGAAGGCCCTGCCCAGCACTGCCCAGATCACTGAGGCCCAGGTGGCTGAGAACCGCCC
GGGAGCCTTCATCAAGCAAGGCCGCAAGCTCGACATTGACTTCGGAGCCGAGGGCAACAGGTACTACGAGGCC
AACTACTGGCAGTTCCCCGATGGCATCCACTACAACGGCTGCTCTGAGGCTAATGTGACCAAGGAGGCATTTG 
                                      lDplrflp 
TCACCGGCTGCATCAATGCCACCCAGGCGGCGAACCAGGGGGAGTTCCAGAAGCCAGACAACAAGCTCCACCA
GCAGGTGCTCTGGCGGCTGGTCCAGGAGCTCTGCTCCCTCAAGCATTGCGAGTTTTGGTTGGAGAGGGGCGCA
GGACTTCGGGTCACCATGCACCAGCCAGTGCTCCTCTGCCTTCTGGCTTTGATCTGGCTCACGGTGAAATAAG 
               rorfDpl 
CTTGCCAGGAGGCTGGCAGTACAGAGTGCAGCAGCGAGCAAATCCTGGCAAGTGACCCAGCTCTTCTCCCCCA
AACCCACGCGTGTTCTGAAGGTGCCCAGGAGCGGCGATGCACTCGCACTGCAAATGCCGCTCCCACGTATGCG 
  rDplrflp 
CCCTGGTATGTGCCTGCGTTCTGA 
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Appendix 9: Detailed information of SNPs in the promoter and ORF region for human (a) 
infertile and (b) control samples. The sequence identifiers that are color coded show more 
than one SNP. 
Infertile Promoter    ORF    
Majority G/G G/G C/C  C/C C/C C/T G/G 
SNP G/A G/C C/A  C/T C/T C/T G/A 
Position -259 -206 -202  77 210 521 522 
 678      678C/C  
 2362      2362T/T  
 751      751C/C  
 2245      2245T/T  
 835      835C/C  
 2039A/A      2039C/C  
 866A/A      866C/C  
 1643 1643       
 1466      1466C/C  
 1616 1616       
 1467      1467T/T  
 1002      1002T/T  
 1658      1658C/C  
 2016     2016   
 1558      1558C/C  
 1559 1559 1559  1559  1559C/C  
 2070 2070       
 2107      2107T/T  
 1406      1406C/C 1406 
  2184 2184  2184    
  412 412  412  412C/C  
  2064   2064  2064C/C  
  920 920  920  920C/C  
  1827 1827  1827  1827C/C  
  1251     1251T/T  
  1752     1752C/C  
 2331 2184       
 817 648       
 756 1019       
 2080 1102       
 1378        
 2297        
 2329        
 975        
 1270        
 806        
 1183A/A        
 821        
 1647        
 1783        
 1529        
 1138        
 2034        
 1672        
 1806        
 1631A/A        
a 
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Control Promoter     ORF    
Majority G/G G/G C/C G/G  C/C C/C C/T G/G 
SNP G/A G/C C/A G/A  C/T C/T C/T A/G 
Position -259 -206 -202 -171  77 167 521 522 
 fmc53       fmc53T/T  
 cc36       cc36T/T  
 cc46       cc46C/C  
 FMC54A/A       fmc54C/C  
 cc42       cc42C/C  
 cc6       cc6C/C  
 cc28 cc28  cc28    cc28C/C  
 cc55       cc55T/T  
 cc59A/A       cc59T/T  
 fmc47       fmc47T/T  
 fmc1 fmc1      fmc1C/C  
 cc24       cc24T/T  
 fmc8       fmc8T/T  
 cc19 cc19      fmc57C/C  
  fmc57        
  fmc39  fmc39      
  fmc13  fmc13      
  cc30      cc30T/T  
  fmc27 fmc27   fmc27    
  fmc14 fmc14   fmc14    
  fmc60      fmc60T/T  
  fmc10      fmc10C/C  
  fmc18 fmc18   fmc18    
      cc21  cc21C/C  
       cc9 cc9T/T  
        cc12C/C cc12 
 fmc61 fmc9    cc44 fmc42 cc17T/T  
 fmc37 cc8      cc56T/T  
 cc37 cc15      cc33T/T  
 cc16 fmc23      cc29C/C  
 fmc32       cc23C/C  
 fmc56       cc50C/C  
 cc58       cc7T/T  
 fmc15       cc14T/T  
 cc51       fmc24C/C  
 fmc28       fmc17T/T  
 cc39       fmc18C/C  
 fmc48       fmc34T/T  
 fmc49       fmc31C/C  
 fmc41       fmc52T/T  
b 
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Appendix 10 Compiled gel picture of the results obtained from RFLP analysis for C521T 
polymorphism. The sample identifiers and genotype for the known samples are indicated 
(2126 to C37). The samples F11 through to 872 are genotyped using this method.  
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Appendix 11 The population frequency from the SNPs found in dbSNP. Minor allele for control is used as reference. Con: Control, Inf: infertile, 
AA: African American, Euro: Europeans, Chi: Chinese, Jap: Japanese, You: Youroba, Cau: Caucasian, sCJD: sporadic Creutzfeldt Jakob 
disease, eAD: early-onset Alzheimer’s disease, lAD: late-onset Alzheimer’s disease, Neu: Neurological disease. [1] Croes et al. (2004) [2] 
Golanska et al. (2004) [3] Jeong et al. (2005) [4] Peoc'h et al. (2000) [5] Mead et al. (2000) [6] Schroder et al. (2001) [7] Infante et al. (2002). 
 
Ethnicity   AA Euro Chi Jap You Cau Dut Dut Pol Pol Kor Kor Fre Fre Bri Bri Bri Ger Ger Spa Spa
n 96 96       250 52 33 43 102 110 106 95 175 76 41 111 58 283 288
Source     HAPMAP   [1]  [2]  [3]  [4]  [5]   [6]  [7]  
 Con Inf       Con sCJD eAD lAD Con sCJD Con sCJD Con sCJD vCJD Con Neu Con AD 
 A A A  A A  A                
G-259A 0.16 0.23 0.07  0.24 0.44  0.23                
 C C  C C C C                 
G-206C 0.09 0.07  0.092 0 0 0.22                 
 T T       T T   T T T T T T T     
C77T 0.02 0.03       0 0.02   0.01 0 0.02 0.04 0 0 0     
 T T T      T T     T T        
C167T 0.011 0.00 0.013      0 0.02     0.01 0.02        
 T T T                     
C210T 0.00 0.005 0.013                     
 T T T T T T T T T T T T T T T T T T T T T T T 
C521T 0.49 0.41 0.541 0.533 0.25 0.32 0.658 0.58 0.43 0.51 0.63 0.63 0.29 0.23 0.49 0.46 0.48 0.45 0.44 0.37 0.46 0.51 0.51
   T T T                   
   0.587 0.458 0.208                   
   T                     
   0.67                     
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